| Year |
Citation |
Score |
| 2022 |
Kim Y, Lee H, Oh H, Haider Z, Choi J, Shin YU, Kim HI, Lee J. Revisiting the Oxidizing Capacity of the Periodate-HO Mixture: Identification of the Primary Oxidants and Their Formation Mechanisms. Environmental Science & Technology. PMID 35442651 DOI: 10.1021/acs.est.1c08502 |
0.485 |
|
| 2021 |
Joo H, Moon JY, An TJ, Choi H, Park SY, Yoo H, Kim CY, Jeong I, Kim JH, Koo HK, Rhee CK, Lee SW, Kim SK, Min KH, Kim YH, ... ... Kim HJ, et al. Revised Korean Cough Guidelines, 2020: Recommendations and Summary statements. Tuberculosis and Respiratory Diseases. PMID 33979988 DOI: 10.4046/trd.2021.0038 |
0.46 |
|
| 2020 |
Lee H, Seok Lee J, Moor KJ, Kim HI, Kim SR, Gim G, Lee J, Kim HH, Fahmy TM, Kim JH, Lee C. Hand-ground fullerene-nanodiamond composite for photosensitized water treatment and photodynamic cancer therapy. Journal of Colloid and Interface Science. 587: 101-109. PMID 33360882 DOI: 10.1016/j.jcis.2020.12.020 |
0.562 |
|
| 2018 |
Sahu SP, Cates SL, Kim HI, Kim JH, Cates EL. The Myth of Visible Light Photocatalysis Using Lanthanide Upconversion Materials. Environmental Science & Technology. PMID 29405068 DOI: 10.1021/Acs.Est.7B05941 |
0.612 |
|
| 2017 |
Yun ET, Yoo HY, Bae H, Kim HI, Lee J. Exploring the Role of Persulfate in the Activation Process: Radical Precursor Versus Electron Acceptor. Environmental Science & Technology. PMID 28753284 DOI: 10.1021/Acs.Est.7B02519 |
0.497 |
|
| 2016 |
Kim G, Choi HJ, Kim HI, Kim J, Monllor-Satoca D, Kim M, Park H. Temperature-boosted photocatalytic H2 production and charge transfer kinetics on TiO2 under UV and visible light. Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society For Photobiology. 15: 1247-1253. PMID 27714276 DOI: 10.1039/C6Pp00263C |
0.339 |
|
| 2016 |
Kim HI, Weon S, Kang H, Hagstrom AL, Kwon OS, Lee YS, Choi W, Kim JH. Plasmon-Enhanced Sub-Bandgap Photocatalysis via Triplet-Triplet Annihilation Upconversion for Volatile Organic Compound Degradation. Environmental Science & Technology. PMID 27684445 DOI: 10.1021/Acs.Est.6B02729 |
0.364 |
|
| 2016 |
Lee H, Kim HI, Weon S, Choi W, Hwang YS, Seo J, Lee C, Kim JH. Activation of Persulfates by Graphitized Nanodiamonds for Removal of Organic Compounds. Environmental Science & Technology. PMID 27589608 DOI: 10.1021/Acs.Est.6B02079 |
0.347 |
|
| 2016 |
Kwon OS, Song HS, Conde J, Kim HI, Artzi N, Kim JH. Dual-Color Emissive Upconversion Nanocapsules for Differential Cancer Bioimaging in vivo. Acs Nano. PMID 26727423 DOI: 10.1021/acsnano.5b07075 |
0.356 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2016 |
Yang K, Choi YY, Zhang WH, Chen XZ, Song MK, Lee J, Zhang B, Chen ZX, Kim HI, Chen JP, Cheong JH, Zhou ZG, Hyung WJ, Hu JK, Noh SH. Strategies to improve treatment outcome in gastric cancer: A retrospective analysis of patients from two high-volume hospitals in Korea and China. Oncotarget. PMID 27191995 DOI: 10.18632/oncotarget.9378 |
0.247 |
|
| 2020 |
Kim HI, Wilson BC. Photodynamic Diagnosis and Therapy for Peritoneal Carcinomatosis from Gastrointestinal Cancers: Status, Opportunities, and Challenges. Journal of Gastric Cancer. 20: 355-375. PMID 33425438 DOI: 10.5230/jgc.2020.20.e39 |
0.193 |
|
| 2012 |
Ahn J, Yang D, Jung S, Lee SR, Kim Y, Kim H, Lee J. Relapse Pattern After Bortezomib Based Salvage Therapy in Patients with Multiple Myeloma Blood. 120: 1869-1869. DOI: 10.1182/blood.v120.21.1869.1869 |
0.172 |
|
| 2015 |
Ahn JS, Kim JY, Kim HJ, Kim YK, Lee SS, Jung SH, Yang DH, Lee JJ, Kim NY, Choi SH, Minden MD, Jung CW, Jang JH, Kim HJ, Moon JH, et al. Normal karyotype acute myeloid leukemia patients with CEBPA double mutation have a favorable prognosis but no survival benefit from allogeneic stem cell transplant. Annals of Hematology. PMID 26537612 DOI: 10.1007/s00277-015-2540-7 |
0.166 |
|
| 2016 |
Jung SH, Choi HJ, Shin MG, Lee SS, Hwang EC, Jung TY, Cho MS, Yang DH, Ahn JS, Kim YK, Kim HJ, Lee JJ. Thalidomide-based induction regimens are as effective as bortezomib-based regimens in elderly patients with multiple myeloma with cereblon expression. Annals of Hematology. PMID 27365142 DOI: 10.1007/s00277-016-2743-6 |
0.165 |
|
| 2009 |
Lee SR, Yang DH, Ahn JS, Kim YK, Lee JJ, Choi YJ, Shin HJ, Chung JS, Cho YY, Chae YS, Kim JG, Sohn SK, Kim HJ. The clinical outcome of FLAG chemotherapy without idarubicin in patients with relapsed or refractory acute myeloid leukemia. Journal of Korean Medical Science. 24: 498-503. PMID 19543516 DOI: 10.3346/jkms.2009.24.3.498 |
0.165 |
|
| 2013 |
Ahn JS, Yang DH, Jung SH, Chae YS, Sohn SK, Yhim HY, Kwak JY, Lee SR, Kim YK, Kim HJ, Lee JJ. Autologous stem cell transplantation with busulfan, cyclophosphamide, and etoposide as an intensifying frontline treatment in patients with peripheral T cell lymphomas: a multicenter retrospective trial. Annals of Hematology. 92: 789-97. PMID 23358616 DOI: 10.1007/s00277-013-1685-5 |
0.164 |
|
| 2005 |
Cho SH, Chung IJ, Song SY, Yang DH, Byun JR, Kim YK, Lee JJ, Na KJ, Kim HJ. Bi-weekly chemotherapy of paclitaxel and cisplatin in patients with metastatic or recurrent esophageal cancer. Journal of Korean Medical Science. 20: 618-23. PMID 16100454 DOI: 10.3346/jkms.2005.20.4.618 |
0.164 |
|
| 2015 |
Ahn JS, Kim YK, Min YH, Cheong JW, Jang JH, Jung CW, Kim IH, Yoon HJ, Lee HG, Sohn SK, Moon JH, Kim H, Kim YJ, Won JH, Chung JS, ... ... Kim HJ, et al. Azacitidine Pre-Treatment Followed by Reduced-Intensity Stem Cell Transplantation in Patients with Higher-Risk Myelodysplastic Syndrome. Acta Haematologica. 134: 40-8. PMID 26066466 DOI: 10.1159/000368711 |
0.163 |
|
| 2016 |
Kim HS, Shin SJ, Beom SH, Jung M, Choi YY, Son T, Kim HI, Cheong JH, Hyung WJ, Noh SH, Chung H, Park JC, Shin SK, Lee SK, Lee YC, ... ... Kim H, et al. Comprehensive expression profiles of gastric cancer molecular subtypes by immunohistochemistry: implications for individualized therapy. Oncotarget. PMID 27331626 DOI: 10.18632/Oncotarget.10115 |
0.163 |
|
| 2016 |
Park H, Lee J, Kim Y, Sohn SK, Yoon S, Kim H, Cheong J, Lee W, Lee G, Joo Y, Kim MK, Kim YS, Kim H. Retrospective Case Series Study of Hypomethylating Therapy in IPSS Lower-Risk Myelodysplastic Syndrome Blood. 128: 1992-1992. DOI: 10.1182/blood.v128.22.1992.1992 |
0.163 |
|
| 2014 |
Chang H, Shin SK, Cho BC, Lee CG, Kim CB, Kim DJ, Lee JG, Hur J, Lee CY, Bae MK, Kim HR, Lee SK, Park JC, Lee H, Kim HI, et al. A prospective phase II trial of S-1 and cisplatin-based chemoradiotherapy for locoregionally advanced esophageal cancer. Cancer Chemotherapy and Pharmacology. 73: 665-71. PMID 24562525 DOI: 10.1007/s00280-013-2371-y |
0.163 |
|
| 2017 |
Song JH, Park E, Kim MS, Cho KM, Park SH, Lee A, Song J, Kim HJ, Koh JT, Kim TS. fl-Asparaginase-mediated downregulation of c-Myc promotes 1,25(OH)2 D3 -induced myeloid differentiation in acute myeloid leukemia cells. International Journal of Cancer. PMID 28224619 DOI: 10.1002/ijc.30662 |
0.16 |
|
| 2020 |
Ahn JS, Kim T, Jung SH, Ahn SY, Jung SY, Song GY, Kim M, Yang DH, Lee JJ, Choi S, Lee JY, Park SK, Moon JH, Lee HY, Kim KH, ... ... Kim HJ, et al. Allogeneic transplant can abrogate the risk of relapse in the patients of first remission acute myeloid leukemia with detectable measurable residual disease by next-generation sequencing. Bone Marrow Transplantation. PMID 33279940 DOI: 10.1038/s41409-020-01165-x |
0.16 |
|
| 2017 |
Son G, Kim DH, Lee JS, Kim HI, Lee C, Kim SR, Lee H. Synchronized methylene blue removal using Fenton-like reaction induced by phosphorous oxoanion and submerged plasma irradiation process. Journal of Environmental Management. 206: 77-84. PMID 29059574 DOI: 10.1016/j.jenvman.2017.10.024 |
0.159 |
|
| 2010 |
Yi JH, Jung CW, Han B, Lee HY, Jang JH, Kim K, Kim HJ, Kim Y, Lee W, Joo Y, Kim MK, Hyun MS, Kim H, Park JH, Kim DH(. Addition of Hemoglobin Level Into the Prognostic Scoring System Together with White Blood Cell and Platelet Count Provides Better Prognostic Stratification for Treatment-Related Mortality and Overall Survival, but Not for Relapse Risk In Adult Patients with Acute Promyelocytic Leukemia Blood. 116: 4371-4371. DOI: 10.1182/blood.v116.21.4371.4371 |
0.159 |
|
| 2006 |
Bang S, Ahn JY, Park J, Park SH, Nam EM, Cho EK, Shin DB, Lee J, Yoo SJ, Jeon IS, Kim Y, Kim HJ, Kim H, Lee I, Kang HJ, et al. Evolution of FLT3 Internal Tandem Duplication at the Diagnosis, Relapse, Remission or Induction Failure during the Treatment in Acute Myeloblastic Leukemia. Blood. 108: 4485-4485. DOI: 10.1182/blood.v108.11.4485.4485 |
0.158 |
|
| 2013 |
Kang BW, Moon JH, Chae YS, Lee SJ, Kim JG, Kim YK, Lee JJ, Yang DH, Kim HJ, Kim JY, Do YR, Park KU, Song HS, Kwon KY, Kim MK, ... ... Kim H, et al. Clinical Outcome of Rituximab-Based Therapy (RCHOP) in Diffuse Large B-Cell Lymphoma Patients with Bone Marrow Involvement. Cancer Research and Treatment : Official Journal of Korean Cancer Association. 45: 112-7. PMID 23864844 DOI: 10.4143/crt.2013.45.2.112 |
0.157 |
|
| 2004 |
Lee J, Lee Y, Kim H, Kim N, Park K, Yang D, Kim Y, Kim H. Clinical Significance of FLT3 Internal Tandem Duplication in Patients with Acute Myeloid Leukemia Who Underwent Allogeneic Bone Marrow Transplantation. Blood. 104: 4419-4419. DOI: 10.1182/blood.v104.11.4419.4419 |
0.156 |
|
| 2009 |
Yang D, Kim WS, Suh C, Kwak J, Jung J, Kim SH, Kim JS, Lee J, Kim H. Phase II Trial of 90y-Ibritumomab Tiuxetan Treatment as Consolidation After 6th R-CHOP Chemotherapy in Patients with Limited-Stage, Bulky Diffuse Large B Cell Lymphoma. Blood. 114: 3751-3751. DOI: 10.1182/BLOOD.V114.22.3751.3751 |
0.155 |
|
| 2022 |
Lee M, Yim H, Kim B, Kim S, Choi W, Kim W, Kim HI. Harnessing Waste Heat from Indoor lamps for Sustainable Thermocatalytic Mineralization of Acetaldehyde using Platinized TiO. Chemosphere. 308: 136350. PMID 36096302 DOI: 10.1016/j.chemosphere.2022.136350 |
0.154 |
|
| 2008 |
Kim Y, Lee J, Sohn S, Shin H, Chung J, Choi Y, Moon J, Chae Y, Kim J, Ahn J, Yang D, Kim H, (KMMWP) tKMMWP. Clinical Efficacy of VEL-CTD (Bortezomib, Cyclophosphamide, Thalidomide, and Dexamethasone) Regimen in Patients with Relapsed or Refractory Multiple Myeloma: A Phase II Study Blood. 112: 3693-3693. DOI: 10.1182/blood.v112.11.3693.3693 |
0.154 |
|
| 2011 |
Lee SJ, Jung CW, Kim DY, Lee KH, Sohn SK, Kwak JY, Kim HJ, Kim IH, Park S, Kim DH. Retrospective multicenter study on the development of peripheral lymphocytosis following second-line dasatinib therapy for chronic myeloid leukemia. American Journal of Hematology. 86: 346-50. PMID 21442637 DOI: 10.1002/ajh.21980 |
0.154 |
|
| 2010 |
Lee HY, Lee SJ, Ha B, Yi JH, Jung CW, Kim D, Lee J, Lee KH, Sohn SK, Kim SH, Lee W, Park JS, Yhim H, Kwak J, Kim HJ, et al. Multicenter Retrospective Study on the Development of Peripheral Lymphocytosis During Second-Line Dasatinib Therapy for Chronic Myeloid Leukemia Blood. 116: 2275-2275. DOI: 10.1182/blood.v116.21.2275.2275 |
0.154 |
|
| 2009 |
Apperley JF, Cortes JE, Kim DW, Roy L, Roboz GJ, Rosti G, Bullorsky EO, Abruzzese E, Hochhaus A, Heim D, de Souza CA, Larson RA, Lipton JH, Khoury HJ, Kim HJ, et al. Dasatinib in the treatment of chronic myeloid leukemia in accelerated phase after imatinib failure: the START a trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 3472-9. PMID 19487385 DOI: 10.1200/JCO.2007.14.3339 |
0.153 |
|
| 2011 |
Ahn J, Yang D, Chae YS, Sohn SK, Kwak J, Yhim H, Lee S, Jung S, Bae S, Kim Y, Kim H, Lee J. Frontline Autologous Stem Cell Transplantation As Intensive Consolidation in Patients with Peripheral T Cell Lymphomas: Multicenter Phase II Trial in Korea Blood. 118: 4477-4477. DOI: 10.1182/blood.v118.21.4477.4477 |
0.151 |
|
| 2014 |
Lim S, Lee K, Kim D, Lee J, Lee J, Chi H, Joo Y, Lee WS, Lee SM, Park S, Kim I, Sohn SK, Moon JH, Ryoo H, Bae SH, ... ... Kim H, ... ... Kim HY, ... ... Kim HJ, et al. Long-Term Follow-up of Continuous Imatinib Plus Combination Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Blood. 124: 3654-3654. DOI: 10.1182/blood.v124.21.3654.3654 |
0.151 |
|
| 2017 |
Kim DJ, Lee HS, Moon JH, Sohn SK, Kim HJ, Cheong JW, Jo DY, Kim H, Lee H, Bang SM, Lee WS, Park Y, Lee MH, Lee JH, Bae SH, et al. Can we consider discontinuation of hypomethylating agents in patients with myelodysplastic syndrome : a retrospective study from The Korean Society of Hematology AML/MDS working party. Oncotarget. PMID 28624804 DOI: 10.18632/oncotarget.18258 |
0.15 |
|
| 2008 |
Hwang J, Cho SH, Shim HJ, Lee SR, Ahn JS, Yang DH, Kim YK, Lee JJ, Kim HJ, Chung IJ. Phase II study of paclitaxel, cisplatin, and 5-fluorouracil combination chemotherapy in patients with advanced gastric cancer. Journal of Korean Medical Science. 23: 586-91. PMID 18756042 DOI: 10.3346/jkms.2008.23.4.586 |
0.149 |
|
| 2014 |
OH Y, Choi SY, Lee S, Kim S, Kim H, Kim Y, Park JS, Jeong SH, Kim S, Zang DY, Oh S, Koo DH, Kim H, Do YR, Kwak J, et al. Results from the Korean Imatinib Discontinuation Study (KIDS): Updated Data with 15-Month Median Follow up Blood. 124: 3155-3155. DOI: 10.1182/blood.v124.21.3155.3155 |
0.149 |
|
| 2021 |
Eom BW, Koo DH, An JY, Lee HH, Kim HI, Hur H, Yoo MW, Ryu MH, Lee HJ, Kim SM, Park JH, Min JS, Seo KW, Jeong SH, Jeong O, et al. Prospective multicentre randomised clinical trial comparing survival rates, quality of life and nutritional status between advanced gastric cancer patients with different follow-up intensities: study protocol for the STOFOLUP trial. Bmj Open. 11: e056187. PMID 34880028 DOI: 10.1136/bmjopen-2021-056187 |
0.149 |
|
| 2011 |
Goh H, Choi S, Bang J, Kim S, Jang E, Kim D, Byeun J, Park JS, Kim H, Kim H, Kim D. Discontinuation of Imatinib Therapy in Chronic Myeloid Leukemia Patients with Sustained Complete Molecular Response4.5 (CMR4.5) Blood. 118: 2763-2763. DOI: 10.1182/blood.v118.21.2763.2763 |
0.148 |
|
| 2007 |
Kim Y, Kim H, Lee I, Bang S, Jo D, Won J, Yim C, Yang D, Lee J, Kim H. Prognostic Significance of FLT3/ITD Mutation in AML1/ETO-Associated Acute Myeloid Leukemia. Blood. 110: 3493-3493. DOI: 10.1182/blood.v110.11.3493.3493 |
0.148 |
|
| 2011 |
Woo Y, Hyung WJ, Obama K, Kim HI, Pak KH, Son T, Noh SH. Elevated high-sensitivity C-reactive protein, a marker of advanced stage gastric cancer and postgastrectomy disease recurrence. Journal of Surgical Oncology. 105: 405-9. PMID 22025360 DOI: 10.1002/jso.22129 |
0.148 |
|
| 2012 |
Lee Y, Kim I, Yoon S, Park S, Cheong J, Min Y, Bang S, Kim CS, Park Y, Mun YC, Park J, Lee JH, Lee HG, Kim Y, Kim H. Head-to-Head Comparison of 5-Azacitidine Versus Decitabine for the Treatment of Myelodysplastic Syndrome. Blood. 120: 2843-2843. DOI: 10.1182/blood.v120.21.2843.2843 |
0.148 |
|
| 2016 |
Lee JY, Kim HI, Kim YN, Hong JH, Alshomimi S, An JY, Cheong JH, Hyung WJ, Noh SH, Kim CB. Clinical Significance of the Prognostic Nutritional Index for Predicting Short- and Long-Term Surgical Outcomes After Gastrectomy: A Retrospective Analysis of 7781 Gastric Cancer Patients. Medicine. 95: e3539. PMID 27149460 DOI: 10.1097/MD.0000000000003539 |
0.148 |
|
| 2013 |
Oh Yj, Choi SY, Lee S, Kim S, Kim H, Kim Y, Park JS, Jeong SH, Kim S, Zang DY, Oh S, Koo DH, Kim H, Do YR, Kwak J, et al. Results From The Korean Imatinib Discontinuation Study (KIDS): Updated Data With 14-Month Median Follow Up Blood. 122: 4003-4003. DOI: 10.1182/blood.v122.21.4003.4003 |
0.148 |
|
| 2017 |
Jung SH, Lee HJ, Lee YK, Yang DH, Kim HJ, Rhee JH, Emmrich F, Lee JJ. A phase I clinical study of autologous dendritic cell therapy in patients with relapsed or refractory multiple myeloma. Oncotarget. PMID 28088784 DOI: 10.18632/oncotarget.14582 |
0.148 |
|
| 2005 |
Shin H, Chung JS, Choi YJ, Lee J, Sohn SK, Cho GJ, Kim H, Yang D, Back JH. Comparison of the Peripheral Blood Stem Cell Mobilization and Harvest after Each Consolidation Chemotherapy in Patients with Acute Myeloid Leukemia in First Complete Remission Who Underwent Autologous Stem Cell Transplantation. Blood. 106: 5495-5495. DOI: 10.1182/blood.v106.11.5495.5495 |
0.147 |
|
| 2013 |
Kim YJ, Jang JH, Kwak JY, Lee JH, Kim HJ. Use of azacitidine for myelodysplastic syndromes: controversial issues and practical recommendations. Blood Research. 48: 87-98. PMID 23826577 DOI: 10.5045/br.2013.48.2.87 |
0.147 |
|
| 2018 |
Kim T, Moon JH, Ahn JS, Kim YK, Lee SS, Ahn SY, Jung SH, Yang DH, Lee JJ, Choi SH, Lee JY, Tyndel MS, Shin MG, Lee YJ, Sohn SK, ... ... Kim HJ, et al. Next-generation sequencing based post-transplant monitoring of acute myeloid leukemia. Blood. PMID 30108064 DOI: 10.1182/Blood-2018-04-848028 |
0.147 |
|
| 2016 |
Lee SS, Jung SH, Ahn JS, Kim YK, Cho MS, Jung SY, Lee JJ, Kim HJ, Yang DH. Pralatrexate in Combination with Bortezomib for Relapsed or Refractory Peripheral T Cell Lymphoma in 5 Elderly Patients. Journal of Korean Medical Science. 31: 1160-3. PMID 27366017 DOI: 10.3346/jkms.2016.31.7.1160 |
0.146 |
|
| 2015 |
Hoang MD, Jung SH, Lee HJ, Lee YK, Nguyen-Pham TN, Choi NR, Vo MC, Lee SS, Ahn JS, Yang DH, Kim YK, Kim HJ, Lee JJ. Dendritic Cell-Based Cancer Immunotherapy against Multiple Myeloma: From Bench to Clinic. Chonnam Medical Journal. 51: 1-7. PMID 25914874 DOI: 10.4068/cmj.2015.51.1.1 |
0.146 |
|
| 2017 |
Cho I, Kwon IG, Guner A, Son T, Kim HI, Kang DR, Noh SH, Lim JS, Hyung WJ. Consideration of clinicopathologic features improves patient stratification for multimodal treatment of gastric cancer. Oncotarget. 8: 79594-79603. PMID 29108339 DOI: 10.18632/oncotarget.18607 |
0.146 |
|
| 2019 |
Moon JH, Cho HJ, Baek DW, Sohn SK, Ahn J, Ahn S, Choi S, Kim KH, Kim T, Zhang Z, Kim H, Kim DDH. High Residual Allelic Burden Increases Leukemic Transformation Irrespective of Clinical Response in Patients with Lower Risk Myelodysplastic Syndrome Treated with Azacitidine Blood. 134: 4263-4263. DOI: 10.1182/Blood-2019-130428 |
0.145 |
|
| 2015 |
Song JH, Cho KM, Kim HJ, Kim YK, Kim NY, Kim HJ, Lee TH, Hwang SY, Kim TS. Concentrative nucleoside transporter 3 as a prognostic indicator for favorable outcome of t(8;21)-positive acute myeloid leukemia patients after cytarabine-based chemotherapy. Oncology Reports. 34: 488-94. PMID 25955569 DOI: 10.3892/or.2015.3959 |
0.145 |
|
| 2005 |
Yang D, Lee J, Kim Y, Baek J, Sohn S, Jin C, Shin H, Kim HJ. Modified Thalidomide, Cyclophosphamide and Dexamethasone (TCD) to Patients with Multiple Myeloma as Primary Therapy Prior to Peripheral Blood Stem Cell Collection. Blood. 106: 5173-5173. DOI: 10.1182/blood.v106.11.5173.5173 |
0.145 |
|
| 2022 |
Song JH, Lee S, Park SH, Kottikias A, Abdulmohsen A, Alrashidi N, Cho M, Kim YM, Kim HI, Hyung WJ. Applicability of endoscopic submucosal dissection for patients with early gastric cancer beyond the expanded indication for endoscopic submucosal dissection. Surgical Endoscopy. PMID 35546209 DOI: 10.1007/s00464-022-09288-6 |
0.144 |
|
| 2008 |
Yang D, Ahn JS, Kim Y, Lee J, Choi YJ, Shin HJ, Chung J, Moon JH, Chae YS, Kim JG, Sohn SK, Kim H. Comparing Standard IPI with Revised-IPI in Patients with Diffuse Large B-Cell Lymphoma: Which Has a More Differential Potential for Predicting the Outcomes after R-CHOP Chemotherapy. Blood. 112: 2003-2003. DOI: 10.1182/blood.v112.11.2003.2003 |
0.144 |
|
| 2008 |
Shin HJ, Chung JS, Lee JJ, Sohn SK, Choi YJ, Kim YK, Yang DH, Kim HJ, Kim JG, Joo YD, Lee WS, Sohn CH, Lee EY, Cho GJ. Treatment outcomes with CHOP chemotherapy in adult patients with hemophagocytic lymphohistiocytosis. Journal of Korean Medical Science. 23: 439-44. PMID 18583880 DOI: 10.3346/jkms.2008.23.3.439 |
0.143 |
|
| 2019 |
Shin HJ, Min WS, Min YH, Cheong JW, Lee JH, Kim IH, Hong DS, Ahn JS, Kim HJ, Lee WS, Jung CW, Jang JH, Park Y, Kim HJ. Different prognostic effects of core-binding factor positive AML with Korean AML registry data. Annals of Hematology. PMID 30758645 DOI: 10.1007/s00277-019-03624-y |
0.143 |
|
| 2015 |
Lim SN, Joo YD, Lee KH, Kim DY, Lee JH, Lee JH, Chi HS, Yun SC, Lee WS, Lee SM, Park S, Kim I, Sohn SK, Moon JH, Ryoo HM, ... ... Kim HJ, ... ... Kim H, et al. Long-term follow-up of imatinib plus combination chemotherapy in for patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. American Journal of Hematology. PMID 26228525 DOI: 10.1002/ajh.24137 |
0.143 |
|
| 2014 |
Jang HI, Cho JH, Baek HJ, Han DK, Kim HJ, Lee IK, Moon JD, Kook H. Epidemiology, Risk Assessment of Environmental Carcinogens and Polymorphism in Childhood Leukemia and Solid Tumors: A Study from Gwangju-Chonnam Area, Korea Blood. 124: 1325-1325. DOI: 10.1182/BLOOD.V124.21.1325.1325 |
0.143 |
|
| 2012 |
Kim Y, Hwang LJ, Kim I, Ho JJ, Kim HJ, Kim SJ, Hong MY. Multicenter Study Evaluating the Impact of Hypomethylating Agents As Bridging Therapy to Hematopoietic Stem Cell Transplantation in Myelodysplastic Syndromes Blood. 120: 3806-3806. DOI: 10.1182/blood.v120.21.3806.3806 |
0.143 |
|
| 2013 |
Lee YG, Kim I, Yoon SS, Park S, Cheong JW, Min YH, Lee JO, Bang SM, Yi HG, Kim CS, Park Y, Kim BS, Mun YC, Seong CM, Park J, ... ... Kim HJ, et al. Comparative analysis between azacitidine and decitabine for the treatment of myelodysplastic syndromes. British Journal of Haematology. 161: 339-47. PMID 23432512 DOI: 10.1111/bjh.12256 |
0.143 |
|
| 2015 |
Jang JH, Kim JS, Jo D, Lee J, Choi CW, Kim HJ, Won J, Chung JS, Kim H, Lee J, Sohn SK, Kim JA, Lee JW. Comparable Outcomes with Eculizumab in Paroxysmal Nocturnal Hemoglobinuria Patients with or without Aplastic Anemia in a Prospective Korean PNH Registry Blood. 126: 4789-4789. DOI: 10.1182/blood.v126.23.4789.4789 |
0.142 |
|
| 2008 |
Kim Y, Kim H, Min W, Won JH, Jo D, Park M, Kim H, Lee I, Ahn J, Yang D, Lee J, Kim H. Prognostic Significance of NQO1 Polymorphism and GST-M1 Deletion in De Novo Acute Myeloid Leukemia Blood. 112: 4846-4846. DOI: 10.1182/blood.V112.11.4846.4846 |
0.142 |
|
| 2019 |
Lee S, Park JS, Kim H, Kim S, Zang DY, Oh S, Do YR, Choi Y, Kwak J, Kim J, Lee KH, Mun Y, Lee WS, Chang MH, Park J, et al. Long-Term Outcomes of Chronic Myeloid Leukemia Patients Who Lost Undetectable Molecular Residual Disease (UMRD) after Imatinib Discontinuation: Korean Imatinib Discontinuation Study (KIDS) Blood. 134: 1643-1643. DOI: 10.1182/blood-2019-126376 |
0.142 |
|
| 2004 |
Kim Y, Lee J, Lee Y, Lee I, Kim H, Kim N, Park K, Yang D, Park M, Kim H. The Presence of FLT3/ITD Mutations Is an Independent Prognostic Factor in Acute Myeloid Leukemia Patients with Normal Karyotype. Blood. 104: 3008-3008. DOI: 10.1182/blood.v104.11.3008.3008 |
0.142 |
|
| 2023 |
Park SH, Kim KY, Cho M, Kim YM, Hyung WJ, Kim HI. Changes in failure to rescue after gastrectomy at a large-volume center with a 16-year experience in Korea. Scientific Reports. 13: 5252. PMID 37002330 DOI: 10.1038/s41598-023-32593-6 |
0.141 |
|
| 2022 |
Choi S, Min JS, Jeong SH, Yoo MW, Son YG, Oh SJ, Kim JH, Park JM, Hur H, Jee YS, Hwang SH, Jin SH, Lee SE, Lee YJ, Seo KW, ... ... Kim HI, et al. Long-Term Survival Outcomes of Elderly Patients Treated With S-1 or Capecitabine Plus Oxaliplatin for Stage II or III Gastric Cancer: A Multicenter Cohort Study. Journal of Gastric Cancer. 22: 67-77. PMID 35425655 DOI: 10.5230/jgc.2022.22.e6 |
0.141 |
|
| 2014 |
Choi N, Jung S, Lee H, Vo M, Hoang M, Kim H, Lee J. The Cancer/Testis Antigens of SSX4, MAGE-A3, and CTAG2 Are Attractive Targets for Cancer Immunotherapy in Korean Patients with Multiple Myeloma Blood. 124: 5757-5757. DOI: 10.1182/blood.v124.21.5757.5757 |
0.141 |
|
| 2005 |
Kim Y, Kim H, Lee J, Yang D, Lee I, Park K, Kim H. Interluekin-10 (IL-10) Promoter Gene Polymorphism (−819*C) Associated with Poor Clinical Outcome in DLBCL Patients Treated with R (Rituximab)-CHOP Regimen as a First Line. Blood. 106: 1923-1923. DOI: 10.1182/blood.v106.11.1923.1923 |
0.141 |
|
| 2010 |
Kim DY, Lee JH, Lee JH, Lee KH, Kim YK, Ahn JS, Kim HJ, Kim I, Yoon SS, Park S, Bae SH, Bang SM, Lee HG, Shin HJ, Lee JH, et al. Comparison of various criteria in predicting treatment response and prognosis of patients with myelodysplastic syndrome treated with azacitidine. Annals of Hematology. 89: 15-23. PMID 19543727 DOI: 10.1007/s00277-009-0771-1 |
0.141 |
|
| 2016 |
Kim T, Moon JH, Lee YJ, Tyndel M, Ahn J, Kim H, Kim Y, Lee S, Ahn S, Jung S, Yang D, Lee J, Park HJ, Choi SH, Jung CW, ... ... Kim H, et al. Longitudinal Tracking of MDS Patients Using Next Generation Sequencing Provides a Predictive Measure for Azacitidine Response and AML Progression Blood. 128: 52-52. DOI: 10.1182/Blood.V128.22.52.52 |
0.141 |
|
| 2015 |
Park JS, Rha SY, Chung HC, Jung M, Kim KH, Jun HJ, Kim H, An JY, Kim HI, Cheong JH, Hyung WJ, Noh SH, Kim HS. Clinicopathological features and prognostic significance of HER2 expression in gastric cancer. Oncology. 88: 147-56. PMID 25402270 DOI: 10.1159/000368555 |
0.14 |
|
| 2006 |
Bang SM, Kim YK, Park YH, Sohn SK, Lee JJ, Cho EK, Ryoo BY, Chung IJ, Yoon SS, Kim HJ, Lee JH, Yoon HJ, Park S. High-dose therapy and autologous stem cell transplantation in Korean patients with aggressive T/NK-cell lymphoma. Leukemia & Lymphoma. 46: 1599-1604. PMID 16334486 DOI: 10.1080/10428190500215191 |
0.14 |
|
| 2011 |
Hong SD, Kim YK, Kim HN, Lee SR, Ahn JS, Yang DH, Lee JJ, Lee IK, Shin MG, Kim HJ. Treatment outcome of all-trans retinoic acid/anthracycline combination chemotherapy and the prognostic impact of FLT3/ITD mutation in acute promyelocytic leukemia patients. The Korean Journal of Hematology. 46: 24-30. PMID 21461300 DOI: 10.5045/kjh.2011.46.1.24 |
0.139 |
|
| 2005 |
Kim Y, Kim H, Lee I, Lee S, Shim H, Park M, Park K, Yang D, Lee J, Kim H. The Feasibility Study for Using FLT3/ITD as a Marker of the Minimal Residual Disease (MRD) in Patients with Acute Myeloid Leukemia (AML) by Serial Analysis in Diagnosis, Remission and Relapse. Blood. 106: 4515-4515. DOI: 10.1182/blood.v106.11.4515.4515 |
0.139 |
|
| 2011 |
Bae SY, Ahn JS, Yang DH, Kim YK, Min JJ, Song HC, Bom HS, Jeong YY, Kim HJ, Lee JJ. A Case of Disseminated and Fulminant Plasmacytomas That Developed during Bortezomib Treatment. Case Reports in Oncology. 4: 101-5. PMID 21475598 DOI: 10.1159/000324920 |
0.139 |
|
| 2018 |
Baek DW, Lee YJ, Kim H, Ahn SY, Ahn JS, Shin HJ, Lee WS, Lee SM, Song IC, Lee HS, Park SW, Choi Y, Cho YY, Bae SH, Kim HJ, et al. Response to hypomethylating agents improves long-term outcomes for lower-risk patients with myelodysplastic syndrome in case-matched cohorts. Annals of Hematology. PMID 30073392 DOI: 10.1007/s00277-018-3458-7 |
0.139 |
|
| 2011 |
Goh H, Jootar S, Kim H, Sohn SK, Park JS, Kim SH, Zang DY, Oh S, Choi S, Bang J, Kim S, Jang E, Lee S, Kim D, Byeun J, ... ... Kim HJ, et al. Efficacy of Nilotinib Versus High-Dose Imatinib in Early Chronic Phase CML Patients Who Have Suboptimal Molecular Responses to Standard-Dose Imatinib (RE-NICE Multicenter Study) Blood. 118: 2765-2765. DOI: 10.1182/blood.v118.21.2765.2765 |
0.138 |
|
| 2018 |
Beom SH, Choi YY, Baek SE, Li SX, Lim JS, Son T, Kim HI, Cheong JH, Hyung WJ, Choi SH, Jung M, Kim HS, Jeung HC, Chung HC, Rha SY, et al. Multidisciplinary treatment for patients with stage IV gastric cancer: the role of conversion surgery following chemotherapy. Bmc Cancer. 18: 1116. PMID 30442107 DOI: 10.1186/s12885-018-4998-x |
0.138 |
|
| 2012 |
Jung SH, Park H, Ahn JS, Yang DH, Kim MY, Kim YK, Kim HJ, Lee JJ. Efficacy of stem cell mobilization in patients with newly diagnosed multiple myeloma after a CTD (cyclophosphamide, thalidomide, and dexamethasone) regimen. International Journal of Hematology. 97: 92-7. PMID 23233155 DOI: 10.1007/s12185-012-1237-0 |
0.138 |
|
| 2012 |
Mittelman M, Assouline S, Briasoulis E, Alonso A, Delgado RG, O'Gorman P, Kim HJ, Yoon S, Zaritskey A, Flynn CM, Min Y, Diez-Campelo M, Myasnikov A, Mannino F, Kamel YM, et al. Eltrombopag Treatment of Thrombocytopenia in Advanced Myelodysplastic Syndromes and Acute Myeloid Leukemia: Results of the 8-Week Open-Label Part of an Ongoing Study Blood. 120: 3822-3822. DOI: 10.1182/Blood.V120.21.3822.3822 |
0.137 |
|
| 2020 |
Lee CM, Yoo MW, Son YG, Oh SJ, Kim JH, Kim HI, Park JM, Hur H, Jee YS, Hwang SH, Jin SH, Lee SE, Park JH, Seo KW, Park S, et al. Long-term Efficacy of S-1 Monotherapy or Capecitabine Plus Oxaliplatin as Adjuvant Chemotherapy for Patients with Stage II or III Gastric Cancer after Curative Gastrectomy: a Propensity Score-Matched Multicenter Cohort Study. Journal of Gastric Cancer. 20: 152-164. PMID 32595999 DOI: 10.5230/jgc.2020.20.e13 |
0.137 |
|
| 2013 |
Park HC, Ahn JS, Yang DH, Jung SH, Oh IJ, Choi S, Lee SS, Kim MY, Kim YK, Kim HJ, Lee JJ. Fatal Interstitial Pneumonitis Rapidly Developed after the First Cycle of CHOP with Etoposide Combination Chemotherapy in a Patient with Lymphoma. Tuberculosis and Respiratory Diseases. 74: 235-9. PMID 23750173 DOI: 10.4046/trd.2013.74.5.235 |
0.137 |
|
| 2022 |
Alrashidi N, Kim KY, Park SH, Lee S, Cho M, Kim YM, Kim HI, Hyung WJ. Fluorescent Lymphography-Guided Lymphadenectomy during Minimally Invasive Completion Total Gastrectomy for Remnant Gastric Cancer Patients. Cancers. 14. PMID 36291822 DOI: 10.3390/cancers14205037 |
0.136 |
|
| 2014 |
Lee JH, Kim JG, Jung HK, Kim JH, Jeong WK, Jeon TJ, Kim JM, Kim YI, Ryu KW, Kong SH, Kim HI, Jung HY, Kim YS, Zang DY, Cho JY, ... ... Kim HJ, et al. Clinical practice guidelines for gastric cancer in Korea: an evidence-based approach. Journal of Gastric Cancer. 14: 87-104. PMID 25061536 DOI: 10.5230/jgc.2014.14.2.87 |
0.136 |
|
| 2016 |
Kim T, Tyndel M, Kim HJ, Ahn J, Choi SH, Park HJ, Kim Y, Yang D, Lee J, Jung S, Kim SY, Min Y, Cheong J, Sohn SK, Moon JH, et al. The Clonal Origins of Leukemic Progression of Myelodysplasia Blood. 128: 4307-4307. DOI: 10.1182/Blood.V128.22.4307.4307 |
0.136 |
|
| 2010 |
Shim HJ, Yun JY, Hwang JE, Bae WK, Cho SH, Lee JH, Kim HN, Shin MH, Kweon SS, Lee JH, Kim HJ, Chung IJ. BRCA1 and XRCC1 polymorphisms associated with survival in advanced gastric cancer treated with taxane and cisplatin. Cancer Science. 101: 1247-54. PMID 20331623 DOI: 10.1111/j.1349-7006.2010.01514.x |
0.135 |
|
| 2016 |
Ahn S, Yhim H, Do YR, Jung S, Ahn J, Kim Y, Min J, Kwak J, Lee J, Kim H, Yang D. Prognostic Value of NCCN-IPI and Interim PET/CT Based on Visual Assessment in the Treatment of Peripheral T Cell Lymphomas Blood. 128: 1822-1822. DOI: 10.1182/blood.V128.22.1822.1822 |
0.135 |
|
| 2009 |
Kim DHD, Kong JH, Park S, Jung CW, Sriharsha L, Xu W, Kamel-Reid S, Kim Y, Kim H, Lipton JH. IFN-γ (interferon-gamma) Genotype Predict Cytogenetic and Molecular Response to Imatinib Therapy in Chronic Myeloid Leukemia. Blood. 114: 2178-2178. DOI: 10.1182/Blood.V114.22.2178.2178 |
0.135 |
|
| 2009 |
Kim DH, Kamel-Reid S, Chang H, Sutherland R, Jung CW, Kim HJ, Lee JJ, Lipton JH. Natural killer or natural killer/T cell lineage large granular lymphocytosis associated with dasatinib therapy for Philadelphia chromosome positive leukemia. Haematologica. 94: 135-9. PMID 19066329 DOI: 10.3324/Haematol.13151 |
0.134 |
|
| 2016 |
Zang DY, Lee S, Choi SY, Kim S, Park S, Park JS, Kim H, Kim S, Oh SJ, Kim H, Do YR, Kwak J, Kim J, Mun Y, Lee W, et al. Comparison of Molecular Kinetics after the First and Second Imatinib Discontinuation: Results from the KID Study Blood. 128: 1920-1920. DOI: 10.1182/BLOOD.V128.22.1920.1920 |
0.134 |
|
| 2011 |
Ahn J, Yang D, Jung S, Bae S, Kim Y, Kim H, Lee J. Influence of Stem Cell Mobilization After Cyclophosphamide, Thalidomide and Dexamethasone (CTD) Regimen in Patients with Newly Diagnosed Multiple Myeloma Blood. 118: 1927-1927. DOI: 10.1182/blood.v118.21.1927.1927 |
0.134 |
|
| 2012 |
Huh J, Kim HJ, Jung CW, Kim HJ, Kim SH, Kim YK, Kim HJ, Shin MG, Moon JH, Sohn SK, Kim SH, Lee WS, Won JH, Mun YC, Kim H, et al. A genome-wide single-nucleotide polymorphism-array can improve the prognostic stratification of the core binding factor acute myeloid leukemia. American Journal of Hematology. 87: 961-8. PMID 22886749 DOI: 10.1002/ajh.23281 |
0.134 |
|
| 2012 |
Choi S, Lee S, Kim S, Jang E, Lee J, Oh Y, Bang J, Park J, Byun J, Jeon H, Woodman RC, Szczudlo T, Jootar S, Kim H, Sohn SK, et al. Nilotinib Versus High-Dose Imatinib in Early Chronic Phase CML Patients Who Have Suboptimal Molecular Responses to Standard-Dose Imatinib: Updated Data From RE-Nice Study Blood. 120: 3775-3775. DOI: 10.1182/blood.V120.21.3775.3775 |
0.133 |
|
| 2016 |
Choi YY, Lee JE, Kim H, Sim MH, Kim KK, Lee G, Kim HI, An JY, Hyung WJ, Kim CB, Noh SH, Kim S, Cheong JH. Establishment and characterisation of patient-derived xenografts as paraclinical models for gastric cancer. Scientific Reports. 6: 22172. PMID 26926953 DOI: 10.1038/Srep22172 |
0.133 |
|
| 2015 |
Song JH, Lee JE, Cho KM, Park SH, Kim HJ, Kim YC, Kim TS. 5-diphenylacetamido-indirubin-3'-oxime as a novel mitochondria-targeting agent with anti-leukemic activities. Molecular Carcinogenesis. PMID 25788004 DOI: 10.1002/mc.22307 |
0.133 |
|
| 2014 |
Jung SH, Kang SJ, Jang HC, Ahn JS, Yang DH, Lee SS, Kim YK, Kim HJ, Lee JJ. Effect of levofloxacin prophylaxis for prevention of severe infections in multiple myeloma patients receiving bortezomib-containing regimens. International Journal of Hematology. 100: 473-7. PMID 25212681 DOI: 10.1007/s12185-014-1672-1 |
0.133 |
|
| 2010 |
Lee HY, Chang M, Jung CW, Kim DH(, Kim WS, Kim SJ, Kim K, Jang JH, Yoon S, Lee K, Kim HJ, Chung J, Sohn SK. Dasatinib for Chronic Phase Chronic Myeloid Leukemia After Failure of Imatinib In Korean Patients. Blood. 116: 4494-4494. DOI: 10.1182/blood.v116.21.4494.4494 |
0.133 |
|
| 2012 |
Jung S, Yang D, Ahn J, Kim Y, Kim H, Lee J. A Modified Glasgow Prognostic Score (mGPS) Based On Systemic Inflammatory Response Is a Useful Indicator to Predict Response and Survival in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL) Blood. 120: 5089-5089. DOI: 10.1182/blood.v120.21.5089.5089 |
0.132 |
|
| 2013 |
Lee SE, Choi SY, Bang JH, Kim SH, Jang EJ, Byeun JY, Park JE, Jeon HR, Oh YJ, Kim HJ, Kim YK, Park JS, Jeong SH, Kim SH, Zang DY, ... ... Kim H, et al. Predictive factors for successful imatinib cessation in chronic myeloid leukemia patients treated with imatinib. American Journal of Hematology. 88: 449-54. PMID 23440689 DOI: 10.1002/ajh.23427 |
0.132 |
|
| 2018 |
Moon JH, Kim T, Ahn J, Ahn S, Jung S, Yang D, Lee J, Choi S, Lee Y, Sohn SK, Kim H, Zhang Z, Kim DDH. Identification of High Risk Group for Leukemic Transformation in Higher Risk MDS Patients Using Targeted RNA-Sequencing: Hematopoietic Stem Cell Signature As a High Risk Profile for Leukemic Transformation Blood. 132: 4361-4361. DOI: 10.1182/Blood-2018-99-116241 |
0.132 |
|
| 2023 |
Park SH, Kim KY, Cho M, Kim HI, Hyung WJ, Kim YM. Chylous Ascites After Gastric Cancer Surgery: Risk Factors and Treatment Results. Journal of Gastric Cancer. 23: 253-263. PMID 37129150 DOI: 10.5230/jgc.2023.23.e2 |
0.132 |
|
| 2012 |
Kim S, Kim HJ, Kwak J, Kim JS, Mun Y, Park JS, Sohn SK, Kim D. Hepatitis B Virus Reactivation in Chronic Myeloid Leukemia Treated with Various Tyrosine Kinase Inhibitors: Multicenter, Retrospective Study Blood. 120: 3738-3738. DOI: 10.1182/BLOOD.V120.21.3738.3738 |
0.132 |
|
| 2020 |
Jeon TH, Monllor-Satoca D, Moon GH, Kim W, Kim HI, Bahnemann DW, Park H, Choi W. Ag(I) ions working as a hole-transfer mediator in photoelectrocatalytic water oxidation on WO film. Nature Communications. 11: 967. PMID 32075977 DOI: 10.1038/S41467-020-14775-2 |
0.132 |
|
| 2014 |
Sohn SK, Moon JH, Jae Sook A, Kim HJ, Song Mk, Shin H, Lee WS, Lee SM, Joo YD, Lee HS, Kim YS, Cho YY, Bae SH. Inferior Long-Term Outcome of Front-Line Hypomethylating Agent Compared to Supportive Care in Patients with Lower Risk Myelodysplastic Syndrome: Prosensity Score Matched Analysis Blood. 124: 3255-3255. DOI: 10.1182/BLOOD.V124.21.3255.3255 |
0.131 |
|
| 2015 |
Lee CK, Jung M, Jung I, Heo SJ, Jeong YH, An JY, Kim HI, Cheong JH, Hyung WJ, Noh SH, Kim HS, Rha SY, Chung HC. Cumulative Metformin Use and Its Impact on Survival in Gastric Cancer Patients After Gastrectomy. Annals of Surgery. PMID 25575260 DOI: 10.1097/Sla.0000000000001086 |
0.131 |
|
| 2016 |
Lee SE, Choi SY, Song HY, Kim SH, Choi MY, Park JS, Kim HJ, Kim SH, Zang DY, Oh S, Kim H, Do YR, Kwak JY, Kim JA, Kim DY, et al. Imatinib withdrawal syndrome and longer duration of imatinib have a close association with a lower molecular relapse after treatment discontinuation: the KID study. Haematologica. PMID 26888022 DOI: 10.3324/haematol.2015.139899 |
0.131 |
|
| 2015 |
Jung SH, Ahn JS, Yang DH, Cho MS, Kim JY, Ahn SY, Kim YK, Kim HJ, Lee JJ. Oliguria as an early indicator of mortality risk in patients with multiple myeloma and renal impairment. Blood Research. 50: 167-72. PMID 26457284 DOI: 10.5045/br.2015.50.3.167 |
0.131 |
|
| 2021 |
Jeong SH, Yoo MW, Son YG, Oh SJ, Kim JH, Kim HI, Park JM, Hur H, Jee YS, Hwang SH, Jin SH, Lee SE, Lee YJ, Seo KW, Park S, et al. Appropriate Number of Adjuvant Chemotherapy Cycles for Patients with Stage 2 or 3 Gastric Cancer After Curative Gastrectomy: A Multicenter Cohort Study. Annals of Surgical Oncology. PMID 33423177 DOI: 10.1245/s10434-020-09504-4 |
0.131 |
|
| 2014 |
Ahn JS, Jung SH, Lee SS, Ahn SY, Yang DH, Kim YK, Kim HJ, Lee JJ. Clinical outcome of bortezomib retreatment in patients with relapsed or refractory multiple myeloma. Biomed Research International. 2014: 145843. PMID 25530955 DOI: 10.1155/2014/145843 |
0.131 |
|
| 2016 |
Li SX, Seo SH, Choi YY, Nakagawa M, An JY, Kim HI, Cheong JH, Hyung WJ, Noh SH. Correlation analyses between pre- and post-operative adverse events in gastric cancer patients receiving preoperative treatment and gastrectomy. Bmc Cancer. 16: 29. PMID 26786480 DOI: 10.1186/s12885-016-2066-y |
0.131 |
|
| 2017 |
Hahn KY, Park CH, Lee YK, Chung H, Park JC, Shin SK, Lee YC, Kim HI, Cheong JH, Hyung WJ, Noh SH, Lee SK. Comparative study between endoscopic submucosal dissection and surgery in patients with early gastric cancer. Surgical Endoscopy. PMID 28639042 DOI: 10.1007/s00464-017-5640-8 |
0.13 |
|
| 2021 |
Roh CK, Choi S, Seo WJ, Cho M, Kim HI, Lee SK, Lim JS, Hyung WJ. Incidence and treatment outcomes of leakage after gastrectomy for gastric cancer: Experience of 14,075 patients from a large volume centre. European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. PMID 33663943 DOI: 10.1016/j.ejso.2021.02.013 |
0.13 |
|
| 2015 |
Jung SH, Kim JS, Lee WS, Oh SJ, Ahn JS, Yang DH, Kim YK, Kim HJ, Lee JJ. Prognostic value of the inverse platelet to lymphocyte ratio (iPLR) in patients with multiple myeloma who were treated up front with a novel agent-containing regimen. Annals of Hematology. PMID 26467916 DOI: 10.1007/s00277-015-2521-x |
0.13 |
|
| 2021 |
Choi S, Song JH, Lee S, Cho M, Kim YM, Kim HI, Hyung WJ. Lymphovascular Invasion: Traditional but Vital and Sensible Prognostic Factor in Early Gastric Cancer. Annals of Surgical Oncology. PMID 34075484 DOI: 10.1245/s10434-021-10224-6 |
0.13 |
|
| 2009 |
Kim Y, Kim H, Ahn J, Yang D, Lee I, Lee J, Kim H. Prognostic Significances of ABCG-2 and hOCT-1 Gene Expression in Chronic Phase Chronic Myeloid Leukemia Patients Treated with Imatinib Mesylate. Blood. 114: 3299-3299. DOI: 10.1182/blood.v114.22.3299.3299 |
0.13 |
|
| 2008 |
Kim Y, Kim H, Yu R, Lee I, Ahn J, Yang D, Lee J, Kim H. Prognostic Significance of hOCT1 and ABCG2 Expression in Chronic Myeloid Leukemia Patients Treated with Imatinib Blood. 112: 5033-5033. DOI: 10.1182/blood.v112.11.5033.5033 |
0.13 |
|
| 2014 |
Kim SH, Menon H, Jootar S, Saikia T, Kwak JY, Sohn SK, Park JS, Jeong SH, Kim HJ, Kim YK, Oh SJ, Kim H, Zang DY, Chung JS, Shin HJ, et al. Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors. Haematologica. 99: 1191-6. PMID 24705186 DOI: 10.3324/haematol.2013.096776 |
0.13 |
|
| 2010 |
Shin H, Chung J, Kim HJ, Sohn SK, Min Y, Won J, Bae SH, Kim I, Lee J, Choi S, Lee J, Yoon H, Lee JH, Kim SJ, Jo DY, et al. Bone Marrow Cellularity Is a Single Most Important Independent Prognostic Factor In AML Patients with t(8;21) Blood. 116: 1707-1707. DOI: 10.1182/blood.V116.21.1707.1707 |
0.13 |
|
| 2023 |
Park DJ, Han SU, Hyung WJ, Hwang SH, Hur H, Yang HK, Lee HJ, Kim HI, Kong SH, Kim YW, Lee HH, Kim BS, Park YK, Lee YJ, Ahn SH, ... ... Kim HH, et al. Effect of Laparoscopic Proximal Gastrectomy With Double-Tract Reconstruction vs Total Gastrectomy on Hemoglobin Level and Vitamin B12 Supplementation in Upper-Third Early Gastric Cancer: A Randomized Clinical Trial. Jama Network Open. 6: e2256004. PMID 36790808 DOI: 10.1001/jamanetworkopen.2022.56004 |
0.13 |
|
| 2013 |
Yang D, Min J, Ahn J, Kim Y, Bom H, Kim H, Chae YS, Sohn SK, Lee SW, Do Y, Lee J. The Prognostic Significance Of Interim PET/CT Using Visual, SUV-Based and MTV-Based Assessment In Treatment Of Peripheral T Cell Lymphoma Blood. 122: 4261-4261. DOI: 10.1182/BLOOD.V122.21.4261.4261 |
0.13 |
|
| 2015 |
Lee S, Choi SY, Kwak J, Kim H, Kim J, Do YR, Kim HJ, Park JS, Chung JS, Shin H, Kim S, Kim D, Bunworasate U, Choi CW, Comia NSC, et al. Predictive Value of 3-Month Early Molecular Response in New Chronic Phase Chronic Myeloid Leukemia Patients Treated with Radotinib Blood. 126: 4053-4053. DOI: 10.1182/blood.V126.23.4053.4053 |
0.129 |
|
| 2015 |
Jung S, Kim HK, Kim SJ, Lee S, Ahn J, Kim Y, Yang D, Kim H, Lee J, Kim K. In the Novel Agents Era, Is the International Staging System Still Has the Prognostic Value in Patients with Renal Impairment? Blood. 126: 5313-5313. DOI: 10.1182/blood.v126.23.5313.5313 |
0.129 |
|
| 2011 |
Ahn JS, Yang DH, Jung SH, Bae SY, Tran HT, Park HC, Kim HN, Kim YK, Kim HJ, Lee JJ. Fludarabine-containing chemotherapy for patients with previously untreated low-grade non-Hodgkin's lymphoma. The Korean Journal of Hematology. 46: 180-5. PMID 22065973 DOI: 10.5045/kjh.2011.46.3.180 |
0.129 |
|
| 2015 |
Park HS, Jung M, Kim HS, Kim HI, An JY, Cheong JH, Hyung WJ, Noh SH, Kim YI, Chung HC, Rha SY. Proper timing of adjuvant chemotherapy affects survival in patients with stage 2 and 3 gastric cancer. Annals of Surgical Oncology. 22: 224-31. PMID 25081339 DOI: 10.1245/s10434-014-3949-2 |
0.129 |
|
| 2018 |
Kim MH, Zhang X, Jung M, Jung I, Park HS, Beom SH, Kim HS, Rha SY, Kim H, Choi YY, Son T, Kim HI, Cheong JH, Hyung WJ, Noh SH, et al. Immunohistochemistry Biomarkers Predict Survival in Stage II/III Gastric Cancer Patients: From a Prospective Clinical Trial. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 30282452 DOI: 10.4143/Crt.2018.331 |
0.129 |
|
| 2015 |
Lee SS, Ahn JS, Jung SH, Ahn SY, Kim JY, Jang HC, Kang SJ, Jang MO, Yang DH, Kim YK, Lee JJ, Kim HJ. Treatment of BK virus-associated hemorrhagic cystitis with low-dose intravenous cidofovir in patients undergoing allogeneic hematopoietic cell transplantation. The Korean Journal of Internal Medicine. 30: 212-8. PMID 25750563 DOI: 10.3904/kjim.2015.30.2.212 |
0.129 |
|
| 2013 |
Yi JH, Huh J, Kim HJ, Kim SH, Kim SH, Kim KH, Do YR, Mun YC, Kim H, Kim MK, Kim HJ, Kim T, Kim DD. Genome-wide single-nucleotide polymorphism array-based karyotyping in myelodysplastic syndrome and chronic myelomonocytic leukemia and its impact on treatment outcomes following decitabine treatment. Annals of Hematology. 92: 459-69. PMID 23262795 DOI: 10.1007/s00277-012-1635-7 |
0.128 |
|
| 2015 |
Lee JY, Son T, Cheong JH, Hyung WJ, Noh SH, Kim CB, Park CG, Kim HI. Association between Chemotherapy-Response Assays and Subsets of Tumor-Infiltrating Lymphocytes in Gastric Cancer: A Pilot Study. Journal of Gastric Cancer. 15: 223-30. PMID 26819801 DOI: 10.5230/jgc.2015.15.4.223 |
0.128 |
|
| 2021 |
Song IC, Jo DY, Kim HJ, Min YH, Hong DS, Lee WS, Shin HJ, Lee JH, Park J, Kim HJ. Clinical features and outcomes of hypocellular acute myeloid leukemia in adults: A Korean AML registry data. Medicine. 100: e24185. PMID 33429807 DOI: 10.1097/MD.0000000000024185 |
0.128 |
|
| 2007 |
Kim S, Lee J, Kim H, Fukuda T, Kanda Y, Kim H, Min W, Mori S, Tanosaki R, Lee J, Lee K, Yamashita T, Sakamaki H, Sohn S, Chae Y, et al. Similar Background of Graft-Versus-Host Disease (GVHD) Following Allogeneic Blood and Marrow Transplantation (Tx) in Korean and Japanese Populations Allows a Uniform Foundation To Perform Large-Scale Clinical Studies in the Region. Blood. 110: 5007-5007. DOI: 10.1182/blood.v110.11.5007.5007 |
0.128 |
|
| 2023 |
Park SH, Hyung WJ, Yang HK, Park YK, Lee HJ, An JY, Kim W, Kim HI, Kim HH, Ryu SW, Hur H, Kim MC, Kong SH, Cho GS, Kim JJ, et al. Standard follow-up after curative surgery for advanced gastric cancer: secondary analysis of a multicentre randomized clinical trial (KLASS-02). The British Journal of Surgery. PMID 36723976 DOI: 10.1093/bjs/znad002 |
0.128 |
|
| 2022 |
Song JH, Shin HJ, Lee S, Park SH, Cho M, Kim YM, Hyung WJ, Kim HI. No detrimental effect of perioperative blood transfusion on recurrence in 2905 stage II/III gastric cancer patients: A propensity-score matching analysis. European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. PMID 35672232 DOI: 10.1016/j.ejso.2022.05.026 |
0.128 |
|
| 2012 |
Nguyen-Pham T, Lee HJ, Tran HTT, Vo M, Hoang M, Choi N, Kim H, Lee J. The Novel Anti-Myeloma Agent Chaetocin Enhances Tumor-Specific Dendritic Cell Response Via the Induction of Heat Shock Protein and Cancer Testis Antigens On Myeloma Cells Blood. 120: 4066-4066. DOI: 10.1182/blood.v120.21.4066.4066 |
0.127 |
|
| 2022 |
Hirata Y, Kim HI, Grotz TE, Matsuda S, Badgwell BD, Ikoma N. The role of proximal gastrectomy in gastric cancer. Chinese Clinical Oncology. 11: 39. PMID 36336898 DOI: 10.21037/cco-22-82 |
0.127 |
|
| 2014 |
Hoang M, Lee H, Lee H, Jung S, Choi N, Vo M, Nguyen-Pham T, Park I, Kim H, Lee J. Branched Polyethylenimine-Superparamagnetic Iron Oxide Nanoparticles (bPEI-SPIONs) Improve Immunogenicity of Myeloma Tumor Antigen to Enhance Th1 Polarization of Dendritic Cells Blood. 124: 5763-5763. DOI: 10.1182/blood.v124.21.5763.5763 |
0.127 |
|
| 2010 |
Koh Y, Kim I, Yoon SS, Kim BK, Kim DY, Lee JH, Lee KH, Park E, Kim HJ, Sohn SK, Joo YD, Kim SJ, Chung J, Shin HJ, Kim SH, et al. Phase IV study evaluating efficacy of escalated dose of imatinib in chronic myeloid leukemia patients showing suboptimal response to standard dose imatinib. Annals of Hematology. 89: 725-31. PMID 20179930 DOI: 10.1007/s00277-010-0910-8 |
0.127 |
|
| 2007 |
Shin M, Kim H, Kim H, Kim M, Hoon K, Hwang T, Shin J, Suh S, Ryang D. Dynamic Mitochondrial Responses to Oxidative Stress in Primary AML Cells Involve Structural Damage and Repair Activity. Blood. 110: 4139-4139. DOI: 10.1182/blood.v110.11.4139.4139 |
0.127 |
|
| 2016 |
Hwang HK, Kim HI, Kim SH, Choi J, Kang CM, Kim KS, Lee WJ. Prognostic impact of the tumor-infiltrating regulatory T-cell (Foxp3(+))/activated cytotoxic T lymphocyte (granzyme B(+)) ratio on resected left-sided pancreatic cancer. Oncology Letters. 12: 4477-4484. PMID 28105157 DOI: 10.3892/ol.2016.5252 |
0.127 |
|
| 2019 |
Guner A, Kim HI. Biomarkers for Evaluating the Inflammation Status in Patients with Cancer. Journal of Gastric Cancer. 19: 254-277. PMID 31598370 DOI: 10.5230/jgc.2019.19.e29 |
0.126 |
|
| 2018 |
Choi YY, Jang E, Seo WJ, Son T, Kim HI, Kim H, Hyung WJ, Huh YM, Noh SH, Cheong JH. Modification of the TNM Staging System for Stage II/III Gastric Cancer Based on a Prognostic Single Patient Classifier Algorithm. Journal of Gastric Cancer. 18: 142-151. PMID 29984064 DOI: 10.5230/jgc.2018.18.e14 |
0.126 |
|
| 2018 |
Park JH, Woo YM, Youm EM, Hamad N, Won HH, Naka K, Park EJ, Park JH, Kim HJ, Kim SH, Kim HJ, Ahn JS, Sohn SK, Moon JH, Jung CW, et al. HMGCLL1 is a predictive biomarker for deep molecular response to imatinib therapy in chronic myeloid leukemia. Leukemia. PMID 30555164 DOI: 10.1038/s41375-018-0321-8 |
0.126 |
|
| 2018 |
Kim IH, Park SS, Lee CM, Kim MC, Kwon IK, Min JS, Kim HI, Lee HH, Lee SI, Chae H. Efficacy of Adjuvant S-1 Versus XELOX Chemotherapy for Patients with Gastric Cancer After D2 Lymph Node Dissection: A Retrospective, Multi-Center Observational Study. Annals of Surgical Oncology. PMID 29450755 DOI: 10.1245/s10434-018-6375-z |
0.126 |
|
| 2006 |
Yang D, Park C, Kim Y, Lee J, Kim HJ. Clinical Correlation of Foxp3 Regulatory Gene Expressions and NK Cells in Early Engraftment after Myeloablative Allogeneic Stem Cell Transplantation. Blood. 108: 2911-2911. DOI: 10.1182/blood.v108.11.2911.2911 |
0.126 |
|
| 2011 |
Kim HI, Kim H, Cho HW, Kim SY, Song KJ, Hyung WJ, Park CG, Kim CB. The ratio of intra-tumoral regulatory T cells (Foxp3+)/helper T cells (CD4+) is a prognostic factor and associated with recurrence pattern in gastric cardia cancer. Journal of Surgical Oncology. 104: 728-33. PMID 21792941 DOI: 10.1002/jso.22038 |
0.126 |
|
| 2021 |
Song JH, Lee S, Choi S, Cho M, Kwon IG, Kim YM, Son T, Kim HI, Jung M, Hyung WJ. Adverse Prognostic Impact of Postoperative Complications After Gastrectomy for Patients With Stage II/III Gastric Cancer: Analysis of Prospectively Collected Real-World Data. Frontiers in Oncology. 11: 611510. PMID 33996540 DOI: 10.3389/fonc.2021.611510 |
0.126 |
|
| 2013 |
Kim H, Kim H, Thi Dai TN, Lee I, Kim H, Shin J, Suh S, Ryang D, Shin M. Development Of Novel Alkylating Chemotherapeutics, Phenyl-Chloroethyl Urea Family, Targeting Mitochondrial Prohibitin For Selective Killing Of Leukemic Cells Blood. 122: 1325-1325. DOI: 10.1182/blood.v122.21.1325.1325 |
0.125 |
|
| 2015 |
Jang JH, Harada H, Shibayama H, Shimazaki R, Kim HJ, Sawada K, Mitani K. A randomized controlled trial comparing darbepoetin alfa doses in red blood cell transfusion-dependent patients with low- or intermediate-1 risk myelodysplastic syndromes. International Journal of Hematology. PMID 26323997 DOI: 10.1007/s12185-015-1862-5 |
0.125 |
|
| 2014 |
Nguyen KC, Muthiah M, Islam MA, Kalash RS, Cho CS, Park H, Lee IK, Kim HJ, Park IK, Cho KA. Selective transfection with osmotically active sorbitol modified PEI nanoparticles for enhanced anti-cancer gene therapy. Colloids and Surfaces. B, Biointerfaces. 119: 126-36. PMID 24880989 DOI: 10.1016/j.colsurfb.2014.05.003 |
0.125 |
|
| 2016 |
Jung SH, Cho MS, Kim HK, Kim SJ, Kim K, Cheong JW, Kim SJ, Kim JS, Ahn JS, Kim YK, Yang DH, Kim HJ, Lee JJ. Risk factors associated with early mortality in patients with multiple myeloma who were treated upfront with a novel agents containing regimen. Bmc Cancer. 16: 613. PMID 27501959 DOI: 10.1186/s12885-016-2645-y |
0.125 |
|
| 2012 |
Ren L, Yang HY, Choi HI, Chung KJ, Yang U, Lee IK, Kim HJ, Lee DS, Park BJ, Lee TH. The role of peroxiredoxin V in (-)-epigallocatechin 3-gallate-induced multiple myeloma cell death. Oncology Research. 19: 391-8. PMID 22329198 DOI: 10.3727/096504011X13127606672922 |
0.125 |
|
| 2021 |
Lee S, Song JH, Park SH, Cho M, Kim YM, Kim HI, Hyung WJ. Determination of Additional Surgery after Non-Curative Endoscopic Submucosal Dissection in Patients with Early Gastric Cancer: A Practically Modified Application of the eCura System. Cancers. 13. PMID 34830922 DOI: 10.3390/cancers13225768 |
0.124 |
|
| 2010 |
Ahn JS, Rew SY, Shin MG, Kim HR, Yang DH, Cho D, Kim SH, Bae SY, Lee SR, Kim YK, Kim HJ, Lee JJ. Clinical significance of clonality and Epstein-Barr virus infection in adult patients with hemophagocytic lymphohistiocytosis. American Journal of Hematology. 85: 719-22. PMID 20652965 DOI: 10.1002/ajh.21795 |
0.124 |
|
| 2017 |
Kim HS, Lee H, Shin SJ, Beom SH, Jung M, Bae S, Lee EY, Park KH, Choi YY, Son T, Kim HI, Cheong JH, Hyung WJ, Park JC, Shin SK, ... ... Kim H, et al. Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancer. Oncotarget. PMID 28418920 DOI: 10.18632/oncotarget.16409 |
0.124 |
|
| 2009 |
Yang D, Kim M, Hong C, Ahn J, Kim Y, Chung I, Kim H, Lee J. Alpha-Type 1-Polarized Dendritic Cells Pulsed with Apoptotic Allogeneic Myeloma Cell Line Could Induce the Strong CTL Responses against Autologous Myeloma Cells. Blood. 114: 4931-4931. DOI: 10.1182/blood.v114.22.4931.4931 |
0.124 |
|
| 2017 |
Vo MC, Nguyen-Pham TN, Lee HJ, Jung SH, Choi NR, Hoang MD, Kim HJ, Lee JJ. Chaetocin enhances dendritic cell function via the induction of heat shock protein and cancer testis antigens in myeloma cells. Oncotarget. PMID 28512265 DOI: 10.18632/oncotarget.17517 |
0.124 |
|
| 2017 |
Shin S, Kim HI, Kim NY, Lee KY, Kim DW, Yoo YC. Effect of postoperative analgesia technique on the prognosis of gastric cancer: a retrospective analysis. Oncotarget. 8: 104594-104604. PMID 29262664 DOI: 10.18632/oncotarget.21979 |
0.124 |
|
| 2009 |
Tran HTT, Kim HN, Kim Y, Ahn J, Lee I, Yang D, Lee J, Kook H, Hwang TJ, Kim H. DNA Methylation Changes Following 5-Azacitidine Treatment in Patients with Myelodysplastic Syndrome. Blood. 114: 2791-2791. DOI: 10.1182/BLOOD.V114.22.2791.2791 |
0.124 |
|
| 2017 |
Lee JH, Kim YJ, Sohn SK, Yoon SS, Kim H, Cheong JW, Lee WS, Lee GW, Lim SN, Kim MK, Lee HS, Kim HJ. Benefits of hypomethylating therapy in IPSS lower-risk myelodysplastic syndrome patients: A retrospective multicenter case series study. Leukemia Research. 60: 135-144. PMID 28826063 DOI: 10.1016/j.leukres.2017.08.004 |
0.124 |
|
| 2012 |
Son T, Hyung WJ, Lee JH, Kim YM, Kim HI, An JY, Cheong JH, Noh SH. Clinical implication of an insufficient number of examined lymph nodes after curative resection for gastric cancer. Cancer. 118: 4687-93. PMID 22415925 DOI: 10.1002/cncr.27426 |
0.124 |
|
| 2014 |
Kim S, Choi SY, Lee S, Oh YJ, Yoo HL, Jang E, Choi M, Jang M, Kim HJ, Kwak J, Kim H, Do Y, Kim D. Distinct Associations Between UGT1A1 Gene Promoter Polymorphism and Hyperbilirubinemia in Korean CML Patients Treated with Nilotinib and Radotinib Blood. 124: 5511-5511. DOI: 10.1182/blood.V124.21.5511.5511 |
0.124 |
|
| 2016 |
Lee YJ, Moon JH, Lee IH, Yoon J, Cho B, Ahn J, Kim HJ, Park S, Jang JH, Jung CW, Park H, Cheong J, Lee J, Sohn SK, Kim H. Killer Cell Immunoglobulin-like Receptor Ligand Matching Determines the Post-Transplant High Risk Groups Among Patients with Permissive HLA Mismatch in Unrelated Donor Hematopoietic Cell Transplantation Blood. 128: 4566-4566. DOI: 10.1182/blood.v128.22.4566.4566 |
0.124 |
|
| 2006 |
Baek JH, Sohn SK, Kim DH, Kim JG, Yang DH, Kim YK, Lee JJ, Kim HJ. Pilot remission induction therapy with idarubicin, plus an intensified dose of ara-C and priming with granulocyte colony-stimulating factor for acute myeloid leukemia. Acta Haematologica. 117: 109-14. PMID 17135724 DOI: 10.1159/000097386 |
0.124 |
|
| 2013 |
Ahn J, Kim H, Kim H, Kim Y, Jung S, Yang D, Lee J, Dai Trang NT, Choi H, Kang M, Kim H, Shin J, Suh S, Ryang D, Shin M. Clinical Significance Of SF3B1, U2AF1 and SRSF2 Spliceosomal Gene Mutations For The Treatment Of Hypomethylating Agents In Myelodysplastic Syndrome Blood. 122: 2802-2802. DOI: 10.1182/BLOOD.V122.21.2802.2802 |
0.123 |
|
| 2004 |
Kim H, Lee J, Yang D, Kim Y, Kim NY, Park K, Kim H, Jang D, Ahn J, Bae S, Ryoo H, Kim H. Prognostic Relevance of Gene Expression Using RT-PCR in Diffuse Large B-Cell Lymphoma. Blood. 104: 4559-4559. DOI: 10.1182/blood.v104.11.4559.4559 |
0.123 |
|
| 2012 |
Kim S, Menon H, Jootar S, Saikia T, Kwak J, Sohn SK, Park JS, Kim HJ, Oh SJ, Kim H, Zang DY, Park S, Lee HA, Park HL, Woo SH, ... Kim HY, et al. Efficacy and Safety of Radotinib in Chronic Phase Chronic Myeloid Leukemia Patients with Resistance or Intolerance to BCR-ABL Tyrosine Kinase Inhibitors: Radotinib Phase 2 Clinical Trial Blood. 120: 695-695. DOI: 10.1182/blood.V120.21.695.695 |
0.123 |
|
| 2006 |
Lee J, Min Y, Chung CW, Kim BK, Yoon H, Jo D, Shin H, Bang S, Won J, Zang DY, Kim HJ, Chi H, Lee KH, Cheong J, Kim JS, et al. Prognostic Implications of the Immunophenotype in Biphenotypic Acute Leukemia. Blood. 108: 2319-2319. DOI: 10.1182/BLOOD.V108.11.2319.2319 |
0.123 |
|
| 2008 |
Kim H, Koo HH, Kook H, Kim BS, Kim SH, Kim H, Kim HJ, Bae SH, Sohn SK, Shin H, Ahn HS, Won J, Yoon S, Lee Y, Jeong D, et al. The Comparison Between Matched Related Donor and Alternative Donor for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acquired Aplastic Anemia: KSBMT2007-02 Study Blood. 112: 2997-2997. DOI: 10.1182/blood.v112.11.2997.2997 |
0.123 |
|
| 2013 |
Moon JH, Sohn SK, Ahn JS, Kim Y, Kim HJ, Song M, Shin H, Chung J, Chan Song I, Jo D, Lim SN, Lee HS, Kim YS, Bae SH. Role Of Hypomethylating Agents For Patients With Lower-Risk Myelodysplastic Syndrome Defined By IPSS and IPSS-R Blood. 122: 2782-2782. DOI: 10.1182/blood.v122.21.2782.2782 |
0.123 |
|
| 2015 |
Ahn J, Kim H, Kim Y, Lee S, Jung S, Yang D, Lee J, Hee Jeong P, Choi SH, Jung CW, Jang J, Kim H, Moon JH, Sohn SK, Kim S, et al. 5-Hydroxymethylcytosine Is Correlated with TET2 or IDH1/2 Mutations However, May Not be a Prognostic Value to Predict the Survivals in Normal Karyotype AML Blood. 126: 3832-3832. DOI: 10.1182/blood.V126.23.3832.3832 |
0.123 |
|
| 2021 |
Jeong SY, Cho YJ, Ryu JY, Choi JJ, Hwang JR, Kim B, Lee YY, Kim HS, Lee JW. Establishment and preclinical application of a patient-derived xenograft model for uterine cancer. Gynecologic Oncology. PMID 33972086 DOI: 10.1016/j.ygyno.2021.04.028 |
0.122 |
|
| 2013 |
Ahn JS, Yang DH, Duk Choi Y, Jung SH, Yhim HY, Kwak JY, Sung Park H, Shin MG, Kim YK, Kim HJ, Lee JJ. Clinical outcome of elderly patients with Epstein-Barr virus positive diffuse large B-cell lymphoma treated with a combination of rituximab and CHOP chemotherapy. American Journal of Hematology. 88: 774-9. PMID 23760676 DOI: 10.1002/ajh.23507 |
0.122 |
|
| 2024 |
Kim KY, Hwang J, Park SH, Cho M, Kim YM, Kim HI, Hyung WJ. Superior lymph node harvest by fluorescent lymphography during minimally invasive gastrectomy for gastric cancer patients with high body mass index. Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. PMID 38502275 DOI: 10.1007/s10120-024-01482-w |
0.122 |
|
| 2017 |
Vo MC, Nguyen-Pham TN, Lee HJ, Jaya Lakshmi T, Yang S, Jung SH, Kim HJ, Lee JJ. Combination therapy with dendritic cells and lenalidomide is an effective approach to enhance antitumor immunity in a mouse colon cancer model. Oncotarget. 8: 27252-27262. PMID 28460478 DOI: 10.18632/oncotarget.15917 |
0.122 |
|
| 2022 |
Lee JY, Oh EG, Hyung WJ, Kim HI. Translation and validation of the patient-Generated Subjective Global Assessment against the Mini-Nutritional Assessment for patients with gastric cancer. Asia-Pacific Journal of Oncology Nursing. 10: 100148. PMID 36386273 DOI: 10.1016/j.apjon.2022.100148 |
0.122 |
|
| 2013 |
Jung SH, Bae SY, Ahn JS, Kang SJ, Yang DH, Kim YK, Kim HJ, Lee JJ. Lymphocytopenia is associated with an increased risk of severe infections in patients with multiple myeloma treated with bortezomib-based regimens. International Journal of Hematology. 97: 382-7. PMID 23355264 DOI: 10.1007/s12185-013-1270-7 |
0.122 |
|
| 2005 |
Lee JJ, Kook H, Park MS, Nam JH, Choi BH, Song WH, Park KS, Lee IK, Chung IJ, Hwang TJ, Kim HJ. Immunotherapy using autologous monocyte-derived dendritic cells pulsed with leukemic cell lysates for acute myeloid leukemia relapse after autologous peripheral blood stem cell transplantation. Journal of Clinical Apheresis. 19: 66-70. PMID 15274198 DOI: 10.1002/jca.10080 |
0.121 |
|
| 2020 |
Jung SH, Jo JC, Song GY, Ahn SY, Yang DH, Ahn JS, Kim HJ, Lee JJ. Frontline therapy for newly diagnosed patients with multiple myeloma. Blood Research. 55: S37-S42. PMID 32719175 DOI: 10.5045/br.2020.S007 |
0.121 |
|
| 2009 |
Goh H, Kim Y, Kim D, Kim H, Kim S, Jang S, Lee J, Kim D, Kim W, Park S, Kweon I. Previous best responses can be re-achieved by resumption after imatinib discontinuation in patients with chronic myeloid leukemia: implication for intermittent imatinib therapy Leukemia & Lymphoma. 50: 944-951. DOI: 10.1080/10428190902926973 |
0.121 |
|
| 2018 |
Park HS, Kim HS, Beom SH, Rha SY, Chung HC, Kim JH, Chun YJ, Lee SW, Choe EA, Heo SJ, Noh SH, Hyung WJ, Cheong JH, Kim HI, Son T, et al. Marked Loss of Muscle, Visceral Fat, or Subcutaneous Fat After Gastrectomy Predicts Poor Survival in Advanced Gastric Cancer: Single-Center Study from the CLASSIC Trial. Annals of Surgical Oncology. PMID 30051367 DOI: 10.1245/s10434-018-6624-1 |
0.121 |
|
| 2018 |
Kim H, Choi Y, Yoon S, Bang S, Kim H, Sohn SK, Mun Y, Do YR, Park Y, Lee JH, Bae SH, Lee HS, Kim MK, Lee W, Ahn J, et al. Allogeneic Hematopoietic Cell Transplantation for Severe Idiopathic Aplastic Anemia Older Than 40y Blood. 132: 3876-3876. DOI: 10.1182/blood-2018-99-116190 |
0.12 |
|
| 2018 |
Do YR, Kwak J, Kim H, Kim J, Kim H, Park JS, Chung J, Shin H, Kim S, Bunworasate U, Choi CW, Comia NSC, Zang DY, Oh S, Jootar S, et al. Final Study Results of Newly Diagnosed Chronic Myeloid Leukemia Chronic Phase (CML-CP) Patients Receiving Radotinib 300 Mg BID or Imatinib: Rerise 48 Months Follow-up Blood. 132: 1733-1733. DOI: 10.1182/BLOOD-2018-99-110568 |
0.12 |
|
| 2014 |
Song JH, Kim SH, Cho KM, Hwang SY, Kim HJ, Kim TS. Analysis of gene profiles involved in the enhancement of all-trans retinoic acid-induced HL-60 cell differentiation by sesquiterpene lactones identifies asparagine synthetase as a novel target for differentiation-inducing therapy. International Journal of Oncology. 44: 970-6. PMID 24398846 DOI: 10.3892/ijo.2013.2241 |
0.12 |
|
| 2020 |
Roh CK, Choi S, Seo WJ, Cho M, Choi YY, Son T, Hyung WJ, Kim HI. Comparison of surgical outcomes between integrated robotic and conventional laparoscopic surgery for distal gastrectomy: a propensity score matching analysis. Scientific Reports. 10: 485. PMID 31949219 DOI: 10.1038/s41598-020-57413-z |
0.12 |
|
| 2008 |
Kim H, Shin M, Lee S, Kim H, Lee I, Kim H, Kook H, Shin JH, Suh S, Ryang D. Discovery of a New Molecular Marker, Prohibitin, and Development of Candidates for New Chemotherapeutic Agents Targeting Prohibitin in Primary AML Cells. Blood. 112: 3342-3342. DOI: 10.1182/blood.v112.11.3342.3342 |
0.12 |
|
| 2011 |
Yang DH, Kim MH, Lee YK, Hong CY, Lee HJ, Nguyen-Pham TN, Bae SY, Ahn JS, Kim YK, Chung IJ, Kim HJ, Kalinski P, Lee JJ. Successful cross-presentation of allogeneic myeloma cells by autologous alpha-type 1-polarized dendritic cells as an effective tumor antigen in myeloma patients with matched monoclonal immunoglobulins. Annals of Hematology. 90: 1419-26. PMID 21465188 DOI: 10.1007/S00277-011-1219-Y |
0.12 |
|
| 2004 |
Bang S, Lee JH, Yoon S, Park S, Lee J, Kim HJ, Jo DY, Park YH, Yoon H, Yuh Y, Ahn M, Im SA, Lee MH, Lee DS. Preliminary Report of Risk-Based Approach in Korean Patients with Newly Diagnosed Multiple Myeloma. Blood. 104: 4911-4911. DOI: 10.1182/blood.v104.11.4911.4911 |
0.119 |
|
| 2013 |
Won EJ, Kim HR, Kim HY, Kook H, Kim HJ, Shin JH, Suh SP, Ryang DW, Shin MG. Diagnostic and prognostic value of mitochondrial DNA minisatellites after stem cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 918-24. PMID 23499734 DOI: 10.1016/j.bbmt.2013.03.002 |
0.119 |
|
| 2015 |
Hoang MD, Lee HJ, Lee HJ, Jung SH, Choi NR, Vo MC, Nguyen-Pham TN, Kim HJ, Park IK, Lee JJ. Branched Polyethylenimine-Superparamagnetic Iron Oxide Nanoparticles (bPEI-SPIONs) Improve the Immunogenicity of Tumor Antigens and Enhance Th1 Polarization of Dendritic Cells. Journal of Immunology Research. 2015: 706379. PMID 26221615 DOI: 10.1155/2015/706379 |
0.119 |
|
| 2012 |
Nguyen-Pham TN, Lee YK, Lee HJ, Kim MH, Yang DH, Kim HJ, Lee JJ. Cellular immunotherapy using dendritic cells against multiple myeloma. The Korean Journal of Hematology. 47: 17-27. PMID 22479274 DOI: 10.5045/kjh.2012.47.1.17 |
0.119 |
|
| 2021 |
Park SJ, Mun J, Lee EJ, Park S, Kim SY, Lim W, Song G, Kim JW, Lee S, Kim HS. Clinical Phenotypes of Tumors Invading the Rectosigmoid Colon Affecting the Extent of Debulking Surgery and Survival in Advanced Ovarian Cancer. Frontiers in Oncology. 11: 673631. PMID 33968784 DOI: 10.3389/fonc.2021.673631 |
0.119 |
|
| 2019 |
Cha JH, Kim JH, Kim HI, Jung DH, Park JJ, Youn YH, Park H, Choi SH, Cheong JH, Hyung WJ, Noh SH. The optimal timing of additional surgery after non-curative endoscopic resection to treat early gastric cancer: long-term follow-up study. Scientific Reports. 9: 18331. PMID 31797969 DOI: 10.1038/s41598-019-54778-8 |
0.119 |
|
| 2015 |
Yang D, Moon JH, Lee S, Min J, Jeong S, Lee Y, Park S, Chae YS, Do YR, Kim H, Lee J. Discrepancy of Interim PET/CT Responses Based on Visual and Quantitative SUV-Based Assessments in the Patients with Diffuse Large B-Cell Lymphoma and Extranodal Involvements Blood. 126: 1446-1446. DOI: 10.1182/blood.V126.23.1446.1446 |
0.119 |
|
| 2006 |
Shin M, Kim HJ, Kim H, Lee S, Lee I, Shin J, Suh S, Ryang D. Frequency of the JAK2 Mutation and Its Usefulness as a Marker for Treatment Response and Disease Progression in Korean Patients with Chronic Myeloproliferative Disorders. Blood. 108: 4876-4876. DOI: 10.1182/blood.v108.11.4876.4876 |
0.119 |
|
| 2007 |
Kim HI, Chung SH, Hwang JE, Kim SH, Ahn JS, Yang DH, Kim YK, Yun SJ, Cho SH, Lee JJ, Chung IJ, Kim HJ. Dermatomyositis associated with cancer of unknown primary site. Journal of Korean Medical Science. 22: S174-7. PMID 17923750 DOI: 10.3346/jkms.2007.22.S.S174 |
0.118 |
|
| 2008 |
Kim DH, Kamel-Reid S, Chang H, Sutherland R, Jung CW, Kim HJ, Lee J, Lipton JH. Natural Killer (NK) or NK/T Cell Lineage Large Granular Lymphocytosis Associated with Dasatinib Therapy for Philadelphia Chromosome Positive Leukemia. Blood. 112: 933-933. DOI: 10.1182/BLOOD.V112.11.933.933 |
0.118 |
|
| 2016 |
Vo MC, Anh-NguyenThi T, Lee HJ, Nguyen-Pham TN, Jaya Lakshmi T, Jung SH, Kim HJ, Lee JJ. Lenalidomide enhances the function of dendritic cells generated from patients with multiple myeloma. Experimental Hematology. PMID 27889516 DOI: 10.1016/j.exphem.2016.11.004 |
0.118 |
|
| 2005 |
Kook H, Yang JM, Kee HJ, Eom GH, Baek HJ, Hwang TJ, Cho D, Shin M, Lee JJ, Kim HJ, Lee J, Eom SH, Kook H. Clinical Characteristics of Autosomal Dominat Giant Platelet Syndromes (GPS) and Mutation Analysis of MYH9 Encoding Non-Muscle Myosin Heavy Chain from 6 Unrelated Korean Patients. Blood. 106: 2169-2169. DOI: 10.1182/blood.v106.11.2169.2169 |
0.118 |
|
| 2019 |
Lee J, Chu T, Vo M, Park H, Lakshmi TJ, Ahn S, Song G, Jung S, Kim H. A Combination Therapy with Dendritic Cells, Pomalidomide and Programmed Death-Ligand 1 Blockade Exerts a Potent Antitumor Immunity in a Murine Model of Multiple Myeloma Blood. 134: 1819-1819. DOI: 10.1182/blood-2019-127964 |
0.118 |
|
| 2014 |
Choi SY, Lee S, Oh Yj, Kim S, Woodman RC, Szczudlo T, Jootar S, Kim H, Sohn SK, Park JS, Kim S, Zang D, Oh S, Kim D. Efficacy of Nilotinib Vs High-Dose Imatinib Vs Sustaining Standard-Dose Imatinib in Early Chronic Phase CML Patients Who Have Suboptimal Molecular Response to Frontline Imatinib Blood. 124: 1816-1816. DOI: 10.1182/blood.v124.21.1816.1816 |
0.118 |
|
| 2008 |
Shin M, Kim H, Kim C, Kim H, Kook H, Kee SJ, Kim S, Shin J, Suh S, Ryang D. Direct Confirmation of Quiescent Property of AML Stem Cells by Showing Markedly Decreased Plating Efficiency in Single Leukemic Stem Cell Culture Blood. 112: 4737-4737. DOI: 10.1182/blood.v112.11.4737.4737 |
0.118 |
|
| 2013 |
Choi S, Lee S, Oh YJ, Kim S, Woodman RC, Szczudlo T, Jootar S, Kim H, Sohn SK, Park JS, Kim S, Zang D, Oh S, Kim D. Nilotinib Or High-Dose Imatinib Compared With Standard-Dose Imatinib In Early Chronic Phase CML Patients Who Have Suboptimal Molecular Responses To Standard-Dose Imatinib: Including Updated Data From RE-Nice Study Blood. 122: 1499-1499. DOI: 10.1182/blood.v122.21.1499.1499 |
0.118 |
|
| 2016 |
Ahn S, Jung S, Kim HK, Kang H, Yang D, Lee S, Ahn J, Kim Y, Kim H, Lee J. Secondary Adrenal Insufficiency Is Associated with Poor Survival Outcomes in Multiple Myeloma Blood. 128: 5631-5631. DOI: 10.1182/blood.V128.22.5631.5631 |
0.118 |
|
| 2009 |
Song JH, Kim SH, Kweon SH, Lee TH, Kim HJ, Kim HJ, Kim TS. Defective expression of deoxycytidine kinase in cytarabine-resistant acute myeloid leukemia cells. International Journal of Oncology. 34: 1165-71. PMID 19287976 DOI: 10.3892/ijo_00000245 |
0.117 |
|
| 2006 |
Ahn BM, Sohn SK, Kim JK, Chae YS, Cho YY, Moon JH, Yang DH, Lee J, Kim Y, Kim H. The Impact of Alemtuzumab as a Component of Conditioning Regimens on Transplantation Outcomes in a Setting of CMV-Seropositive Recipient and Donor. Blood. 108: 5270-5270. DOI: 10.1182/blood.v108.11.5270.5270 |
0.117 |
|
| 2014 |
Shlush LI, Zandi S, Mitchell A, Chen WC, Brandwein JM, Gupta V, Kennedy JA, Schimmer AD, Schuh AC, Yee KW, McLeod JL, Doedens M, Medeiros JJ, Marke R, Kim HJ, et al. Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia. Nature. 506: 328-33. PMID 24522528 DOI: 10.1038/nature13038 |
0.117 |
|
| 2016 |
Suh KJ, Cheong JW, Kim I, Kim HJ, Shin DY, Koh Y, Yoon SS, Min YH, Ahn JS, Kim YK, Lee YG, Lee JO, Bang SM, Mun YC, Seong CM, et al. Prognostic Impact of IPSS-R and Chromosomal Translocations in 751 Korean Patients with Primary Myelodysplastic Syndrome. Plos One. 11: e0166245. PMID 27824923 DOI: 10.1371/journal.pone.0166245 |
0.117 |
|
| 2021 |
Kim H, Keller A, Beriwal S, Smith KJ, Vargo JA. Cost-Effectiveness of Prophylactic Cranial Irradiation versus MRI Surveillance for Extensive Stage Small Cell Lung Cancer. International Journal of Radiation Oncology, Biology, Physics. PMID 33984410 DOI: 10.1016/j.ijrobp.2021.04.049 |
0.117 |
|
| 2019 |
Ahn JS, Kim T, Kim YK, Cho YC, Cho S, Jung SH, Ahn SY, Jung SY, Yang DH, Lee JJ, Choi S, Lee JY, Shin MG, Yoshida K, Ogawa S, ... ... Kim HJ, et al. Remission clone in acute myeloid leukemia shows growth advantage after chemotherapy but is distinct from leukemic clone. Experimental Hematology. PMID 31199945 DOI: 10.1016/J.Exphem.2019.06.001 |
0.117 |
|
| 2004 |
Kim H, Cho J, Kim JJ, Park SG, Lee DH, Park BC, Cho S. Identification of B-Cell Translocation Gene 1 as a Biomarker for Monitoring the Remission of Acute Myeloid Leukemia. Blood. 104: 4463-4463. DOI: 10.1182/blood.v104.11.4463.4463 |
0.117 |
|
| 2011 |
Tran HT, Kim HN, Lee IK, Kim YK, Ahn JS, Yang DH, Lee JJ, Kim HJ. DNA methylation changes following 5-azacitidine treatment in patients with myelodysplastic syndrome. Journal of Korean Medical Science. 26: 207-13. PMID 21286011 DOI: 10.3346/jkms.2011.26.2.207 |
0.117 |
|
| 2018 |
Kim T, Choi HY, Lee HS, Jung SH, Ahn JS, Kim HJ, Lee JJ, Yoo HD, Yang DH. Clinical response and pharmacokinetics of bendamustine as a component of salvage R-B(O)AD therapy for the treatment of primary central nervous system lymphoma (PCNSL). Bmc Cancer. 18: 729. PMID 29986691 DOI: 10.1186/s12885-018-4632-y |
0.117 |
|
| 2011 |
Huh J, Kim H, Min W, Jung CW, Kim H, Kim S, Kim Y, Kim HJ, Moon JH, Sohn SK, Kim SH, Lee WS, Won J, Mun Y, Kim H, et al. Genome-Wide Single-Nucleotide Polymorphism-Array Can Improve Prognostic Stratification of Core Binding Factor Acute Myeloid Leukemia, Especially in the Subgroup with Inv(16)/t(16;16) or without D816 C-KIT Mutation, Blood. 118: 3515-3515. DOI: 10.1182/BLOOD.V118.21.3515.3515 |
0.117 |
|
| 2008 |
Koh Y, Kim D, Kwon H, Kim MK, Kim B, Kim Y, Kim I, Kim JS, Kim JS, Kim CS, Kim H, Kwak J, Lee N, Min Y, Park CW, et al. Molecular Predictive Markers in Dose Escalation Treatment for Suboptimal Responders to Standard Dose Imatinib in CML Blood. 112: 3221-3221. DOI: 10.1182/blood.v112.11.3221.3221 |
0.116 |
|
| 2019 |
Park SH, Lee S, Song JH, Choi S, Cho M, Kwon IG, Son T, Kim HI, Cheong JH, Hyung WJ, Choi SH, Noh SH, Choi YY. Prognostic significance of body mass index and prognostic nutritional index in stage II/III gastric cancer. European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. PMID 31668977 DOI: 10.1016/j.ejso.2019.10.024 |
0.116 |
|
| 2019 |
Park S, Baek DW, Sohn SK, Ahn JS, Kim HJ, Shin HJ, Chung JS, Lee SM, Lee WS, Lim SN, Lee YJ, Choi Y, Lee HS, Cho YY, Lee GW, et al. Favorable Outcomes With Tumor Burden Reduction Following Administration of Hypomethylating Agents Before Allogeneic Hematopoietic Cell Transplantation in Patients With Higher Risk Myelodysplastic Syndrome. Clinical Lymphoma, Myeloma & Leukemia. PMID 31060990 DOI: 10.1016/j.clml.2019.03.016 |
0.116 |
|
| 2021 |
Moon WK, Kim HS. Theranostics for Breast Cancer Stem Cells. Advances in Experimental Medicine and Biology. 1187: 267-281. PMID 33983583 DOI: 10.1007/978-981-32-9620-6_13 |
0.116 |
|
| 2010 |
Shin HJ, Kim HJ, Sohn SK, Min YH, Won JH, Kim I, Yoon HJ, Lee JH, Jo DY, Joo YD, Jung CW, Lee KH, Chung JS, Ahn JS, et al. Re-analysis of the outcomes of post-remission therapy for acute myeloid leukemia with core binding factor according to years of patient enrollment. Japanese Journal of Clinical Oncology. 40: 556-66. PMID 20185460 DOI: 10.1093/jjco/hyq007 |
0.116 |
|
| 2018 |
Lee SE, Choi SY, Kim SH, Jootar S, Kim HJ, Sohn SK, Park JS, Kim SH, Zang DY, Oh SJ, Kim DW. Comparative analyses of nilotinib versus high-dose imatinib versus sustained standard-dose imatinib in patients with chronic phase chronic myeloid leukemia following suboptimal molecular response to first-line imatinib. Leukemia Research. 70: 100-105. PMID 29908417 DOI: 10.1016/j.leukres.2018.06.002 |
0.116 |
|
| 2016 |
Suh KJ, Cheong J, Shin D, Koh Y, Yoon S, Min Y, Ahn J, Kim Y, Lee Y, Lee J, Bang S, Mun Y, Seong C, Park Y, Kim B, ... ... Kim H, et al. Prognostic Impact of Chromosomal Translocations in 751 Korean Patients with Primary Myelodysplastic Syndrome Blood. 128: 5432-5432. DOI: 10.1182/blood.v128.22.5432.5432 |
0.116 |
|
| 2021 |
Park MY, Yoon YS, Kim HE, Lee JL, Park IJ, Lim SB, Yu CS, Kim JC. Surgical options for perianal fistula in patients with Crohn's disease: A comparison of seton placement, fistulotomy, and stem cell therapy. Asian Journal of Surgery. PMID 33966965 DOI: 10.1016/j.asjsur.2021.03.013 |
0.115 |
|
| 2019 |
Kim HS, Koom WS, Baek SE, Kim HI, Jung M, Beom SH, Kang B, Kim H, Chang JS, Choi YY, Son T, Cheong JH, Noh SH, Kim EH, Park JC, et al. Phase II trial of preoperative sequential chemotherapy followed by chemoradiotherapy for high-risk gastric cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 140: 143-149. PMID 31302344 DOI: 10.1016/J.Radonc.2019.06.029 |
0.115 |
|
| 2011 |
Yi JH, Huh J, Kim HJ, Kim SH, Kim HJ, Kim YK, Sohn SK, Moon JH, Kim SH, Kim KH, Won JH, Mun YC, Kim H, Park J, Jung CW, et al. Adverse prognostic impact of abnormal lesions detected by genome-wide single nucleotide polymorphism array-based karyotyping analysis in acute myeloid leukemia with normal karyotype. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 4702-8. PMID 22084373 DOI: 10.1200/JCO.2011.35.5719 |
0.115 |
|
| 2016 |
Lee YJ, Park SW, Lee IH, Ahn JS, Kim HJ, Chung JS, Shin HJ, Lee WS, Lee SM, Joo YD, Kim H, Lee HS, Kim YS, Cho YY, Moon JH, et al. Report on outcomes of hypomethylating therapy for analyzing prognostic value of Revised International Prognostic Scoring System for patients with lower-risk myelodysplastic syndromes. Annals of Hematology. PMID 27530461 DOI: 10.1007/s00277-016-2759-y |
0.115 |
|
| 2012 |
Lee HJ, Hong CY, Kim MH, Lee YK, Nguyen-Pham TN, Park BC, Yang DH, Chung IJ, Kim HJ, Lee JJ. In vitro induction of anterior gradient-2-specific cytotoxic T lymphocytes by dendritic cells transduced with recombinant adenoviruses as a potential therapy for colorectal cancer. Experimental & Molecular Medicine. 44: 60-7. PMID 22089087 DOI: 10.3858/emm.2012.44.1.006 |
0.115 |
|
| 2012 |
Lee SJ, Kang BW, Moon JH, Chae YS, Kim JG, Jung JS, Cho GJ, Jo DY, Kim YK, Kim HJ, Ryoo HM, Eom HS, Lee SM, Le SM, Joo YD, et al. Comparable analysis of outcomes for allogeneic peripheral blood stem cell transplantation from matched related and matched unrelated donors in acute myeloid leukemia. Acta Haematologica. 127: 81-9. PMID 22143083 DOI: 10.1159/000333133 |
0.114 |
|
| 2005 |
Cho JW, Kim JJ, Park SG, Lee DH, Lee SC, Kim HJ, Park BC, Cho S. Identification of B-cell translocation gene 1 as a biomarker for monitoring the remission of acute myeloid leukemia. Proteomics. 4: 3456-63. PMID 15449376 DOI: 10.1002/pmic.200400968 |
0.114 |
|
| 2007 |
Shin M, Kim H, Kim H, Lee I, Kim M, Shin J, Suh S, Ryang D. Identification of Differentially Expressed Proteins from the Mitochondria Enriched Cytoplasmic Fractions in Primary AML Cells. Blood. 110: 4302-4302. DOI: 10.1182/blood.V110.11.4302.4302 |
0.114 |
|
| 2012 |
Kim Y, Lee I, Kim DDH, Jung CW, Jang J, Kim HJ, Moon JH, Sohn SK, Won J, Kim S, Huh J, Kim N, Lee YG, Jung S, Lee J, ... Kim H, et al. NPM1, IDH1/2 and DNAH11 Gene Mutations Can Improve a Prognostic Stratification of Acute Myeloid Leukemia Patients with Normal Karyotype but Not Harboring FLT3/ITD Mutation. Blood. 120: 2534-2534. DOI: 10.1182/BLOOD.V120.21.2534.2534 |
0.114 |
|
| 2012 |
Jung SH, Ahn JS, Yang DH, Chul Park H, Bae SY, Kim YK, Kim HJ, Lee JJ. Successful Treatment of Pure Red Cell Aplasia with Rituximab in Patients after ABO-Compatible Allogeneic Hematopoietic Stem Cell Transplantation. Case Reports in Oncology. 5: 110-3. PMID 22539923 DOI: 10.1159/000337022 |
0.114 |
|
| 2016 |
Kim T, Ahn J, Tyndel MS, Kim H, Kim Y, Lee S, Ahn S, Jung S, Yang D, Lee J, Park HJ, Choi SH, Jung CW, Jang JH, Kim H, et al. Replication of New Genomic Classification System in Acute Myeloid Leukemia with Normal Karyotype Blood. 128: 2876-2876. DOI: 10.1182/Blood.V128.22.2876.2876 |
0.114 |
|
| 2010 |
Yang DH, Kim MH, Hong CY, Lee YK, Jin CJ, Pham TN, Ahn JS, Bae WK, Kim YK, Chung IJ, Kim HJ, Kalinski P, Lee JJ. Alpha-type 1-polarized dendritic cells loaded with apoptotic allogeneic myeloma cell line induce strong CTL responses against autologous myeloma cells. Annals of Hematology. 89: 795-801. PMID 20238114 DOI: 10.1007/S00277-010-0931-3 |
0.114 |
|
| 2010 |
Kang BW, Moon JH, Chae YS, Kim JG, Jung JS, Cho GJ, Jo DY, Kim YK, Kim HJ, Ryoo HM, Eom HS, Lee SM, Joo YD, Won JH, Park MR, et al. Comparative analysis of outcomes of allogeneic peripheral blood stem cell transplantation from related and unrelated donors. Annals of Hematology. 89: 813-20. PMID 20177897 DOI: 10.1007/s00277-010-0913-5 |
0.114 |
|
| 2009 |
Cheong J, Kim H, Lee K, Yoon S, Lee JH, Park H, Kim JS, Kim HY, Shim H, Seung C, Kim CS, Chung J, Hyun MS, Jo D, Jung CW, et al. Efficacy of ICT with Deferasirox in Transfusional Iron Overloaded Patients with MDS or AA. Blood. 114: 3810-3810. DOI: 10.1182/blood.v114.22.3810.3810 |
0.114 |
|
| 2009 |
Kim YK, Sohn SK, Lee JH, Yang DH, Moon JH, Ahn JS, Kim HJ, Lee JJ. Clinical efficacy of a bortezomib, cyclophosphamide, thalidomide, and dexamethasone (Vel-CTD) regimen in patients with relapsed or refractory multiple myeloma: a phase II study. Annals of Hematology. 89: 475-82. PMID 19921192 DOI: 10.1007/s00277-009-0856-x |
0.114 |
|
| 2023 |
Park SH, Kim KY, Cho M, Kim YM, Kim HI, Hyung WJ. Prognostic impact of fluorescent lymphography on gastric cancer. International Journal of Surgery (London, England). PMID 37352518 DOI: 10.1097/JS9.0000000000000572 |
0.114 |
|
| 2016 |
Byun JM, Kim YJ, Yoon HJ, Kim SY, Kim HJ, Yoon J, Min YH, Cheong JW, Park J, Lee JH, Hong DS, Park SK, Kim HJ, Ahn JS, Shin HJ, et al. Cytogenetic profiles of 2806 patients with acute myeloid leukemia-a retrospective multicenter nationwide study. Annals of Hematology. PMID 27230620 DOI: 10.1007/s00277-016-2691-1 |
0.114 |
|
| 2011 |
Sohn SK, Oh SJ, Kim BS, Ryoo HM, Chung JS, Joo YD, Bang SM, Jung CW, Kim DH, Yoon SS, Kim H, Lee HG, Won JH, Min YH, Cheong JW, ... ... Kim H, ... ... Kim HJ, et al. Trough plasma imatinib levels are correlated with optimal cytogenetic responses at 6 months after treatment with standard dose of imatinib in newly diagnosed chronic myeloid leukemia. Leukemia & Lymphoma. 52: 1024-9. PMID 21463107 DOI: 10.3109/10428194.2011.563885 |
0.113 |
|
| 2021 |
Lee MK, Zhang X, Kim HJ, Hwang YS. Peroxiredoxin 5 is involved in cancer cell invasion and tumor growth of oral squamous cell carcinoma. Oral Diseases. PMID 33969595 DOI: 10.1111/odi.13910 |
0.113 |
|
| 2014 |
Jung SH, Jang HC, Lee SS, Ahn JS, Yang DH, Kim YK, Kim HJ, Lee JJ. The impact of hyperglycemia on risk of severe infections during early period of induction therapy in patients with newly diagnosed multiple myeloma. Biomed Research International. 2014: 413149. PMID 24822205 DOI: 10.1155/2014/413149 |
0.113 |
|
| 2014 |
Ahn JS, Jung SH, Yang DH, Bae SY, Kim YK, Kim HJ, Lee JJ. Patterns of relapse or progression after bortezomib-based salvage therapy in patients with relapsed/refractory multiple myeloma. Clinical Lymphoma, Myeloma & Leukemia. 14: 389-94. PMID 24630919 DOI: 10.1016/j.clml.2014.02.004 |
0.113 |
|
| 2021 |
Kim DG, Seo WJ, Cho M, Kim YM, Huh KH, Cheong JH, Hyung WJ, Kim MS, Kim HI. Perioperative, short-, and long-term outcomes of gastric cancer surgery: Propensity score-matched analysis of patients with or without prior solid organ transplantation. European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. PMID 33906787 DOI: 10.1016/j.ejso.2021.04.017 |
0.113 |
|
| 2021 |
Kim J, Han SH, Kim HI. Detection of sarcopenic obesity and prediction of long-term survival in patients with gastric cancer using preoperative computed tomography and machine learning. Journal of Surgical Oncology. PMID 34490899 DOI: 10.1002/jso.26668 |
0.113 |
|
| 2018 |
Guner A, Kim SY, Yu JE, Min IK, Roh YH, Roh C, Seo WJ, Cho M, Choi S, Choi YY, Son T, Cheong JH, Hyung WJ, Noh SH, Kim HI. Parameters for Predicting Surgical Outcomes for Gastric Cancer Patients: Simple Is Better Than Complex. Annals of Surgical Oncology. PMID 30069658 DOI: 10.1245/s10434-018-6684-2 |
0.113 |
|
| 2009 |
Lee SR, Ryu J, Ahn J, Kim Y, Yang DH, Lee J, Sung HJ, Choi CW, Kim BS, Park BC, Kim H. Changes in Serum Protein Profiles During Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT): Clinical Significance of Serum C-Reactive Protein and Haptoglobin Levels. Blood. 114: 4658-4658. DOI: 10.1182/blood.v114.22.4658.4658 |
0.112 |
|
| 2020 |
Song GY, Jung SH, Kim K, Kim SJ, Yoon SE, Lee HS, Kim M, Ahn SY, Ahn JS, Yang DH, Kim HJ, Lee JJ. Endothelial activation and stress index (EASIX) is a reliable predictor for overall survival in patients with multiple myeloma. Bmc Cancer. 20: 803. PMID 32831058 DOI: 10.1186/s12885-020-07317-y |
0.112 |
|
| 2012 |
Park HC, Jung SH, Ahn JS, Kim MY, Yang DH, Kim YK, Kim HJ, Lee JJ. Rituximab plus Ifosfamide, Carboplatin and Etoposide for T-Cell/Histiocyte-Rich B-Cell Lymphoma Arising in Nodular Lymphocyte-Predominant Hodgkin's Lymphoma. Case Reports in Oncology. 5: 413-9. PMID 22949903 DOI: 10.1159/000341562 |
0.112 |
|
| 2019 |
Yang D, Ahn J, Ahn S, Jung S, Lee J, Kim H, Do YR, Song SY, Song G, Kim HJ, Kim T. Genomic Profiles and Subset Characterization of CD8+terminally Differentiated Effector Memory (TEMRA) Cells from Cancer Patients Blood. 134: 2329-2329. DOI: 10.1182/blood-2019-126533 |
0.112 |
|
| 2023 |
Park SH, Kim YN, Hwang J, Kim KY, Cho M, Kim YM, Hyung WJ, Kim HI. Safety and feasibility of reduced-port robotic distal gastrectomy for gastric cancer: a phase I/II clinical trial using the da Vinci Single Port(SP) robotic system. Scientific Reports. 13: 18578. PMID 37903856 DOI: 10.1038/s41598-023-45655-6 |
0.112 |
|
| 2017 |
Jung S, Lee H, Lee Y, Yang D, Kim H, Lee JH, Emmich F, Lee J. A Phase I Clinical Study of Autologous Dendritic Cell Therapy in Patients with Relapsed or Refractory Multiple Myeloma Clinical Lymphoma Myeloma and Leukemia. 17: e129-e130. DOI: 10.1016/J.CLML.2017.03.234 |
0.112 |
|
| 2019 |
Son T, Sun J, Choi S, Cho M, Kwon IG, Kim HI, Cheong JH, Choi SH, Noh SH, Woo Y, Fong Y, Park S, Hyung WJ. Multi-institutional validation of the 8th AJCC TNM staging system for gastric cancer: Analysis of survival data from high-volume Eastern centers and the SEER database. Journal of Surgical Oncology. PMID 31338834 DOI: 10.1002/jso.25639 |
0.112 |
|
| 2019 |
Ahn S, Jung S, Song G, Yang D, Ahn J, Kim H, Lee J. Clinical Impact of Enrollment of Clinical Trial in Multiple Myeloma; Single Center Experience Blood. 134: 5525-5525. DOI: 10.1182/blood-2019-127889 |
0.112 |
|
| 2009 |
Kim H, Shin M, Kweon S, Kim H, Kim H, Lee I, Shin J, Suh S, Ryang D. The Prohibitin 3′ Untranslated Region Polymorphisms Are Associated with AML Susceptibility. Blood. 114: 5038-5038. DOI: 10.1182/blood.V114.22.5038.5038 |
0.111 |
|
| 2023 |
Hong M, Choi M, Lee J, Kim KH, Kim H, Lee CK, Kim HS, Rha SY, Pih GY, Choi YJ, Jung DH, Park JC, Shin SK, Lee SK, Lee YC, ... ... Kim HI, et al. Impact of Coronavirus Disease 2019 on Gastric Cancer Diagnosis and Stage: A Single-Institute Study in South Korea. Journal of Gastric Cancer. 23: 574-583. PMID 37932224 DOI: 10.5230/jgc.2023.23.e36 |
0.111 |
|
| 2012 |
Taki T, Kim H, Ohtake S, Cho B, Kiyoi H, Min W, Asou N, Choi S, Miyazaki Y, Kim Y, Sakamaki H, Cheong J, Honda S, Miyawaki S, Taniwaki M, ... Kim H, et al. Incidence and Clinical Features of Core Binding Factor Acute Myeloid Leukemia: A Collaborative Study of the Japan Adult Leukemia Study Group and the Korean Society of Hematology. Blood. 120: 2584-2584. DOI: 10.1182/blood.v120.21.2584.2584 |
0.111 |
|
| 2016 |
Jung S, Kim K, Kim JS, Kim SJ, Cheong J, Kim S, Ahn J, Ahn S, Yang D, Kim H, Lee J. A Prognostic Scoring System for Patients with Multiple Myeloma Who Were Classified Stage II By Revised International Staging System Blood. 128: 3284-3284. DOI: 10.1182/blood.V128.22.3284.3284 |
0.111 |
|
| 2012 |
Nguyen-Pham TN, Yang DH, Nguyen TA, Lim MS, Hong CY, Kim MH, Lee HJ, Lee YK, Cho D, Bae SY, Ahn JS, Kim YK, Chung IJ, Kim HJ, Lee JJ. Optimal culture conditions for the generation of natural killer cell-induced dendritic cells for cancer immunotherapy. Cellular & Molecular Immunology. 9: 45-53. PMID 21822297 DOI: 10.1038/cmi.2011.23 |
0.111 |
|
| 2016 |
Nguyen HH, Kim T, Song SY, Park S, Cho HH, Jung SH, Ahn JS, Kim HJ, Lee JJ, Kim HO, Cho JH, Yang DH. Naïve CD8(+) T cell derived tumor-specific cytotoxic effectors as a potential remedy for overcoming TGF-β immunosuppression in the tumor microenvironment. Scientific Reports. 6: 28208. PMID 27306834 DOI: 10.1038/srep28208 |
0.111 |
|
| 2018 |
Guner A, Kim HI. ASO Author Reflections: Parameters for Predicting Surgical Outcomes for Gastric Cancer Patients: Simple Is Better Than Complex. Annals of Surgical Oncology. PMID 30167908 DOI: 10.1245/s10434-018-6725-x |
0.111 |
|
| 2008 |
Kim JY, Song HJ, Lim HJ, Shin MG, Kim JS, Kim HJ, Kim BY, Lee SW. Platelet factor-4 is an indicator of blood count recovery in acute myeloid leukemia patients in complete remission. Molecular & Cellular Proteomics : McP. 7: 431-41. PMID 17998245 DOI: 10.1074/mcp.M700194-MCP200 |
0.11 |
|
| 2009 |
Ahn JS, Cho SH, Kim YK, Yang DH, Bae WK, Shim HJ, Lee JJ, Chung IJ, Juhng SW, Kim HJ. Polymyositis and myocarditis after donor lymphocyte infusion. International Journal of Hematology. 90: 113-116. PMID 19472035 DOI: 10.1007/s12185-009-0332-3 |
0.11 |
|
| 2014 |
Chung DY, Kim HI, Chung YH, Lee MJ, Yoo SJ, Bokare AD, Choi W, Sung YE. Inhibition of CO poisoning on Pt catalyst coupled with the reduction of toxic hexavalent chromium in a dual-functional fuel cell. Scientific Reports. 4: 7450. PMID 25502744 DOI: 10.1038/Srep07450 |
0.11 |
|
| 2015 |
Ahn JS, Kim JY, Kim HJ, Kim YK, Lee SS, Jung SH, Yang DH, Lee JJ, Kim NY, Choi SH, Minden MD, Jung CW, Jang JH, Kim HJ, Moon JH, et al. Erratum to: Normal karyotype acute myeloid leukemia patients with CEBPA double mutation have a favorable prognosis but no survival benefit from allogeneic stem cell transplant. Annals of Hematology. PMID 26630982 DOI: 10.1007/s00277-015-2563-0 |
0.11 |
|
| 2020 |
Song JH, Son T, Lee S, Choi S, Cho M, Kim YM, Kim HI, Hyung WJ. D2 Lymph Node Dissections during Reduced-port Robotic Distal Subtotal Gastrectomy and Conventional Laparoscopic Surgery Performed by a Single Surgeon in a High-volume Center: a Propensity Score-matched Analysis. Journal of Gastric Cancer. 20: 431-441. PMID 33425444 DOI: 10.5230/jgc.2020.20.e36 |
0.11 |
|
| 2021 |
Kim ST, Park CI, Kim HW, Jeon S, Kang JI, Kim SJ. Dysfunctional Metacognitive Beliefs in Patients With Obsessive-Compulsive Disorder and Pattern of Their Changes Following a 3-Month Treatment. Frontiers in Psychiatry. 12: 628985. PMID 33967851 DOI: 10.3389/fpsyt.2021.628985 |
0.11 |
|
| 2018 |
Hyung WJ, Yang HK, Han SU, Lee YJ, Park JM, Kim JJ, Kwon OK, Kong SH, Kim HI, Lee HJ, Kim W, Ryu SW, Jin SH, Oh SJ, Ryu KW, et al. A feasibility study of laparoscopic total gastrectomy for clinical stage I gastric cancer: a prospective multi-center phase II clinical trial, KLASS 03. Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. PMID 30128720 DOI: 10.1007/s10120-018-0864-4 |
0.11 |
|
| 2012 |
Kong JH, Mun YC, Kim S, Choi HS, Kim YK, Kim HJ, Moon JH, Sohn SK, Kim SH, Jung CW, Dennis Kim DH. Polymorphisms of ERCC1 genotype associated with response to imatinib therapy in chronic phase chronic myeloid leukemia. International Journal of Hematology. 96: 327-33. PMID 22821389 DOI: 10.1007/s12185-012-1142-6 |
0.11 |
|
| 2007 |
Kim JG, Sohn SK, Chae YS, Cho YY, Yang DH, Lee JJ, Kim HJ, Shin HJ, Chung JS, Cho GJ, Lee WS, Joo YD, Sohn CH, Oh SJ. Alemtuzumab plus CHOP as front-line chemotherapy for patients with peripheral T-cell lymphomas: a phase II study. Cancer Chemotherapy and Pharmacology. 60: 129-34. PMID 17406867 DOI: 10.1007/s00280-007-0469-9 |
0.11 |
|
| 2016 |
Son MH, Kim T, Ahn J, Tyndel M, Kim H, Kim Y, Lee S, Ahn S, Jung S, Yang D, Lee J, Park HJ, Choi SH, Zhang Z, Kim DDH. Aside from the Allelic Burden of JAK2-V617F, Acquisition of Mutations in Myeloid Gene Panel Is Associated with the Transformation of Myeloproliferative Neoplasm into Secondary AML Blood. 128: 4281-4281. DOI: 10.1182/Blood.V128.22.4281.4281 |
0.11 |
|
| 2018 |
Kim T, Moon JH, Ahn J, Tyndel MS, Lee S, Ahn S, Jung S, Yang D, Lee J, Choi S, Lee J, Lee Y, Sohn SK, Zhang Z, Kim H, et al. RNA Sequencing-Based Measurement of Fusion-Transcript for Minimal Residual Disease (MRD) Monitoring in Core-Binding Factor Acute Myeloid Leukemia (CBF-AML) Blood. 132: 2669-2669. DOI: 10.1182/Blood-2018-99-112037 |
0.11 |
|
| 2006 |
Jeong S, Lee J, Sohn S, Shin H, Yang D, Kim Y, Kim S, Baek J, Kim D, Kim J, Chung J, Cho G, Kim H. Clinical Efficacy of Thalidomide Containing Regimens as a Primary Therapy in Patients with Multiple Myeloma The Korean Journal of Hematology. 41: 83. DOI: 10.5045/kjh.2006.41.2.83 |
0.11 |
|
| 2002 |
Chung IJ, Lee JJ, Park MR, Kook H, Cho SH, Hwang TJ, Kim HJ. Allogeneic peripheral blood stem cell rescue of late graft failure after bone marrow transplantation in patients with aplastic anemia. Journal of Korean Medical Science. 17: 468-74. PMID 12172040 DOI: 10.3346/jkms.2002.17.4.468 |
0.109 |
|
| 2010 |
Kang SJ, Park KH, Jung SI, Jang HC, Ji SY, Ahn JS, Kim HJ, Shin JH, Kim DM. Scrub typhus induced by peripheral blood stem cell transplantation in the immunocompromised patient: diagnostic usefulness of nested polymerase chain reaction. Transfusion. 50: 467-70. PMID 19843286 DOI: 10.1111/j.1537-2995.2009.02442.x |
0.109 |
|
| 2021 |
Kim SH, Choo GS, Yoo ES, Woo JS, Lee JH, Han SH, Jung SH, Kim HJ, Jung JY. Silymarin inhibits proliferation of human breast cancer cells via regulation of the MAPK signaling pathway and induction of apoptosis. Oncology Letters. 21: 492. PMID 33968208 DOI: 10.3892/ol.2021.12753 |
0.109 |
|
| 2022 |
Guner A, Kim KY, Park SH, Cho M, Kim YM, Hyung WJ, Kim HI. Safe Discharge Criteria After Curative Gastrectomy for Gastric Cancer. Journal of Gastric Cancer. 22: 395-407. PMID 36316113 DOI: 10.5230/jgc.2022.22.e32 |
0.109 |
|
| 2013 |
Jung SH, Yang DH, Ahn JS, Lee SS, Ahn SY, Kim YK, Kim HJ, Lee JJ. Decreased body mass index is associated with poor prognosis in patients with multiple myeloma. Annals of Hematology. 93: 835-40. PMID 24310866 DOI: 10.1007/s00277-013-1977-9 |
0.109 |
|
| 2009 |
Kim HR, Shin M, Kim Y, Kim HJ, Cho D, Kee S, Kim S, Shin J, Suh S, Ryang D. AML FAB Subtypes Shows Different Proportion of Leukemia Initiating Cell Which Has Lower Single Cell Dividing Property. Blood. 114: 4568-4568. DOI: 10.1182/BLOOD.V114.22.4568.4568 |
0.109 |
|
| 2010 |
Ahn J, Kim HN, Kim NY, Li Y, Lee I, Kim Y, Bae S, Yang D, Lee J, Kim HJ. Clinical Significance of Polymorphisms During Hepatopoietic Stem Cell Transplantation. Blood. 116: 3497-3497. DOI: 10.1182/blood.v116.21.3497.3497 |
0.109 |
|
| 2013 |
Kim Y, Chung S, Ahn J, Yang D, Lee I, Kim N, Yu L, Lee J, Kim H. Efficacy and Safety Of Eltrombopag In Korean Adult Patients With Refractory Chronic Immune Thrombocytopenia Blood. 122: 4758-4758. DOI: 10.1182/blood.V122.21.4758.4758 |
0.108 |
|
| 2015 |
Kwon IG, Cho I, Guner A, Kim HI, Noh SH, Hyung WJ. Minimally invasive surgery as a treatment option for gastric cancer in the elderly: comparison with open surgery for patients 80 years and older. Surgical Endoscopy. 29: 2321-30. PMID 25480603 DOI: 10.1007/s00464-014-3955-2 |
0.108 |
|
| 2012 |
Lee HJ, Hong CY, Jin CJ, Kim MH, Lee YK, Nguyen-Pham TN, Lee H, Park BC, Chung IJ, Kim HJ, Lee JJ. Identification of novel HLA-A*0201-restricted epitopes from anterior gradient-2 as a tumor-associated antigen against colorectal cancer. Cellular & Molecular Immunology. 9: 175-83. PMID 22231555 DOI: 10.1038/cmi.2011.52 |
0.108 |
|
| 2009 |
Kim JA, Kim DHD, Won YW, Park S, Kim H, Kim S, Jang JH, Kim K, Kim Y, Lee J, Kim H, Moon JH, Sohn SK, Jung CW. Candidate Pathway Approach of Single Nucleotide Polymorphism On Imatinib Transport/Metabolism Pathway and DNA Repair Enzyme Pathway Associated with Response and Resistance to Imatinib Therapy in Chronic Myeloid Leukemia. Blood. 114: 3284-3284. DOI: 10.1182/blood.v114.22.3284.3284 |
0.108 |
|
| 2012 |
Jung S, Ahn J, Kang S, Yang D, Kim Y, Kim H, Lee J. Lymphocytopenia Is Associated with an Increased Risk of Severe Infections in Patients with Multiple Myeloma Treated with Bortezomib-Based Regimens Blood. 120: 5042-5042. DOI: 10.1182/BLOOD.V120.21.5042.5042 |
0.108 |
|
| 2019 |
Brenkman HJF, Cho M, Ruurda JP, Song K, Son T, Kim HI, Noh SH, van Hillegersberg R, Hyung WJ. European validation of the Yonsei Gastric Cancer Prognosis Prediction Model after gastrectomy: Validation with the Netherlands Cancer Registry. European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. PMID 30654921 DOI: 10.1016/j.ejso.2019.01.001 |
0.108 |
|
| 2021 |
Park SM, Kim DA, Jo JK, Jun SK, Jang TS, Kim HW, Lee JH, Lee HH. Ceria-Incorporated Biopolymer for Preventing Fungal Adhesion. Acs Biomaterials Science & Engineering. 7: 1808-1816. PMID 33966380 DOI: 10.1021/acsbiomaterials.0c01039 |
0.108 |
|
| 2020 |
Yang HK, Hyung WJ, Han SU, Lee YJ, Park JM, Cho GS, Kwon OK, Kong SH, Kim HI, Lee HJ, Kim W, Ryu SW, Jin SH, Oh SJ, Ryu KW, et al. Comparison of surgical outcomes among different methods of esophagojejunostomy in laparoscopic total gastrectomy for clinical stage I proximal gastric cancer: results of a single-arm multicenter phase II clinical trial in Korea, KLASS 03. Surgical Endoscopy. PMID 32144557 DOI: 10.1007/s00464-020-07480-0 |
0.108 |
|
| 2010 |
Ryu J, Lee SR, Park SG, Kang S, Kim HJ, Park BC. Change in serum proteome during allogeneic hematopoietic stem cell transplantation and clinical significance of serum C-reactive protein and haptoglobin. Experimental & Molecular Medicine. 42: 651-61. PMID 20716902 DOI: 10.3858/Emm.2010.42.9.065 |
0.108 |
|
| 2012 |
Ahn JS, Yang DH, Jung SH, Park HC, Moon JH, Sohn SK, Bae SY, Kim YK, Kim HJ, Lee JJ. A comparison of bortezomib, cyclophosphamide, and dexamethasone (Vel-CD) chemotherapy without and with thalidomide (Vel-CTD) for the treatment of relapsed or refractory multiple myeloma. Annals of Hematology. 91: 1023-30. PMID 22314843 DOI: 10.1007/s00277-012-1420-7 |
0.108 |
|
| 2020 |
Hyung WJ, Yang HK, Park YK, Lee HJ, An JY, Kim W, Kim HI, Kim HH, Ryu SW, Hur H, Kim MC, Kong SH, Cho GS, Kim JJ, Park DJ, et al. Long-Term Outcomes of Laparoscopic Distal Gastrectomy for Locally Advanced Gastric Cancer: The KLASS-02-RCT Randomized Clinical Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2001210. PMID 32816629 DOI: 10.1200/JCO.20.01210 |
0.108 |
|
| 2006 |
Kim JG, Sohn SK, Chae YS, Kim DH, Baek JH, Lee KB, Lee JJ, Chung IJ, Kim HJ, Yang DH, Lee WS, Joo YD, Sohn CH. CHOP plus etoposide and gemcitabine (CHOP-EG) as front-line chemotherapy for patients with peripheral T cell lymphomas. Cancer Chemotherapy and Pharmacology. 58: 35-9. PMID 16308699 DOI: 10.1007/s00280-005-0136-y |
0.108 |
|
| 2013 |
Yang DH, Ahn JS, Byun BH, Min JJ, Kweon SS, Chae YS, Sohn SK, Lee SW, Kim HW, Jung SH, Kim YK, Kim HJ, Bom HS, Lee JJ. Interim PET/CT-based prognostic model for the treatment of diffuse large B cell lymphoma in the post-rituximab era. Annals of Hematology. 92: 471-9. PMID 23238895 DOI: 10.1007/s00277-012-1640-x |
0.108 |
|
| 2015 |
Kim YK, Lee SS, Jeong SH, Ahn JS, Yang DH, Lee JJ, Kim HJ. Efficacy and safety of eltrombopag in adult refractory immune thrombocytopenia. Blood Research. 50: 19-25. PMID 25830126 DOI: 10.5045/br.2015.50.1.19 |
0.107 |
|
| 2013 |
Kim H, Jeong K, Park J. Evaluation of saliva and cariogenic activity in patients with hematologic malignancy Journal of Korean Society of Dental Hygiene. 13: 509-515. DOI: 10.13065/JKSDH.2013.13.3.509 |
0.107 |
|
| 2021 |
Guner A, Cho M, Kim YM, Cheong JH, Hyung WJ, Kim HI. Prognostic Value of Postoperative Neutrophil and Albumin: Reassessment One Month After Gastric Cancer Surgery. Frontiers in Oncology. 11: 633924. PMID 33833991 DOI: 10.3389/fonc.2021.633924 |
0.107 |
|
| 2023 |
Ikoma N, Grotz T, Kawakubo H, Kim HI, Matsuda S, Hirata Y, Nakao A, Williams LA, Wang XS, Mendoza T, Wang X, Badgwell BD, Mansfield PF, Hyung WJ, Strong VE, et al. Trans-pacific multicenter collaborative study of minimally invasive proximal versus total gastrectomy for proximal gastric and gastroesophageal junction cancers. Bmc Surgery. 23: 262. PMID 37653380 DOI: 10.1186/s12893-023-02163-8 |
0.107 |
|
| 2010 |
Yang D, Min J, Song H, Jeong YY, Chung W, Bae S, Ahn J, Kim Y, Bom H, Chung I, Kim HJ, Lee J. Prognostic Significance of Interim 18f-FDG PET/CT for the Treatment of Diffuse Large B-Cell Lymphoma In the Post-Rituximab Era. Blood. 116: 1799-1799. DOI: 10.1182/blood.v116.21.1799.1799 |
0.107 |
|
| 2006 |
Choi HW, Shin MG, Sawyer JR, Cho D, Kee SJ, Baek HJ, Kook H, Kim HJ, Shin JH, Suh SP, Hwang TJ, Ryang DW. Unusual type of TLS/FUS-ERG chimeric transcript in a pediatric acute myelocytic leukemia with 47,XX,+10,t(16;21)(p11;q22). Cancer Genetics and Cytogenetics. 167: 172-6. PMID 16737920 DOI: 10.1016/j.cancergencyto.2006.01.003 |
0.107 |
|
| 2021 |
Kim HY, Kim YM, Hong S. DNAJB9 suppresses the metastasis of triple-negative breast cancer by promoting FBXO45-mediated degradation of ZEB1. Cell Death & Disease. 12: 461. PMID 33966034 DOI: 10.1038/s41419-021-03757-x |
0.107 |
|
| 2010 |
Kim Y, Bae S, Kim HN, Kim NY, Kim H, Bang S, Jo D, Won J, Lee N, Kwak J, Ahn J, Yang D, Lee I, Lee J, Kim HJ. Prognostic Impact of DNA Repair and MDR-1 Gene Polymorphisms In De Novo Acute Myeloid Leukemia with t(8;21) or Inv(16) Blood. 116: 1714-1714. DOI: 10.1182/blood.v116.21.1714.1714 |
0.107 |
|
| 2018 |
Kim T, Moon JH, Ahn J, Tyndel MS, Lee S, Ahn S, Jung S, Yang D, Lee J, Choi S, Lee J, Lee Y, Sohn SK, Kim H, Zhang Z, et al. Residual Allelic Burden Measured By Next-Generation Sequencing (NGS) at Remission Provides Limited Prognostic Value to Predict Relapse and Long-Term Outcome in Core Binding Factor Acute Myeloid Leukemia (CBF-AML) Blood. 132: 1391-1391. DOI: 10.1182/Blood-2018-99-112906 |
0.106 |
|
| 2011 |
Koh Y, Kim DY, Park SH, Jung SH, Park E, Kim HJ, Sohn SK, Joo YD, Kim SJ, Shin HJ, Kim SH, Song HS, Chung J, Kim I, Yoon SS, et al. GSTT1 copy number gain is a poor predictive marker for escalated-dose imatinib treatment in chronic myeloid leukemia: genetic predictive marker found using array comparative genomic hybridization. Cancer Genetics and Cytogenetics. 203: 215-21. PMID 21156236 DOI: 10.1016/j.cancergencyto.2010.08.022 |
0.106 |
|
| 2013 |
An JY, Kim HI, Cheong JH, Hyung WJ, Kim CB, Noh SH. Pathologic and oncologic outcomes in locally advanced gastric cancer with neoadjuvant chemotherapy or chemoradiotherapy. Yonsei Medical Journal. 54: 888-94. PMID 23709422 DOI: 10.3349/ymj.2013.54.4.888 |
0.106 |
|
| 2005 |
Lee I, Choi J, Lee YR, Kim Y, Kim HN, Park K, Lee J, Shin MG, Choi C, Kook H, Hwang TJ, Park MR, Jo DY, Won JH, Kim H. A Single Nucleotide Polymorphism and Its Haplotype of ZNF42 Transcriptional Modulator Gene Predisposes Individuals to High-Risk Acute Myelogenous Leukemia (AML). Blood. 106: 4248-4248. DOI: 10.1182/blood.v106.11.4248.4248 |
0.106 |
|
| 2021 |
Amoozgar Z, Kloepper J, Ren J, Tay RE, Kazer SW, Kiner E, Krishnan S, Posada JM, Ghosh M, Mamessier E, Wong C, Ferraro GB, Batista A, Wang N, Badeaux M, ... ... Kim HJ, et al. Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas. Nature Communications. 12: 2582. PMID 33976133 DOI: 10.1038/s41467-021-22885-8 |
0.106 |
|
| 2017 |
Jung SH, Lee HJ, Vo MC, Kim HJ, Lee JJ. Immunotherapy for the treatment of multiple myeloma. Critical Reviews in Oncology/Hematology. 111: 87-93. PMID 28259300 DOI: 10.1016/j.critrevonc.2017.01.011 |
0.106 |
|
| 2021 |
Seo WJ, Choi S, Roh CK, Cho M, Kim YM, Kim HI, Hyung WJ. Omentum preservation as an oncologically comparable and surgically superior alternative to total omentectomy during radical gastrectomy for T3-T4 gastric cancer. Surgery. PMID 33714618 DOI: 10.1016/j.surg.2021.02.008 |
0.106 |
|
| 2020 |
Do YR, Kwak JY, Kim JA, Kim HJ, Chung JS, Shin HJ, Kim SH, Bunworasate U, Choi CW, Zang DY, Oh SJ, Jootar S, Reksodiputro AH, Lee WS, Mun YC, ... ... Kim H, et al. Long-term data from a phase 3 study of radotinib versus imatinib in patients with newly diagnosed, chronic myeloid leukaemia in the chronic phase (RERISE). British Journal of Haematology. PMID 32012231 DOI: 10.1111/bjh.16381 |
0.105 |
|
| 2010 |
Pham TN, Hong CY, Min JJ, Rhee JH, Nguyen TA, Park BC, Yang DH, Park YK, Kim HR, Chung IJ, Kim HJ, Lee JJ. Enhancement of antitumor effect using dendritic cells activated with natural killer cells in the presence of Toll-like receptor agonist. Experimental & Molecular Medicine. 42: 407-19. PMID 20386085 DOI: 10.3858/emm.2010.42.6.042 |
0.105 |
|
| 2016 |
Ahn JS, Kim HJ, Kim YK, Lee SS, Ahn SY, Jung SH, Yang DH, Lee JJ, Park HJ, Choi SH, Jung CW, Jang JH, Kim HJ, Moon JH, Sohn SK, et al. 5-Hydroxymethylcytosine correlates with epigenetic regulatory mutations, but may not have prognostic value in predicting survival in normal karyotype acute myeloid leukemia. Oncotarget. PMID 28039446 DOI: 10.18632/oncotarget.14171 |
0.105 |
|
| 2009 |
Kang BW, Kim SN, Moon JH, Jung J, Cho G, Jo DY, Kim Y, Kim HJ, Ryoo H, Eom HS, Lee SM, Joo Y, Won JH, Park M, Kim MK, et al. Comparative Analysis of Outcomes of Allogeneic Peripheral Blood Stem Cell Transplantation From Related and Unrelated Donors. Blood. 114: 3381-3381. DOI: 10.1182/blood.v114.22.3381.3381 |
0.104 |
|
| 2006 |
Kim SH, Song JH, Choi BG, Kim HJ, Kim TS. Chemical modification of santonin into a diacetoxy acetal form confers the ability to induce differentiation of human promyelocytic leukemia cells via the down-regulation of NF-kappaB DNA binding activity. The Journal of Biological Chemistry. 281: 13117-25. PMID 16554308 DOI: 10.1074/jbc.M510944200 |
0.104 |
|
| 2010 |
Kim DH(, Han B, Lee K, Ahn T, Son D, Sohn I, Jung S, Park K, Jang JH, Kim K, Kim HJ, Sohn SK, Moon JH, Kim J, Huh N, et al. Pharmacogenomics-Based Drug Response Prediction Model for Acute Myeloid Leukemia with Normal Karyotype Blood. 116: 2698-2698. DOI: 10.1182/Blood.V116.21.2698.2698 |
0.104 |
|
| 2017 |
Jung DH, Lee YC, Kim JH, Chung H, Park JC, Shin SK, Lee SK, Kim HI, Hyung WJ, Noh SH. Postoperative Helicobacter pylori Infection as a Prognostic Factor for Gastric Cancer Patients after Curative Resection. Gut and Liver. PMID 28395509 DOI: 10.5009/gnl16397 |
0.104 |
|
| 2005 |
Yang D, Mun Y, Shin H, Kim Y, Lee J, Jin C, Seong C, Kim H. Predictable Prognostic Factor of CD56 Expression in Acute Myeloid Leukemia with t(8:21) Including Allogeneic Hematopoietic Stem Cell Transplantation. Blood. 106: 3288-3288. DOI: 10.1182/blood.V106.11.3288.3288 |
0.104 |
|
| 2021 |
Choi S, Song JH, Lee S, Cho M, Kim YM, Kim HI, Hyung WJ. Trends in clinical outcomes and long-term survival after robotic gastrectomy for gastric cancer: a single high-volume center experience of consecutive 2000 patients. Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. PMID 34405291 DOI: 10.1007/s10120-021-01231-3 |
0.104 |
|
| 2019 |
Shin SJ, Kim SY, Choi YY, Son T, Cheong JH, Hyung WJ, Noh SH, Park CG, Kim HI. Mismatch Repair Status of Gastric Cancer and Its Association with the Local and Systemic Immune Response. The Oncologist. PMID 30894409 DOI: 10.1634/theoncologist.2018-0273 |
0.104 |
|
| 2014 |
Kim YK, Lee SS, Jeong SH, Ahn JS, Yang DH, Lee JJ, Shin MG, Kim HJ. OCT-1, ABCB1, and ABCG2 Expression in Imatinib-Resistant Chronic Myeloid Leukemia Treated with Dasatinib or Nilotinib. Chonnam Medical Journal. 50: 102-11. PMID 25568846 DOI: 10.4068/cmj.2014.50.3.102 |
0.104 |
|
| 2020 |
Seo WJ, Son T, Shin H, Choi S, Roh CK, Cho M, Kim HI, Hyung WJ. Reduced-port totally robotic distal subtotal gastrectomy for gastric cancer: 100 consecutive cases in comparison with conventional robotic and laparoscopic distal subtotal gastrectomy. Scientific Reports. 10: 16015. PMID 32994484 DOI: 10.1038/s41598-020-73118-9 |
0.104 |
|
| 2023 |
Moon J, Chun DH, Kong HJ, Lee HS, Jeon S, Park J, Kim NY, Kim HI. The Intraoperative Administration of Dexmedetomidine Alleviates Postoperative Inflammatory Response in Patients Undergoing Laparoscopy-Assisted Gastrectomy: A Double-Blind Randomized Controlled Trial. Biomedicines. 11. PMID 38137474 DOI: 10.3390/biomedicines11123253 |
0.104 |
|
| 2023 |
Kim HI, Lee SH, Shin SJ, Park JH, Yu JE, Lee SW, Yang SH, Pires L, Wilson BC. Phonozen-mediated photodynamic therapy comparing two wavelengths in a mouse model of peritoneal carcinomatosis. Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society For Photobiology. PMID 37632684 DOI: 10.1007/s43630-023-00470-w |
0.104 |
|
| 2014 |
Nguyen H, Kim D, Lee H, Jung S, Kim H, Lee J, Yang D. Generation of Potent Tumor-Specific CTLs from High-Dose IL-2 Activated naïve CD8 T Cells with Overcoming the Tumor-Derived Immune Suppression Blood. 124: 4973-4973. DOI: 10.1182/blood.V124.21.4973.4973 |
0.104 |
|
| 2008 |
Kim HN, Yu L, Kim NY, Lee I, Kim Y, Yang D, Lee J, Kim H, Min WS, Park M, Jo D, Won J, Kwak J, Kim HJ. GST T1 and GST M1 Polymorphisms Are Associated with the Risk of Acute Myeloid Leukemia Blood. 112: 3978-3978. DOI: 10.1182/blood.v112.11.3978.3978 |
0.104 |
|
| 2015 |
Ahn JS, Kim HJ, Kim YK, Lee SS, Jung SH, Yang DH, Lee JJ, Kim NY, Choi SH, Jung CW, Jang JH, Kim HJ, Moon JH, Sohn SK, Won JH, et al. DNMT3A R882 mutation with FLT3-ITD positivity is an extremely poor prognostic factor in patients with normal-karyotype AML after allogeneic hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 26234722 DOI: 10.1016/j.bbmt.2015.07.030 |
0.104 |
|
| 2015 |
Park CH, Park JC, Kim EH, Chung H, An JY, Kim HI, Shin SK, Lee SK, Cheong JH, Hyung WJ, Lee YC, Noh SH, Kim CB. Impact of carcinomatosis and ascites status on long-term outcomes of palliative treatment for patients with gastric outlet obstruction caused by unresectable gastric cancer: stent placement versus palliative gastrojejunostomy. Gastrointestinal Endoscopy. 81: 321-32. PMID 25085332 DOI: 10.1016/j.gie.2014.06.024 |
0.103 |
|
| 2005 |
Lee JJ, Choi BH, Nam JH, Park MS, Song WH, Yang DH, Kim YK, Cho SH, Chung IJ, Park KS, Lee IK, Kim HJ. The generation of leukemic dendritic cells from acute myeloid leukemia cells is potentiated by the addition of CD40L at the terminal maturation stage. Journal of Clinical Apheresis. 19: 130-6. PMID 15493054 DOI: 10.1002/jca.20015 |
0.103 |
|
| 2014 |
Jung SH, Lee YK, Lee HJ, Choi NR, Vo MC, Hoang MD, Lim MS, Nguyen-Pham TN, Kim HJ, Lee JJ. Dendritic cells loaded with myeloma cells pretreated with a combination of JSI-124 and bortezomib generate potent myeloma-specific cytotoxic T lymphocytes in vitro. Experimental Hematology. 42: 274-81. PMID 24407159 DOI: 10.1016/j.exphem.2013.12.008 |
0.103 |
|
| 2006 |
Kim HN, Tran HTT, Lee I, Kim Y, Yang D, Lee J, Shin M, Kook H, Hwang TJ, Park MR, Jo DY, Won JH, Kim H. Polymorphisms of Thymidylate Synthase in the 5′- and 3′-Untranslated Regions Associated with Risk of Non-Hodgkin’s Lymphoma. Blood. 108: 2394-2394. DOI: 10.1182/blood.v108.11.2394.2394 |
0.103 |
|
| 2015 |
Park SH, Lee HJ, Kim IS, Kang JE, Lee EY, Kim HJ, Kim YK, Won JH, Bang SM, Kim H, Song MK, Chung JS, Shin HJ. Incidences and Prognostic Impact of c-KIT, WT1, CEBPA, and CBL Mutations, and Mutations Associated With Epigenetic Modification in Core Binding Factor Acute Myeloid Leukemia: A Multicenter Study in a Korean Population. Annals of Laboratory Medicine. 35: 288-97. PMID 25932436 DOI: 10.3343/alm.2015.35.3.288 |
0.103 |
|
| 2022 |
Son SY, Hur H, Hyung WJ, Park YK, Lee HJ, An JY, Kim W, Kim HI, Kim HH, Ryu SW, Kim MC, Kong SH, Cho GS, Kim JJ, Park DJ, et al. Laparoscopic vs Open Distal Gastrectomy for Locally Advanced Gastric Cancer: 5-Year Outcomes of the KLASS-02 Randomized Clinical Trial. Jama Surgery. PMID 35857305 DOI: 10.1001/jamasurg.2022.2749 |
0.103 |
|
| 2021 |
Chandra Barman S, Sharifuzzaman M, Zahed MA, Park C, Yoon SH, Zhang S, Kim H, Yoon H, Park JY. A highly selective and stable cationic polyelectrolyte encapsulated black phosphorene based impedimetric immunosensor for Interleukin-6 biomarker detection. Biosensors & Bioelectronics. 186: 113287. PMID 33962178 DOI: 10.1016/j.bios.2021.113287 |
0.103 |
|
| 2014 |
Harada H, Shibayama H, Jang JH, Shimazaki R, Mitani K, Sawada K, Kim H. A Randomized Study to Determine the Optimal Dose of Darbepoetin Alfa in Patients with Low- or Intermediate-1 Risk Myelodysplastic Syndromes Blood. 124: 4642-4642. DOI: 10.1182/blood.V124.21.4642.4642 |
0.103 |
|
| 2021 |
Jeong YH, Hwang S, Lee GD, Choi SH, Kim HR, Kim YH, Park SI, Kim DK. Surgical Outcome of Pulmonary Metastasectomy for Hepatocellular Carcinoma Recurrence in Liver Transplant Patients. Annals of Transplantation. 26: e930383. PMID 33972494 DOI: 10.12659/AOT.930383 |
0.103 |
|
| 2006 |
Yang D, Lee J, Min J, Lee S, Kim Y, Bom H, Kim H. Clinical Usefulness and Therapeutic Plan with Interim PET/CT Analysis in Malignant Lymphoma. Blood. 108: 2403-2403. DOI: 10.1182/blood.v108.11.2403.2403 |
0.103 |
|
| 2018 |
Ahn S, Jung S, Jung S, Ahn J, Lee J, Kim H, Kang S, Han Y, Kwak J, Yhim H, Yang D. Prognostic Significance of FDG-PET/CT on Determining Upfront Autologous Stem Cell Transplantation for the Treatment of Peripheral T Cell Lymphomas Blood. 132: 1632-1632. DOI: 10.1182/blood-2018-99-118168 |
0.103 |
|
| 2019 |
Alhossaini RM, Altamran AA, Cho M, Roh CK, Seo WJ, Choi S, Son T, Kim HI, Hyung WJ. Lower rate of conversion using robotic-assisted surgery compared to laparoscopy in completion total gastrectomy for remnant gastric cancer. Surgical Endoscopy. PMID 31139994 DOI: 10.1007/s00464-019-06838-3 |
0.103 |
|
| 2011 |
Hong CY, Kalinski P, Kim H, Lee J. The Lymphoid Chemokine CCL21 Enhances the Migration- and CTL-Inducing Functions of Dendritic Cells Blood. 118: 1127-1127. DOI: 10.1182/Blood.V118.21.1127.1127 |
0.102 |
|
| 2006 |
Shin M, Joon Kim H, Kim H, Lee I, Cho D, Kee S, Kook H, Hwang T, Shin J, Suh S, Ryang D. Impaired Activity of Mitochondrial Respiratory Chain Enzyme Complexes and Mitochondrial Genomic Aberrations in Leukemia Cells from Patients with Acute Myeloid Leukemia. Blood. 108: 1918-1918. DOI: 10.1182/blood.V108.11.1918.1918 |
0.102 |
|
| 2001 |
Choi CW, Kim BS, Seo JH, Shin SW, Kim YH, Kim JS, Sohn SK, Kim JS, Shin DG, Ryoo HM, Lee KH, Lee JJ, Chung IJ, Kim HJ, Kwak JY, et al. Response to high-dose intravenous immune globulin as a valuable factor predicting the effect of splenectomy in chronic idiopathic thrombocytopenic purpura patients. American Journal of Hematology. 66: 197-202. PMID 11279626 DOI: 10.1002/1096-8652(200103)66:3<197::AID-AJH1044>3.0.CO;2-6 |
0.102 |
|
| 2015 |
Ahn JS, Kim HJ, Kim YK, Jung SH, Yang DH, Lee JJ, Kim NY, Choi SH, Jung CW, Jang JH, Kim HJ, Moon JH, Sohn SK, Won JH, Kim SH, et al. Transplant outcomes of the triple-negative NPM1/FLT3-ITD/CEBPA mutation subgroup are equivalent to those of the favourable ELN risk group, but significantly better than the intermediate-I risk group after allogeneic transplant in normal-karyotype AML. Annals of Hematology. PMID 26692090 DOI: 10.1007/s00277-015-2580-z |
0.102 |
|
| 2015 |
Jung SH, Ahn JS, Kim YK, Kweon SS, Min JJ, Bom HS, Kim HJ, Chae YS, Moon JH, Sohn SK, Lee SW, Byun BH, Do YR, Lee JJ, Yang DH. Prognostic significance of interim PET/CT based on visual, SUV-based, and MTV-based assessment in the treatment of peripheral T-cell lymphoma. Bmc Cancer. 15: 198. PMID 25879747 DOI: 10.1186/s12885-015-1193-1 |
0.102 |
|
| 2021 |
Lee JS, Cha YS, Yeon S, Kim TY, Lee Y, Choi JG, Cha KC, Lee KH, Kim H. Changes in Diagnosis of Poisoning in Patients in the Emergency Room Using Systematic Toxicological Analysis with the National Forensic Service. Journal of Korean Medical Science. 36: e118. PMID 33975395 DOI: 10.3346/jkms.2021.36.e118 |
0.102 |
|
| 2021 |
Han EJ, Kim SY, Han HJ, Kim HS, Kim KN, Fernando IPS, Madusanka DMD, Dias MKHM, Cheong SH, Park SR, Han YS, Lee K, Ahn G. UVB protective effects of Sargassum horneri through the regulation of Nrf2 mediated antioxidant mechanism. Scientific Reports. 11: 9963. PMID 33976251 DOI: 10.1038/s41598-021-88949-3 |
0.102 |
|
| 2013 |
Kim HJ, Ahn HK, Jung CW, Moon JH, Park CH, Lee KO, Kim SH, Kim YK, Kim HJ, Sohn SK, Kim SH, Lee WS, Kim KH, Mun YC, Kim H, ... ... Kim HJ, et al. KIT D816 mutation associates with adverse outcomes in core binding factor acute myeloid leukemia, especially in the subgroup with RUNX1/RUNX1T1 rearrangement. Annals of Hematology. 92: 163-71. PMID 23053179 DOI: 10.1007/s00277-012-1580-5 |
0.102 |
|
| 2020 |
Eom BW, Lee J, Lee IS, Son YG, Ryu KW, Kim SG, Kim HI, Kim YW, Kong SH, Kwon OK, Park JH, An JY, Kim CH, Suh BJ, Yoon HM, et al. Development and Validation of a Symptom-Focused Quality of Life Questionnaire (KOQUSS-40) for Gastric Cancer Patients after Gastrectomy. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 33421981 DOI: 10.4143/crt.2020.1270 |
0.102 |
|
| 2010 |
Moon JH, Sohn SK, Lee SJ, Lee YJ, Do YR, Kim HJ, Kim YK, Joo YD, Jung CW, Kim DH, Hyun MS, Kim MK, Chung J, Park S, Kim I, ... ... Kim H, et al. Trough Plasma Imatinib Levels and ABCG2 Polymorphisms Are Correlated with Optimal Cytogenetic Responses at 6 Months After Treatment with Standard Dose of Imatinib In Newly Diagnosed CML Blood. 116: 2272-2272. DOI: 10.1182/blood.V116.21.2272.2272 |
0.102 |
|
| 2011 |
Choi HJ, Kim HR, Shin MG, Kook H, Kim HJ, Shin JH, Suh SP, Ryang DW. Spectra of chromosomal aberrations in 325 leukemia patients and implications for the development of new molecular detection systems. Journal of Korean Medical Science. 26: 886-92. PMID 21738341 DOI: 10.3346/jkms.2011.26.7.886 |
0.102 |
|
| 2009 |
Ha Kim K, Kim DHD, Jang JH, Kim K, Jung CW, Won J, Moon JH, Sohn SK, Kim Y, Yang D, Lee J, Kim H, Kim JS, Min YH, Kim D, et al. Multicenter Retrospective Analysis of Second Allogeneic HSCT Outcomes for Hematologic Malignancies in Korea. Blood. 114: 4298-4298. DOI: 10.1182/blood.v114.22.4298.4298 |
0.102 |
|
| 2012 |
Kim IY, Lee JM, Kim TW, Kim HN, Kim HI, Choi W, Hwang SJ. A strong electronic coupling between graphene nanosheets and layered titanate nanoplates: a soft-chemical route to highly porous nanocomposites with improved photocatalytic activity. Small (Weinheim An Der Bergstrasse, Germany). 8: 1038-48. PMID 22323425 DOI: 10.1002/Smll.201101703 |
0.101 |
|
| 2008 |
Lee JJ, Choi BH, Kang HK, Kim SK, Nam JH, Yang DH, Kim YK, Kim HJ, Chung IJ. Monocyte-derived dendritic cells from HLA-matched allogeneic donors showed a greater ability to induce leukemic cell-specific T cells in comparison to leukemic cell-derived dendritic cells or monocyte-derived dendritic cells from AML patients. Leukemia Research. 32: 1653-60. PMID 18501426 DOI: 10.1016/j.leukres.2008.03.038 |
0.101 |
|
| 2020 |
Kim T, Moon JH, Ahn JS, Ahn SY, Jung SH, Yang DH, Lee JJ, Shin MG, Choi SH, Lee JY, Tyndel MS, Lee HY, Kim KH, Cai Y, Lee YJ, ... ... Kim HJ, et al. RNA sequencing as an alternative tool for detecting measurable residual disease in core-binding factor acute myeloid leukemia. Scientific Reports. 10: 20119. PMID 33208771 DOI: 10.1038/s41598-020-76933-2 |
0.101 |
|
| 2007 |
Yang DH, Lee JJ, Mun YC, Shin HJ, Kim YK, Cho SH, Chung IJ, Seong CM, Kim HJ. Predictable prognostic factor of CD56 expression in patients with acute myeloid leukemia with t(8:21) after high dose cytarabine or allogeneic hematopoietic stem cell transplantation. American Journal of Hematology. 82: 1-5. PMID 16986129 DOI: 10.1002/ajh.20739 |
0.101 |
|
| 2015 |
Jung SH, Yang DH, Ahn JS, Kim YK, Kim HJ, Lee JJ. Serum lactate dehydrogenase with a systemic inflammation score is useful for predicting response and survival in patients with newly diagnosed diffuse large B-cell lymphoma. Acta Haematologica. 133: 10-7. PMID 24969101 DOI: 10.1159/000360068 |
0.101 |
|
| 2011 |
Lee Y, Kim M, Hong CY, Lim M, Nguyen-Pham T, Jin C, Lee HJ, Yang D, Jung S, Ahn J, Bae S, Kim Y, Chung I, Hwang TJ, Kim H, et al. Dendritic Cells Loaded with Treating Myeloma Cells with Combination of JSI-124 and Bortezomib Can Generate Potent Myeloma-Specific CTLs Through Recovering Dysfunction of Dendritic Cells in Myeloma Patients Blood. 118: 4926-4926. DOI: 10.1182/blood.v118.21.4926.4926 |
0.101 |
|
| 2017 |
Park JC, Lee YK, Kim SY, Roh Y, Hahn KY, Shin SK, Lee SK, Lee YC, Kim HI, Cheong JH, Hyung WJ, Noh SH. Long-term outcomes of endoscopic submucosal dissection in comparison to surgery in undifferentiated-type intramucosal gastric cancer using propensity score analysis. Surgical Endoscopy. PMID 29052072 DOI: 10.1007/s00464-017-5901-6 |
0.101 |
|
| 2023 |
Chung JH, Hwang J, Park SH, Kim KY, Cho M, Kim YM, Shin HJ, Lee SH, Hwang SH, Hyung WJ, Kim HI. Identifying the best candidates for reduced port gastrectomy. Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. PMID 37872358 DOI: 10.1007/s10120-023-01438-6 |
0.101 |
|
| 2021 |
Nguyen VD, Min HK, Kim HY, Han J, Choi YH, Kim CS, Park JO, Choi E. Primary Macrophage-Based Microrobots: An Effective Tumor Therapy by Dual-Targeting Function and Near-Infrared-Triggered Drug Release. Acs Nano. PMID 33973786 DOI: 10.1021/acsnano.1c00114 |
0.101 |
|
| 2008 |
Min Y, Kim HJ, Lee KH, Yoon S, Lee JH, Park H, Kim JS, Kim HY, Shim H, Seong C, Kim CS, Chung J, Hyun MS, Jo D, Jung CW, et al. A Multi-Center, Open Label Study Evaluating the Efficacy of Iron Chelation Therapy with Deferasirox in Transfusional Iron Overload Patients with Myelodysplastic Syndromes or Aplastic Anemia Using Quantitative R2 MRI Blood. 112: 3649-3649. DOI: 10.1182/blood.v112.11.3649.3649 |
0.101 |
|
| 2019 |
Kim DG, An JY, Kim H, Shin SJ, Choi S, Seo WJ, Roh CK, Cho M, Son T, Kim HI, Cheong JH, Hyung WJ, Noh SH, Choi YY. Clinical Implications of Microsatellite Instability in Early Gastric Cancer. Journal of Gastric Cancer. 19: 427-437. PMID 31897345 DOI: 10.5230/Jgc.2019.19.E38 |
0.101 |
|
| 2020 |
Choi JH, Han SU, Yang HK, Kim YW, Ryu KW, Park JM, An JY, Kim MC, Park S, Song KY, Oh SJ, Kong SH, Suh BJ, Yang DH, Ha TK, ... Kim HI, et al. The pattern of postoperative quality of life following minimally invasive gastrectomy for gastric cancer: a prospective cohort from Korean multicenter robotic gastrectomy trial. Annals of Surgical Treatment and Research. 99: 275-284. PMID 33163457 DOI: 10.4174/astr.2020.99.5.275 |
0.101 |
|
| 2007 |
Tran HTT, Kim HN, Ahn J, Lee I, Yang D, Kim Y, Lee J, Park K, Kim H. No Reversal of Demethylation after Azacitidine Treatment in Concordance with Poor Clinical Response. Blood. 110: 4629-4629. DOI: 10.1182/blood.V110.11.4629.4629 |
0.101 |
|
| 2021 |
Yoo KH, Kim HJ, Min YH, Hong DS, Lee WS, Kim HJ, Shin HJ, Park Y, Lee JH, Kim H. Age and remission induction therapy for acute myeloid leukemia: An analysis of data from the Korean acute myeloid leukemia registry. Plos One. 16: e0251011. PMID 33961640 DOI: 10.1371/journal.pone.0251011 |
0.1 |
|
| 2018 |
Vo MC, Jung SH, Chu TH, Lee HJ, Lakshmi TJ, Park HS, Kim HJ, Rhee JH, Lee JJ. Lenalidomide and Programmed Death-1 Blockade Synergistically Enhances the Effects of Dendritic Cell Vaccination in a Model of Murine Myeloma. Frontiers in Immunology. 9: 1370. PMID 29967612 DOI: 10.3389/fimmu.2018.01370 |
0.1 |
|
| 2021 |
Thangaraj JL, Ahn SY, Jung SH, Vo MC, Chu TH, Thi Phan MT, Kwon M, Lee KH, Kim M, Song GY, Yang DH, Ahn JS, Kim HJ, Cho D, Lee JJ. Expanded natural killer cells augment the antimyeloma effect of daratumumab, bortezomib, and dexamethasone in a mouse model. Cellular & Molecular Immunology. PMID 33980993 DOI: 10.1038/s41423-021-00686-9 |
0.1 |
|
| 2018 |
Kim H, Kim S, Kim HJ, Kim YK, Kwak JY, Yhim HY, Kim SH, Do YR, Oh S, Lee SE, Jootar S, Cui JW, Kim DW. Comparison of Frequency and Sensitivity of BCR-ABL1 Kinase Domain Mutations in Asian and White Patients With Imatinib-resistant Chronic-Phase Chronic Myeloid Leukemia. Clinical Lymphoma, Myeloma & Leukemia. PMID 30082224 DOI: 10.1016/j.clml.2018.06.031 |
0.1 |
|
| 2015 |
Lee S, Kim YN, Son T, Kim HI, Cheong JH, Hyung WJ, Noh SH. Oncologic Safety of Laparoscopic Wedge Resection with Gastrotomy for Gastric Gastrointestinal Stromal Tumor: Comparison with Conventional Laparoscopic Wedge Resection. Journal of Gastric Cancer. 15: 231-7. PMID 26819802 DOI: 10.5230/jgc.2015.15.4.231 |
0.1 |
|
| 2008 |
Kim HN, Yu L, Kim Ny, Lee I, Kim Y, Yang D, Lee J, Kim H, Min W, Park M, Jo D, Won J, Kwak J, Kim HJ. Polymorphisms in Myeloid Cell Leukemia-1 and the Risk for Acute Myeloid Leukemia Blood. 112: 3977-3977. DOI: 10.1182/blood.v112.11.3977.3977 |
0.1 |
|
| 2005 |
Kang H, Park J, Choi B, Nguyen T, Zhu X, Cho D, Nam J, Kim Y, Kim HJ, Lee J. Down-Regulation of Cellular Vascular Endothelial Growth Factor (VEGF) Levels Induces Differentiation of Leukemic Cells into Leukemic-Dendritic Cells in Patients with Acute Myeloid Leukemia. Blood. 106: 2226-2226. DOI: 10.1182/blood.v106.11.2226.2226 |
0.1 |
|
| 2015 |
Kwak J, Kim H, Kim JA, Do YR, Kim HJ, Park JS, Chung JS, Shin H, Kim S, Kim D, Bunworasate U, Choi CW, Comia NSC, Zang DY, Oh S, et al. Efficacy and Safety of Radotinib Compared with Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients: 12 Months Result of Phase 3 Clinical Trial Blood. 126: 476-476. DOI: 10.1182/blood.V126.23.476.476 |
0.1 |
|
| 2010 |
Kim DH(, Huh J, Han B, Lee HY, Yi JH, Jang JH, Kim K, Kim HJ, Kim Y, Sohn SK, Moon JH, Kim SH, Jung CW. Genome-Wide Single-Nucleotide Polymorphism-Array Based Karyotyping Detects Clonal Aberrations Including Uniparental Disomy (UPD), Gain or Loss Which Were Unfavorable Prognostic Factor In Acute Myeloid Leukemia with Normal Karyotype. Blood. 116: 1669-1669. DOI: 10.1182/blood.v116.21.1669.1669 |
0.1 |
|
| 2015 |
Kim TS, Zhang Z, Tyndel M, Ahn J, Kim Y, Choi SH, Kim H, Lee M, Choi M, Lipton JH, Kim DDH. Whole Exome Sequencing Reveals the Landscape of Clonal Evolution from MDS to AML Progression Blood. 126: 2596-2596. DOI: 10.1182/Blood.V126.23.2596.2596 |
0.1 |
|
| 2005 |
Calmels B, Ferguson C, Laukkanen MO, Adler R, Faulhaber M, Kim HJ, Sellers S, Hematti P, Schmidt M, von Kalle C, Akagi K, Donahue RE, Dunbar CE. Recurrent retroviral vector integration at the Mds1/Evi1 locus in nonhuman primate hematopoietic cells. Blood. 106: 2530-3. PMID 15933056 DOI: 10.1182/Blood-2005-03-1115 |
0.099 |
|
| 2011 |
Han DK, Yu L, Tran HTT, Kim HN, Lee IK, Baek HJ, Bae SH, Kim HJ, Kook H, Hwang TJ. Copy Number Alterations of PAX5, CDKN2A/B Genes Rather Than IKZF1 gene Are Associated with Pathogenesis of Childhood ALL in Korean Assessed by Multiplex Ligation-Dependent Probe Amplification Blood. 118: 4231-4231. DOI: 10.1182/blood.v118.21.4231.4231 |
0.099 |
|
| 2005 |
Nam H, Kim Y, Lee I, Yang D, Park K, Lee J, Kim H. Methylenetetrahydrofolate Reductase and Methionine Synthase Polymorphism and Risk of Non-Hodgkin’s Lymphoma. Blood. 106: 4691-4691. DOI: 10.1182/blood.v106.11.4691.4691 |
0.099 |
|
| 2018 |
Lee J, Vo M, Jung S, Chu T, Lee H, Lakshmi TJ, Kim H. Enhancement of Antitumor Immunity Using Dendritic Cells Combined with Lenalidomide and Programmed Death Ligand-1 Blockade in Multiple Myeloma Mouse Model Blood. 132: 3194-3194. DOI: 10.1182/blood-2018-99-112359 |
0.099 |
|
| 2007 |
Kim Y, Kim H, Lee I, Bang S, Jo D, Won J, Kwak J, Yim C, Yang D, Lee J, Kim H. Prognostic Significance of ABCB1 (MDR1) Gene Polymorphisms in De Novo Acute Myeloid Leukemia with t(8;21) or inv(16). Blood. 110: 4271-4271. DOI: 10.1182/blood.v110.11.4271.4271 |
0.099 |
|
| 2022 |
Kim M, Li S, Kong DS, Song YE, Park SY, Kim HI, Jae J, Chung I, Kim JR. Polydopamine/polypyrrole-modified graphite felt enhances biocompatibility for electroactive bacteria and power density of microbial fuel cell. Chemosphere. 137388. PMID 36455658 DOI: 10.1016/j.chemosphere.2022.137388 |
0.099 |
|
| 2012 |
Kim H, Choi H, Kim Y, Sohn SK, Moon JH, Kim T, Zhang Z, Kim DDH. Genome-Wide Genotype-Based Risk Model for Survival in Acute Myeloid Leukemia Patients with Normal Karyotype. Blood. 120: 2526-2526. DOI: 10.1182/BLOOD.V120.21.2526.2526 |
0.099 |
|
| 2012 |
Huh J, Jung CW, Kim HJ, Kim YK, Moon JH, Sohn SK, Kim HJ, Min WS, Kim DH. Different characteristics identified by single nucleotide polymorphism array analysis in leukemia suggest the need for different application strategies depending on disease category. Genes, Chromosomes & Cancer. 52: 44-55. PMID 23023762 DOI: 10.1002/gcc.22005 |
0.099 |
|
| 2010 |
Ahn JS, Kim YK, Lee SR, Yu L, Yang DH, Cho SH, Shim HJ, Bae WK, Lee JJ, Chung IJ, Shin MG, Kim HJ. Coexisting with clonal evolution and BCR-ABL mutant in CML patients treated with second-generation tyrosine kinase inhibitors predict the discrepancy of in vitro drug sensitivity. Cancer Research and Treatment : Official Journal of Korean Cancer Association. 42: 37-41. PMID 20369050 DOI: 10.4143/crt.2010.42.1.37 |
0.099 |
|
| 2022 |
Hwang SH, Park DJ, Kim HH, Hyung WJ, Hur H, Yang HK, Lee HJ, Kim HI, Kong SH, Kim YW, Lee HH, Kim BS, Park YK, Lee YJ, Ahn SH, et al. Short-Term Outcomes of Laparoscopic Proximal Gastrectomy With Double-Tract Reconstruction Versus Laparoscopic Total Gastrectomy for Upper Early Gastric Cancer: A KLASS 05 Randomized Clinical Trial. Journal of Gastric Cancer. 22: 94-106. PMID 35534447 DOI: 10.5230/jgc.2022.22.e8 |
0.099 |
|
| 2008 |
Lim SU, Lee SR, Seo SR, Ahn JS, Kim YK, Yang DH, Lee JJ, Kim HJ. All-trans Retinoic Acid-induced Nephrotic-range Proteinuria in a Patient with Acute Promyelocytic Leukemia The Korean Journal of Hematology. 43: 166. DOI: 10.5045/KJH.2008.43.3.166 |
0.098 |
|
| 2014 |
Ahn J, Kim H, Kim Y, Lee I, Kim NY, Minden MD, Jung CW, Jang J, Kim H, Moon JH, Sohn SK, Won J, Kim S, Kim N, Yoshida K, et al. An Adverse Prognostic Effect of Homozygous TET2 Mutational Status on the Relapse Risk of Acute Myeloid Leukemia Patients of Normal Karyotype Blood. 124: 1052-1052. DOI: 10.1182/blood.v124.21.1052.1052 |
0.098 |
|
| 2008 |
Hwang JE, Cho SH, Kim OK, Shim HJ, Lee SR, Ahn JS, Yang DH, Kim YK, Lee JJ, Kim HJ, Chung IJ. Newly developed multiple myeloma in a patient with primary T-cell lymphoma of bone. Journal of Korean Medical Science. 23: 544-7. PMID 18583898 DOI: 10.3346/jkms.2008.23.3.544 |
0.098 |
|
| 2016 |
Shin H, Chung J, Min W, Min YH, Cheong J, Lee J, Kim I, Hong DS, Ahn J, Kim H, Lee W, Jung CW, Jang JH, Park Y, Kim H. Allogeneic Stem Cell Transplantation Outcomes in Acute Myeloid Leukemia Patients with t(8;21)(q22;q22) in First Remission According to Conditioning Regimen Biology of Blood and Marrow Transplantation. 22: S209-S210. DOI: 10.1016/J.BBMT.2015.11.605 |
0.098 |
|
| 2015 |
Okumura N, Son T, Kim YM, Kim HI, An JY, Noh SH, Hyung WJ. Robotic gastrectomy for elderly gastric cancer patients: comparisons with robotic gastrectomy in younger patients and laparoscopic gastrectomy in the elderly. Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. PMID 26541766 DOI: 10.1007/s10120-015-0560-6 |
0.098 |
|
| 2011 |
Nguyen-Pham TN, Im CM, Nguyen TA, Lim MS, Hong CY, Kim MH, Lee HJ, Lee YK, Cho D, Ahn JS, Yang DH, Kim YK, Chung IJ, Kim HJ, Lee JJ. Induction of myeloma-specific cytotoxic T lymphocytes responses by natural killer cells stimulated-dendritic cells in patients with multiple myeloma. Leukemia Research. 35: 1241-7. PMID 21612823 DOI: 10.1016/j.leukres.2011.03.032 |
0.098 |
|
| 2011 |
Moon JH, Sohn SK, Kim SN, Park SY, Yoon SS, Kim IH, Kim HJ, Kim YK, Min YH, Cheong JW, Kim JS, Jung CW, Kim DH. Patient counseling program to improve the compliance to imatinib in chronic myeloid leukemia patients. Medical Oncology (Northwood, London, England). 29: 1179-85. PMID 21472487 DOI: 10.1007/s12032-011-9926-8 |
0.098 |
|
| 2000 |
Lee JJ, Chung IJ, Park MR, Yang DH, Cho SH, Ryang DW, Kim HJ. Acquired hemophilia successfully treated with oral immunosuppressive therapy Korean Journal of Internal Medicine. 15: 135-137. PMID 10992727 DOI: 10.3904/KJIM.2000.15.2.135 |
0.098 |
|
| 2019 |
Vo MC, Lakshmi TJ, Jung SH, Cho D, Park HS, Chu TH, Lee HJ, Kim HJ, Kim SK, Lee JJ. Cellular immunotherapy in multiple myeloma. The Korean Journal of Internal Medicine. PMID 30754964 DOI: 10.3904/kjim.2018.325 |
0.098 |
|
| 2007 |
Ahn JS, Cho SH, Kim OK, Lee JK, Yang DH, Kim YK, Lee JJ, Lim SC, Kim HJ, Chung WK, Chung IJ. The efficacy of an induction chemotherapy combination with docetaxel, cisplatin, and 5-FU followed by concurrent chemoradiotherapy in advanced head and neck cancer. Cancer Research and Treatment : Official Journal of Korean Cancer Association. 39: 93-8. PMID 19746222 DOI: 10.4143/crt.2007.39.3.93 |
0.098 |
|
| 2011 |
Kim DH, Lee ST, Won HH, Kim S, Kim MJ, Kim HJ, Kim SH, Kim JW, Kim HJ, Kim YK, Sohn SK, Moon JH, Jung CW, Lipton JH. A genome-wide association study identifies novel loci associated with susceptibility to chronic myeloid leukemia. Blood. 117: 6906-11. PMID 21540461 DOI: 10.1182/blood-2011-01-329797 |
0.097 |
|
| 2021 |
Lee S, Son WJ, Roh YH, Song JH, Park SH, Cho M, Kim YM, Hyung WJ, Kim HI. Indication of Proximal Gastrectomy for Advanced Proximal Gastric Cancer Based on Lymph Node Metastasis at the Distal Part of the Stomach. Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches. 2: e107. PMID 37637877 DOI: 10.1097/AS9.0000000000000107 |
0.097 |
|
| 2011 |
Nguyen-Pham T, Tran HTT, Jung S, Ahn J, Yang D, Hwang TJ, Kim H, Lee J. Potent Immunomodulatory Drug Lenalidomide Synergistically Enhance the Effect of Dendritic Cell Vaccination on Multiple Myeloma in Mouse Model, Blood. 118: 3237-3237. DOI: 10.1182/blood.v118.21.3237.3237 |
0.097 |
|
| 2007 |
Shin M, Kim H, Kim H, Kim M, Kim H, Kim Y, Kim S, Shin J, Suh S, Ryang D. Allelic Expression Imbalance of JAK2 V617F Mutant Contributes to Phenotypic Variation in BCR-ABL Negative Chronic Myeloproliferative Disorders. Blood. 110: 4651-4651. DOI: 10.1182/blood.v110.11.4651.4651 |
0.097 |
|
| 2015 |
Park JS, Lee SE, Jeong SH, Jang EJ, Choi MY, Kim HJ, Kim YK, Kim SH, Zang DY, Oh S, Koo DH, Kim H, Do YR, Kwak JY, Kim JA, et al. Change of health-related profiles after Imatinib cessation in chronic phase chronic myeloid leukemia patients. Leukemia & Lymphoma. 1-7. PMID 25947037 DOI: 10.3109/10428194.2015.1049166 |
0.097 |
|
| 2018 |
Jung S, Jung S, Ahn S, Lee J, Kim H, Lee JH, Shin MG, Yoo SW, Yang D. Diagnostic Accuracy of Immunoglobulin Heavy Chain Rearrangement, FDG-PET/CT and Unilateral Bone Marrow Trephination for Detecting Bone Marrow Involvement in Diffuse Large B Cell Lymphoma Blood. 132: 4236-4236. DOI: 10.1182/BLOOD-2018-99-116398 |
0.097 |
|
| 2017 |
Obama K, Kim YM, Kang DR, Son T, Kim HI, Noh SH, Hyung WJ. Long-term oncologic outcomes of robotic gastrectomy for gastric cancer compared with laparoscopic gastrectomy. Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. PMID 28639136 DOI: 10.1007/s10120-017-0740-7 |
0.096 |
|
| 2002 |
Kim SH, Kang SN, Kim HJ, Kim TS. Potentiation of 1,25-dihydroxyvitamin D(3)-induced differentiation of human promyelocytic leukemia cells into monocytes by costunolide, a germacranolide sesquiterpene lactone. Biochemical Pharmacology. 64: 1233-42. PMID 12234604 DOI: 10.1016/S0006-2952(02)01292-3 |
0.096 |
|
| 2010 |
Kim HJ, Jin XM, Kim HN, Lee IK, Park KS, Park MR, Jo DY, Won JH, Kwak JY, Kim HJ, Choi JS, Juhng SW, Choi C. Fas and FasL polymorphisms are not associated with acute myeloid leukemia risk in Koreans. Dna and Cell Biology. 29: 619-24. PMID 20438363 DOI: 10.1089/dna.2010.1032 |
0.096 |
|
| 2010 |
Yang D, Min J, Song H, Jeong YY, Bae S, Ahn J, Kim Y, Bom H, Chung I, Kim HJ, Lee J. Clinical Usefulness and Prognostic Value of Interim PET/CT for the Treatment of Peripheral T Cell Lymphomas. Blood. 116: 2808-2808. DOI: 10.1182/blood.v116.21.2808.2808 |
0.096 |
|
| 2017 |
Kim T, Tyndel MS, Zhang Z, Ahn J, Choi S, Szardenings M, Lipton JH, Kim HJ, Kim Dong Hwan D. Exome sequencing reveals DNMT3A and ASXL1 variants associate with progression of chronic myeloid leukemia after tyrosine kinase inhibitor therapy. Leukemia Research. 59: 142-148. PMID 28667884 DOI: 10.1016/J.Leukres.2017.06.009 |
0.096 |
|
| 2011 |
Min Y, Yoon S, Kim HJ, Lee K, Lee JH, Won JH, Cho JY, Shim H, Kim HY, Seung C, Kim CS, Lee MH, Chung J, Hyun MS, Jo D, et al. Hematologic Improvement with Iron Chelation using therapy Deferasirox in Patients with Aplastic Anemia: A Subgroup Analysis of KAMS0112 Prospective Study, Blood. 118: 3424-3424. DOI: 10.1182/blood.v118.21.3424.3424 |
0.096 |
|
| 2017 |
Kwak JY, Kim SH, Oh SJ, Zang DY, Kim H, Kim JA, Do YR, Kim HJ, Park JS, Choi CW, Lee WS, Mun YC, Kong JH, Chung JS, Shin HJ, et al. Phase III clinical trial (RERISE study) results of Efficacy and safety of radotinib compared with imatinib in newly diagnosed chronic phase chronic myeloid leukemia. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28939746 DOI: 10.1158/1078-0432.CCR-17-0957 |
0.096 |
|
| 2007 |
Kim HN, Kim Y, Lee I, Yang D, Shin MG, Kook H, Hwang TJ, Park MR, Jo DY, Won JH, Kim H. Functional Polymorphisms of Notch 4 and the Risk of Aplastic Anemia. Blood. 110: 1732-1732. DOI: 10.1182/blood.v110.11.1732.1732 |
0.096 |
|
| 2017 |
Lee S, Kim JK, Kim YN, Jang DS, Kim YM, Son T, Hyung WJ, Kim HI. Safety and feasibility of reduced-port robotic distal gastrectomy for gastric cancer: a phase I/II clinical trial. Surgical Endoscopy. PMID 28205030 DOI: 10.1007/s00464-017-5435-y |
0.096 |
|
| 2022 |
Kim DJ, Hyung WJ, Park YK, Lee HJ, An JY, Kim HI, Kim HH, Ryu SW, Hur H, Kim MC, Kong SH, Kim JJ, Park DJ, Ryu KW, Kim YW, et al. Accuracy of preoperative clinical staging for locally advanced gastric cancer in KLASS-02 randomized clinical trial. Frontiers in Surgery. 9: 1001245. PMID 36211302 DOI: 10.3389/fsurg.2022.1001245 |
0.095 |
|
| 2011 |
Jin XM, Kim HN, Shin MH, Lee IK, Lee JS, Lee JH, Kim HJ, Choi JS, Juhng SW, Choi C. H2AFX polymorphisms are associated with decreased risk of diffuse large B cell lymphoma in Koreans. Dna and Cell Biology. 30: 1039-44. PMID 21631283 DOI: 10.1089/dna.2010.1130 |
0.095 |
|
| 2010 |
Lee I, Kim NY, Kim HN, Kim Y, Lee J, Yang D, Hwang TJ, Kim HJ. Genome-Wide Detection of Copy Number Variation and Identification of Genes Associated with Risk of Multiple Myeloma Blood. 116: 4047-4047. DOI: 10.1182/blood.V116.21.4047.4047 |
0.095 |
|
| 2014 |
Son T, Hyung WJ, Kim JW, Kim HI, An JY, Cheong JH, Choi SH, Noh SH. Anatomic extent of metastatic lymph nodes: still important for gastric cancer prognosis. Annals of Surgical Oncology. 21: 899-907. PMID 24276641 DOI: 10.1245/s10434-013-3403-x |
0.095 |
|
| 2013 |
Ahn JS, Rew SY, Yang DH, Jung SH, Kang SJ, Kim MY, Lee SS, Kim YK, Kim HJ, Lee JJ. Poor prognostic significance of Mycobacterium tuberculosis infection during bortezomib-containing chemotherapy in patients with multiple myeloma. Blood Research. 48: 35-9. PMID 23589793 DOI: 10.5045/br.2013.48.1.35 |
0.095 |
|
| 2005 |
Kim Y, Lee J, Park M, Bae S, Kim HJ, Kim SJ, Yang D, Kim BS, Kim H, Choi CW. The Feasibility of High-Dose Dexamethasone (HD-DEX) in Idiopathic Thrombocytopenic Purpura (ITP) in Adults; a Multi-Center Study in Korea. Blood. 106: 4009-4009. DOI: 10.1182/blood.v106.11.4009.4009 |
0.095 |
|
| 2019 |
Ahn SY, Jung SY, Jung SH, Ahn JS, Lee JJ, Kim HJ, Kang SR, Han YH, Kwak JY, Yhim HY, Yang DH. Prognostic significance of FDG-PET/CT in determining upfront autologous stem cell transplantation for the treatment of peripheral T cell lymphomas. Annals of Hematology. PMID 31807859 DOI: 10.1007/s00277-019-03867-9 |
0.095 |
|
| 2016 |
Park CH, Kim EH, Chung H, Park JC, Shin SK, Lee YC, An JY, Kim HI, Cheong JH, Hyung WJ, Noh SH, Kim CB, Lee SK. Periodic Endoscopies Might Not Increase the Detection of Early Gastric Cancer in a Young Population. Plos One. 11: e0159759. PMID 27448311 DOI: 10.1371/journal.pone.0159759 |
0.094 |
|
| 2018 |
Cho M, Son T, Kim HI, Noh SH, Choi S, Seo WJ, Roh CK, Hyung WJ. Similar hematologic and nutritional outcomes after proximal gastrectomy with double-tract reconstruction in comparison to total gastrectomy for early upper gastric cancer. Surgical Endoscopy. PMID 30203207 DOI: 10.1007/s00464-018-6448-x |
0.094 |
|
| 2009 |
Shin M, Kim HR, Kim H, Kook H, Hwang TJ, Shin J, Suh S, Ryang D. Profound Length Heteroplasmic Alterations in Mitochondrial DNA Control Region From Primary AML Cells: Implication of Impaired Mitochondrial Replication and Demonstration of ‘vicious cycle’ Hypothesis. Blood. 114: 3116-3116. DOI: 10.1182/blood.v114.22.3116.3116 |
0.094 |
|
| 2008 |
Ahn JS, Yang DH, Kim YK, Cho SH, Kim IY, Lee JJ, Chung IJ, Kim HJ. Multiple intracranial tuberculomas mimicking granulocytic sarcomas in acute myeloid leukemia. Journal of Korean Medical Science. S171-3. PMID 17923749 DOI: 10.3346/jkms.2007.22.S.S171 |
0.094 |
|
| 2017 |
Kim YW, Bae JM, Park YK, Yang HK, Yu W, Yook JH, Noh SH, Han M, Ryu KW, Sohn TS, Lee HJ, Kwon OK, Ryu SY, Lee JH, Kim S, ... ... Kim HI, et al. Effect of Intravenous Ferric Carboxymaltose on Hemoglobin Response Among Patients With Acute Isovolemic Anemia Following Gastrectomy: The FAIRY Randomized Clinical Trial. Jama. 317: 2097-2104. PMID 28535237 DOI: 10.1001/jama.2017.5703 |
0.093 |
|
| 1996 |
Kim YC, Park KO, Choi IS, Kim HJ, Lim SC, Bom HS. A comparison of serum CYFRA 21-1 and SCC Ag in the diagnosis of squamous cell lung carcinoma. The Korean Journal of Internal Medicine. 11: 50-7. PMID 8882476 DOI: 10.3904/kjim.1996.11.1.50 |
0.093 |
|
| 2011 |
Kim Y, Bae S, Yu L, Kim N, Lee SR, Ahn J, Yang D, Lee I, Lee J, Kim H. Renal Adverse Effect of Anagrelide in Patients with Myeloproliferative Neoplasms Blood. 118: 5151-5151. DOI: 10.1182/blood.V118.21.5151.5151 |
0.093 |
|
| 2021 |
Jung J, Park JY, Kim YC, Lee H, Kim E, Kim YS, Lee JP, Kim H. Effects of air pollution on mortality of patients with chronic kidney disease: A large observational cohort study. The Science of the Total Environment. 786: 147471. PMID 33971609 DOI: 10.1016/j.scitotenv.2021.147471 |
0.093 |
|
| 2011 |
Min Y, Yoon S, Hwang DY, Kim Y, Kim Y, Kim Y, Cho JY, Kim JS, Kim SJ, Cheong J, Kim HJ. Circulating Exosomal MicroRNA-21 As a Potential Biomarker That May Predict Response to Azacitidine Treatment in Myelodysplastic Syndromes, Blood. 118: 3804-3804. DOI: 10.1182/BLOOD.V118.21.3804.3804 |
0.093 |
|
| 2004 |
Lee J, Choi B, Park M, Yang D, Kim Y, Kim H. Monocyte-Derived Dendritic Cells from HLA-Matched Allogeneic Donors Showed Superiority To Induce Leukemic Cell-Specific T Cells in Comparison to Leukemic Cell-Derived Dendritic Cells or Monocyte-Derived Dendritic Cells from AML Patients. Blood. 104: 1798-1798. DOI: 10.1182/blood.V104.11.1798.1798 |
0.093 |
|
| 2008 |
Chae YS, Sohn SK, Kim JG, Cho YY, Moon JH, Yang DH, Lee JJ, Kim YK, Kim HJ, Shin HJ, Chung JS, Cho GJ. Impact of alemtuzumab as conditioning regimen component on transplantation outcomes in case of CMV-seropositive recipients and donors. American Journal of Hematology. 83: 649-53. PMID 18528826 DOI: 10.1002/ajh.21215 |
0.092 |
|
| 2010 |
Kim DH, Kong JH, Byeun JY, Jung CW, Xu W, Liu X, Kamel-Reid S, Kim YK, Kim HJ, Lipton JH. The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 5339-50. PMID 20959405 DOI: 10.1158/1078-0432.Ccr-10-1638 |
0.092 |
|
| 2022 |
Cho M, Kim KY, Park SH, Kim YM, Kim HI, Hyung WJ. Securing Resection Margin Using Indocyanine Green Diffusion Range on Gastric Wall during NIR Fluorescence-Guided Surgery in Early Gastric Cancer Patients. Cancers. 14. PMID 36358639 DOI: 10.3390/cancers14215223 |
0.092 |
|
| 2007 |
Lee JJ, Kim DH, Lee NY, Sohn SK, Kim JG, Kim HJ, Do YR, Park YH. Interleukin-10 gene polymorphism influences the prognosis of T-cell non-Hodgkin lymphomas. British Journal of Haematology. 137: 329-36. PMID 17408400 DOI: 10.1111/j.1365-2141.2007.06570.x |
0.092 |
|
| 2018 |
Vo MC, Yang S, Jung SH, Chu TH, Lee HJ, Lakshmi TJ, Park HS, Kim HJ, Lee JJ. Synergistic Antimyeloma Activity of Dendritic Cells and Pomalidomide in a Murine Myeloma Model. Frontiers in Immunology. 9: 1798. PMID 30123221 DOI: 10.3389/fimmu.2018.01798 |
0.092 |
|
| 2021 |
Kim HJ, Hwang H, Hong H, Yim JJ, Lee J. A systematic review and meta-analysis of regional risk factors for critical outcomes of COVID-19 during early phase of the pandemic. Scientific Reports. 11: 9784. PMID 33963250 DOI: 10.1038/s41598-021-89182-8 |
0.092 |
|
| 2021 |
Kang ES, Kim H, Han Y, Cho YW, Son H, Luo Z, Kim TH. Enhancing osteogenesis of adipose-derived mesenchymal stem cells using gold nanostructure/peptide-nanopatterned graphene oxide. Colloids and Surfaces. B, Biointerfaces. 204: 111807. PMID 33964530 DOI: 10.1016/j.colsurfb.2021.111807 |
0.092 |
|
| 2017 |
Guner A, Cho M, Son T, Kim HI, Noh SH, Hyung WJ. Improved glycemic control with proximal intestinal bypass and weight loss following gastrectomy in non-obese diabetic gastric cancer patients. Oncotarget. 8: 104605-104614. PMID 29262665 DOI: 10.18632/oncotarget.22262 |
0.092 |
|
| 2012 |
Nguyen-Pham T, Jung S, Vo M, Lee HJ, Hoang M, Choi N, Kim H, Lee J. Lenalidomide Synergistically Enhances the Effect of Dendritic Cell Vaccination in Mouse Multiple Myeloma Model Blood. 120: 5010-5010. DOI: 10.1182/blood.v120.21.5010.5010 |
0.092 |
|
| 2007 |
Cheong J, Kim I, Yoon S, Lee DS, Jung CW, Ahn JS, Kim K, Kim SH, Seo E, Park C, Chi H, Kim S, Kwon H, Kim H, Kim HJ, et al. Clinical Features and Prognosis of MDS Patients with Chromosome 5 Abnormalities Other Than ‘5q-Syndrome’: Results of Multi-Center Analysis in Korea. Blood. 110: 4618-4618. DOI: 10.1182/blood.v110.11.4618.4618 |
0.091 |
|
| 2012 |
Nguyen-Pham TN, Lee YK, Kim HJ, Lee JJ. Immunotherapy using dendritic cells against multiple myeloma: how to improve? Clinical & Developmental Immunology. 2012: 397648. PMID 22481968 DOI: 10.1155/2012/397648 |
0.091 |
|
| 2021 |
Mukhiya T, Muthurasu A, Tiwari AP, Chhetri K, Chae SH, Kim H, Dahal B, Lee BM, Kim HY. Integrating the Essence of a Metal-Organic Framework with Electrospinning: A New Approach for Making a Metal Nanoparticle Confined N-Doped Carbon Nanotubes/Porous Carbon Nanofibrous Membrane for Energy Storage and Conversion. Acs Applied Materials & Interfaces. PMID 33977710 DOI: 10.1021/acsami.1c04104 |
0.091 |
|
| 2004 |
Lee JJ, Kim YK, Cho SH, Park KS, Chung IJ, Cho D, Ryang DW, Kim HJ. Hemolytic Anemia as a Sequela of Arsenic Intoxication Following Long-Term Ingestion of Traditional Chinese Medicine Journal of Korean Medical Science. 19: 127-129. PMID 14966354 DOI: 10.3346/jkms.2004.19.1.127 |
0.091 |
|
| 2010 |
Han B, Huh J, Yi JH, Lee HY, Kim J, Kim H, Kim Y, Kim HJ, Moon JH, Sohn SK, Jung CW, Kim DH(. Genome-Wide Single-Nucleotide Polymorphism-Array Based Karyotyping Detects Clonal Aberrations, and Predicts the Risk of Imatinib Failure In Chronic Myeloid Leukemia. Blood. 116: 3387-3387. DOI: 10.1182/blood.v116.21.3387.3387 |
0.091 |
|
| 2015 |
Cho JS, Kim HI, Lee KY, An JY, Bai SJ, Cho JY, Yoo YC. Effect of Intraoperative Dexmedetomidine Infusion on Postoperative Bowel Movements in Patients Undergoing Laparoscopic Gastrectomy: A Prospective, Randomized, Placebo-Controlled Study. Medicine. 94: e959. PMID 26091461 DOI: 10.1097/MD.0000000000000959 |
0.091 |
|
| 2013 |
Choi H, Jung C, Sohn SK, Kim S, Kim HJ, Kim YK, Kim T, Zhang Z, Shin ES, Lee JE, Moon JH, Kim SH, Kim KH, Mun YC, Kim H, et al. Genome-wide genotype-based risk model for survival in acute myeloid leukaemia patients with normal karyotype. British Journal of Haematology. 163: 62-71. PMID 24159609 DOI: 10.1182/Blood.V120.21.2526.2526 |
0.091 |
|
| 2017 |
Son T, Kwon IG, Lee JH, Choi YY, Kim HI, Cheong JH, Noh SH, Hyung WJ. Impact of splenic hilar lymph node metastasis on prognosis in patients with advanced gastric cancer. Oncotarget. 8: 84515-84528. PMID 29137444 DOI: 10.18632/oncotarget.18762 |
0.091 |
|
| 2021 |
Choi S, Son T, Song JH, Lee S, Cho M, Kim YM, Kim HI, Hyung WJ. Intracorporeal Esophagojejunostomy during Reduced-port Totally Robotic Gastrectomy for Proximal Gastric Cancer: a Novel Application of the Single-Site Plus 2-port System. Journal of Gastric Cancer. 21: 132-141. PMID 34234975 DOI: 10.5230/jgc.2021.21.e16 |
0.091 |
|
| 2004 |
Lee JJ, Nam CE, Nam JH, Lee HC, Chung IJ, Park MS, Choi BH, Song WH, Lee IK, Park KS, Kook H, Hwang TJ, Takei M, Takaue Y, Kim HJ. Generation of cytotoxic donor CD8+ T cells against relapsing leukemic cells following allogeneic transplantation by stimulation with leukemic cell- or leukemic lysate pulsed donor cell-derived dendritic cells. Leukemia Research. 28: 517-24. PMID 15068905 DOI: 10.1016/j.leukres.2003.08.018 |
0.09 |
|
| 2003 |
Lee JJ, Takei M, Hori S, Inoue Y, Harada Y, Tanosaki R, Kanda Y, Kami M, Makimoto A, Mineishi S, Kawai H, Shimosaka A, Heike Y, Ikarashi Y, Wakasugi H, ... ... Kim HJ, et al. The role of PGE(2) in the differentiation of dendritic cells: how do dendritic cells influence T-cell polarization and chemokine receptor expression? Stem Cells (Dayton, Ohio). 20: 448-59. PMID 12351815 DOI: 10.1634/stemcells.20-5-448 |
0.09 |
|
| 2016 |
Park S, Hangseok C, Kim H, Ahn J, Kim HJ, Kim S, Mun Y, Jung CW, Kim DH. Genome-Wide Genotype-Based Risk Model for Survival in Core Binding Factor Acute Myeloid Leukemia Patients Blood. 128: 1623-1623. DOI: 10.1182/blood.v128.22.1623.1623 |
0.09 |
|
| 2021 |
Park JE, Eun D, Kim HS, Lee DH, Jang RW, Kim N. Generative adversarial network for glioblastoma ensures morphologic variations and improves diagnostic model for isocitrate dehydrogenase mutant type. Scientific Reports. 11: 9912. PMID 33972663 DOI: 10.1038/s41598-021-89477-w |
0.09 |
|
| 2014 |
Jung SH, Yang DH, Ahn JS, Kim YK, Kim HJ, Lee JJ. Advanced lytic lesion is a poor mobilization factor in peripheral blood stem cell collection in patients with multiple myeloma. Journal of Clinical Apheresis. 29: 305-10. PMID 24764270 DOI: 10.1002/jca.21326 |
0.09 |
|
| 2005 |
Lee I, Yun JH, Kim NY, Choi J, Kim Y, Kim HN, Park K, Lee J, Shin MG, Choi C, Kook H, Hwang TJ, Park MR, Jo DY, Won JH, ... Kim H, et al. Denaturing- HPLC and HR-1 Melter-Based Detection of ABL Mutations in Patients with Chronic Myelogenous Leukemia (CML). Blood. 106: 4876-4876. DOI: 10.1182/blood.v106.11.4876.4876 |
0.089 |
|
| 2005 |
Kang H, Park M, Lee S, Rhee J, Park J, Nguyen T, Zhu X, Cho D, Nam J, Kim Y, Kim HJ, Lee J. Vibrio parahaemolyticus Flagellin Stimulates the Maturation of Human Monocyte-Derived Dendritic Cells and Elicits Th1-Type Immune Response. Blood. 106: 3872-3872. DOI: 10.1182/BLOOD.V106.11.3872.3872 |
0.089 |
|
| 2010 |
Kim HN, Yu L, Kim NY, Lee IK, Kim YK, Yang DH, Lee JJ, Shin MH, Park KS, Choi JS, Kim HJ. Association with TP53 codon 72 polymorphism and the risk of non-Hodgkin lymphoma. American Journal of Hematology. 85: 822-4. PMID 20734458 DOI: 10.1002/ajh.21834 |
0.089 |
|
| 2015 |
Nguyen-Pham TN, Jung SH, Vo MC, Thanh-Tran HT, Lee YK, Lee HJ, Choi NR, Hoang MD, Kim HJ, Lee JJ. Lenalidomide Synergistically Enhances the Effect of Dendritic Cell Vaccination in a Model of Murine Multiple Myeloma. Journal of Immunotherapy (Hagerstown, Md. : 1997). 38: 330-339. PMID 26325377 DOI: 10.1097/CJI.0000000000000097 |
0.089 |
|
| 2006 |
Lee I, Yun JH, Kim Y, Kim HN, Park K, Shin MG, Choi C, Kim HJ. High-Sensitivity Mutational Analysis of BCR-ABL Mutations in the Kinase Domain Using Pyrosequencing Could Provides Alternative Methodology for Monitoring the Proportion of Mutant Alleles in Patient with Chronic Myelogenous Leukemia. Blood. 108: 4801-4801. DOI: 10.1182/blood.v108.11.4801.4801 |
0.089 |
|
| 2009 |
Shim HJ, Lee SR, Ahn JS, Yang DH, Kim YK, Cho SH, Lee JJ, Kim HJ, Chung IJ. Metastatic breast cancer presenting as cancer of unknown primary associated with superior vena cava syndrome. The Breast Journal. 15: 202-3. PMID 19292809 DOI: 10.1111/j.1524-4741.2009.00698.x |
0.089 |
|
| 2013 |
Jung S, Ahn J, Yang D, Kim Y, Kim H, Lee J. Effect Of Advanced Lytic Bone Lesions On Peripheral Stem Cell Mobilization In Patients With Multiple Myeloma Blood. 122: 3276-3276. DOI: 10.1182/blood.v122.21.3276.3276 |
0.089 |
|
| 2023 |
Jeong O, Lee HH, Hur H, Kim HI. Splenic hilar lymph node dissection enhances survival in Bormann type 4 gastric cancer. Scientific Reports. 13: 15390. PMID 37717100 DOI: 10.1038/s41598-023-42707-9 |
0.088 |
|
| 2018 |
Seo WJ, Son T, Roh CK, Cho M, Kim HI, Hyung WJ. Reduced-port totally robotic distal subtotal gastrectomy with lymph node dissection for gastric cancer: a modified technique using Single-Site and two additional ports. Surgical Endoscopy. PMID 29777355 DOI: 10.1007/s00464-018-6208-y |
0.088 |
|
| 2021 |
Kim J, Ryu S, Kim HY. Innate Lymphoid Cells in Tissue Homeostasis and Disease Pathogenesis. Molecules and Cells. PMID 33972473 DOI: 10.14348/molcells.2021.0053 |
0.088 |
|
| 2006 |
Kim HN, Choi J, Yun J, Kim Y, Lee I, Yang D, Shin M, Kook H, Hwang TJ, Park M, Jo D, Won JH, Kim H. Notch 4 Plymorphism Associated with Risk of Aplastic Anemia. Blood. 108: 988-988. DOI: 10.1182/blood.v108.11.988.988 |
0.088 |
|
| 2016 |
Choi YY, An JY, Katai H, Seto Y, Fukagawa T, Okumura Y, Kim DW, Kim HI, Cheong JH, Hyung WJ, Noh SH. A Lymph Node Staging System for Gastric Cancer: A Hybrid Type Based on Topographic and Numeric Systems. Plos One. 11: e0149555. PMID 26967161 DOI: 10.1371/journal.pone.0149555 |
0.088 |
|
| 2012 |
Huh J, Jung CW, Kim H, Kim Y, Moon JH, Sohn SK, Kim H, Min W, Kim DDH. Different Characteristics Identified by Single Nucleotide Polymorphism Array Analsysis in Leukemia Suggest the Need for Different Application Strategics Depending On Disease Category. Blood. 120: 2490-2490. DOI: 10.1182/blood.v120.21.2490.2490 |
0.088 |
|
| 2016 |
Lee S, Ahn J, Kim T, Kim HJ, Kim Y, Ahn S, Jung S, Yang D, Lee J, ParK HJ, Choi SH, Jung CW, Jang J, Kim H, Moon JH, et al. RUNX1 Mutation in Cytogenetically Normal Acute Myeloid Leukemia : Clinical Implications, Co-Mutation Analysis Blood. 128: 5253-5253. DOI: 10.1182/Blood.V128.22.5253.5253 |
0.087 |
|
| 2012 |
Lee I, Kim N, Kim Y, Kim DDH, Trinh Q, Minden MD, Jung CW, Jang J, Kim H, Moon JH, Sohn SK, Won J, Kim S, Huh J, Kim NY, ... ... Kim H, et al. Whole Exome Sequencing Analysis in AML with Normal Karyotype Not Harboring FLT3/ITD Mutation Reveals Novel Genetic Alterations. Blood. 120: 2593-2593. DOI: 10.1182/blood.v120.21.2593.2593 |
0.087 |
|
| 2018 |
Park S, Choi H, Kim HJ, Ahn JS, Kim HJ, Kim SH, Mun YC, Jung CW, Kim DDH. Genome-wide genotype-based risk model for survival in core binding factor acute myeloid leukemia patients. Annals of Hematology. PMID 29500710 DOI: 10.1007/s00277-018-3260-6 |
0.087 |
|
| 2002 |
Lee JJ, Chung IJ, Yang DH, Cho SH, Cho D, Ryang DW, Kim HJ. Clinical significance of CD56 expression in patients with acute myeloid leukemia [4] Leukemia and Lymphoma. 43: 1897-1899. PMID 12685854 DOI: 10.1080/1042819021000009283 |
0.087 |
|
| 2016 |
Hong CY, Lee HJ, Choi NR, Jung SH, Vo MC, Hoang MD, Kim HJ, Lee JJ. Sarcoplasmic reticulum Ca(2+) ATPase 2 (SERCA2) reduces the migratory capacity of CCL21-treated monocyte-derived dendritic cells. Experimental & Molecular Medicine. 48: e253. PMID 27538371 DOI: 10.1038/emm.2016.69 |
0.087 |
|
| 2014 |
Shim CN, Kim HI, Hyung WJ, Noh SH, Song MK, Kang DR, Park JC, Lee H, Shin SK, Lee YC, Lee SK. Self-expanding metal stents or nonstent endoscopic therapy: which is better for anastomotic leaks after total gastrectomy? Surgical Endoscopy. 28: 833-40. PMID 24114516 DOI: 10.1007/s00464-013-3228-5 |
0.087 |
|
| 2008 |
Kim HR, Shin MG, Kim MJ, Kim HJ, Shin JH, Suh SP, Ryang DW. Mitochondrial DNA aberrations of bone marrow cells from patients with aplastic anemia. Journal of Korean Medical Science. 23: 1062-7. PMID 19119453 DOI: 10.3346/jkms.2008.23.6.1062 |
0.087 |
|
| 2015 |
Sung HJ, Lee SR, Choi IK, Park Y, Choi CW, Kim HJ, Yhim HY, Kim BS. Imatinib Mesylate Dose Adjustment Based on Body Surface Area for CML Chronic Phase Patients Intolerant to Standard Dosage. Acta Haematologica. 134: 59-68. PMID 25871321 DOI: 10.1159/000369444 |
0.087 |
|
| 2009 |
Kang M, Oh J, Kim H, Kim H, Lee I, Choi H, Kim O, Ko Y, Lim W, Park H, Yu M, Chung K, Kim S, Lim H. Prevalence of Oral Microbes in the Saliva of Oncological Patients Journal of Bacteriology and Virology. 39: 277. DOI: 10.4167/JBV.2009.39.4.277 |
0.087 |
|
| 2010 |
Lee I, Kim NY, Kim HN, Han DK, Baek H, Hwang TJ, Kook H, Kim HJ. Genome-Wide Screening of Copy Number Variation In Childhood Neuroblastoma Blood. 116: 4454-4454. DOI: 10.1182/blood.v116.21.4454.4454 |
0.087 |
|
| 2019 |
Kim JH, Kim J, Lee WJ, Seong H, Choi H, Ahn JY, Jeong SJ, Ku NS, Son T, Kim HI, Han SH, Choi JY, Yeom JS, Hyung WJ, Song YG, et al. A High Visceral-To-Subcutaneous Fat Ratio is an Independent Predictor of Surgical Site Infection after Gastrectomy. Journal of Clinical Medicine. 8. PMID 30979055 DOI: 10.3390/jcm8040494 |
0.086 |
|
| 2021 |
Kim H, Choi B, Lee C, McAdam SAM, Paik JH, Jang TS. Micromorphological differentiation of Korean Disporum species using light and scanning electron microscopy. Microscopy Research and Technique. PMID 33969936 DOI: 10.1002/jemt.23812 |
0.086 |
|
| 2017 |
Jung SH, Ahn SY, Choi HW, Shin MG, Lee SS, Yang DH, Ahn JS, Kim YK, Kim HJ, Lee JJ. STAT3 expression is associated with poor survival in non-elderly adult patients with newly diagnosed multiple myeloma. Blood Research. 52: 293-299. PMID 29333406 DOI: 10.5045/br.2017.52.4.293 |
0.086 |
|
| 2010 |
Yang DH, Kim YK, Sohn SK, Chung JS, Joo YD, Lee JH, Lee JL, Ahn JS, Moon JH, Shin HJ, Choi YJ, Lee WS, Kim HJ, Lee JJ. Induction treatment with cyclophosphamide, thalidomide, and dexamethasone in newly diagnosed multiple myeloma: a phase II study. Clinical Lymphoma, Myeloma & Leukemia. 10: 62-7. PMID 20223731 DOI: 10.3816/CLML.2010.n.007 |
0.086 |
|
| 2021 |
Choi S, Song JH, Lee S, Cho M, Kim YM, Hyung WJ, Kim HI. Surgical Merits of Open, Laparoscopic, and Robotic Gastrectomy Techniques with D2 Lymphadenectomy in Obese Patients with Gastric Cancer. Annals of Surgical Oncology. PMID 33834323 DOI: 10.1245/s10434-021-09952-6 |
0.086 |
|
| 2021 |
Muthike AK, Carlotti B, Madu IK, Jiang H, Kim H, Wu Q, Yu L, Zimmerman PM, Goodson T. The Role of the Core Attachment Positioning in Triggering Intramolecular Singlet Exciton Fission in Perylene Diimide Tetramers. The Journal of Physical Chemistry. B. PMID 33961426 DOI: 10.1021/acs.jpcb.1c02534 |
0.086 |
|
| 1998 |
Kim HJ, Chung IJ, Lee JJ, Seo JS, Park MR, Choi KS, Kook H, Hwang TJ. A case of chronic graft-versus-host-disease following allogeneic peripheral blood stem cell rescue for poor graft function after bone marrow transplantation. The Korean Journal of Internal Medicine. 13: 60-3. PMID 9538634 DOI: 10.3904/kjim.1998.13.1.60 |
0.086 |
|
| 2019 |
Park SH, Son T, Seo WJ, Lee JH, Choi YY, Kim HI, Cheong JH, Noh SH, Hyung WJ. Prognostic Impact of Extended Lymph Node Dissection versus Limited Lymph Node Dissection on pN0 Proximal Advanced Gastric Cancer: a Propensity Score Matching Analysis. Journal of Gastric Cancer. 19: 212-224. PMID 31245166 DOI: 10.5230/jgc.2019.19.e20 |
0.086 |
|
| 2013 |
Lee JH, Hyung WJ, Kim HI, Kim YM, Son T, Okumura N, Hu Y, Kim CB, Noh SH. Method of reconstruction governs iron metabolism after gastrectomy for patients with gastric cancer. Annals of Surgery. 258: 964-9. PMID 23324857 DOI: 10.1097/SLA.0b013e31827eebc1 |
0.085 |
|
| 2020 |
Kim HI, Kim SY, Yu JE, Shin SJ, Roh YH, Cheong JH, Hyung WJ, Noh SH, Park CG, Lee HJ. Contrasting Prognostic Effects of Tumor-Infiltrating Lymphocyte Density in Cardia and Non-cardia Gastric Adenocarcinomas. Journal of Gastric Cancer. 20: 190-201. PMID 32596002 DOI: 10.5230/jgc.2020.20.e21 |
0.085 |
|
| 2015 |
Rothman N, Bassig BA, Cerhan JR, Au W, Kim HN, Sangrajrang S, Hu W, Tse J, Berndt S, Zheng T, Zhang H, Pornsopone P, Lee J, Kim H, Skibola CF, et al. Abstract 4626: Genetic susceptibility to diffuse large B-cell lymphoma in a pooled study of three Eastern Asian populations Cancer Research. 75: 4626-4626. DOI: 10.1158/1538-7445.Am2015-4626 |
0.085 |
|
| 2008 |
Lee JH, Min YH, Chung CW, Kim BK, Yoon HJ, Jo DY, Shin HJ, Bang SM, Won JH, Zang DY, Kim HJ, Chi HS, Lee KH, Cheong JW, Kim JS, et al. Prognostic implications of the immunophenotype in biphenotypic acute leukemia. Leukemia & Lymphoma. 49: 700-9. PMID 18398737 DOI: 10.1080/10428190701843247 |
0.085 |
|
| 2017 |
Sohn SK, Moon JH, Lee IH, Ahn JS, Kim HJ, Chung JS, Shin HJ, Park SW, Lee WS, Lee SM, Kim H, Lee HS, Kim YS, Cho YY, Bae SH, et al. No benefit of hypomethylating agents compared to supportive care for higher risk myelodysplastic syndrome. The Korean Journal of Internal Medicine. PMID 29232940 DOI: 10.3904/kjim.2016.426 |
0.085 |
|
| 2004 |
Hori S, Heike Y, Takei M, Maruyama M, Inoue Y, Lee JJ, Kim HJ, Harada Y, Kawai H, Shimosaka A, Kami M, Tanosaki MD, Wakasugi H, Saito S, Takaue Y, et al. Freeze-thawing procedures have no influence on the phenotypic and functional development of dendritic cells generated from peripheral blood CD14+ monocytes. Journal of Immunotherapy (Hagerstown, Md. : 1997). 27: 27-35. PMID 14676631 DOI: 10.1097/00002371-200401000-00003 |
0.085 |
|
| 2006 |
Choi BH, Kang HK, Park JS, Kim SK, Pham TN, Zhu XW, Cho D, Nam JH, Chung IJ, Kim YJ, Rhee JH, Kim HJ, Lee JJ. Optimization of the concentration of autologous serum for generation of leukemic dendritic cells from acute myeloid leukemic cells for clinical immunotherapy. Journal of Clinical Apheresis. 21: 233-40. PMID 17120232 DOI: 10.1002/jca.20105 |
0.085 |
|
| 2021 |
Kim H, Park SH, Park JH, Lee KJ. Nonsurgical maxillary expansion in a 60-year-old patient with gingival recession and crowding. Korean Journal of Orthodontics. 51: 217-227. PMID 33984228 DOI: 10.4041/kjod.2021.51.3.217 |
0.084 |
|
| 2007 |
Kim HN, Lee IK, Kim YK, Tran HT, Yang DH, Lee JJ, Shin MH, Park KS, Shin MG, Choi JS, Kim HJ. Association between folate-metabolizing pathway polymorphism and non-Hodgkin lymphoma. British Journal of Haematology. 140: 287-94. PMID 18042267 DOI: 10.1111/J.1365-2141.2007.06893.X |
0.084 |
|
| 2014 |
Cheong JW, Kim HJ, Lee KH, Yoon SS, Lee JH, Park HS, Kim HY, Shim H, Seong CM, Kim CS, Chung J, Hyun MS, Jo DY, Jung CW, Sohn SK, et al. Deferasirox improves hematologic and hepatic function with effective reduction of serum ferritin and liver iron concentration in transfusional iron overload patients with myelodysplastic syndrome or aplastic anemia. Transfusion. 54: 1542-51. PMID 24313463 DOI: 10.1111/trf.12507 |
0.084 |
|
| 2007 |
Nguyen Pham TN, Choi BH, Kang HK, Jin CC, Minh NH, Kim SK, Nam JH, Yang DH, Kim YK, Kim HJ, Chung IJ, Lee JJ. Optimization and limitation of calcium ionophore to generate DCs from acute myeloid leukemic cells. Cancer Research and Treatment : Official Journal of Korean Cancer Association. 39: 175-80. PMID 19746185 DOI: 10.4143/crt.2007.39.4.175 |
0.084 |
|
| 2020 |
Chu TH, Vo MC, Park HS, Lakshmi TJ, Jung SH, Kim HJ, Lee JJ. Potent anti-myeloma efficacy of dendritic cell therapy in combination with pomalidomide and programmed death-ligand 1 blockade in a preclinical model of multiple myeloma. Cancer Immunology, Immunotherapy : Cii. PMID 32623477 DOI: 10.1007/s00262-020-02654-0 |
0.084 |
|
| 2005 |
Shin M, Kim H, Kim H, Lee I, Cho D, Kee S, Kook H, Hwang T, Shin J, Suh S, Ryang D. Mitochondrial Genome Instability in AML Is Associated with Reduction in the Mitochondrial Replication. Blood. 106: 2754-2754. DOI: 10.1182/blood.V106.11.2754.2754 |
0.083 |
|
| 2023 |
Lee CM, Park S, Park SH, Kim KY, Cho M, Kim YM, Hyung WJ, Kim HI. Short-term outcomes and cost-effectiveness of laparoscopic gastrectomy with articulating instruments for gastric cancer compared with the robotic approach. Scientific Reports. 13: 9355. PMID 37291374 DOI: 10.1038/s41598-023-36601-7 |
0.083 |
|
| 2009 |
Lee HR, Hong DS, Zang DY, Lee HG, Yoon H, Kim H, Kim I, Ahn J, Lee J, Cheong J, Lee K, Bang S, Park SY, Yun YM, Min Y, et al. Incidence and Biologic Features of 5q Deletion and 5q- Syndrome in Myelodysplastic Syndrome in Korea; According to Reclassification of Myelodysplastic Syndrome by WHO 2008. Blood. 114: 2778-2778. DOI: 10.1182/Blood.V114.22.2778.2778 |
0.083 |
|
| 2008 |
Yang DH, Min JJ, Jeong YY, Ahn JS, Kim YK, Cho SH, Chung IJ, Bom HS, Kim HJ, Lee JJ. The combined evaluation of interim contrast-enhanced computerized tomography (CT) and FDG-PET/CT predicts the clinical outcomes and may impact on the therapeutic plans in patients with aggressive non-Hodgkin's lymphoma. Annals of Hematology. 88: 425-32. PMID 19002686 DOI: 10.1007/s00277-008-0616-3 |
0.083 |
|
| 2018 |
Cho I, Son Y, Song S, Bae YJ, Kim YN, Kim HI, Lee DT, Hyung WJ. Feasibility and Effects of a Postoperative Recovery Exercise Program Developed Specifically for Gastric Cancer Patients (PREP-GC) Undergoing Minimally Invasive Gastrectomy. Journal of Gastric Cancer. 18: 118-133. PMID 29984062 DOI: 10.5230/jgc.2018.18.e12 |
0.083 |
|
| 2008 |
Bang SM, Ahn JY, Park J, Park SH, Park J, Cho EK, Shin DB, Lee JH, Yoo SJ, Jeon IS, Kim YK, Kim HJ, Kim HN, Lee IK, Kang HJ, et al. Low frequency and variability of FLT3 mutations in Korean patients with acute myeloid leukemia. Journal of Korean Medical Science. 23: 833-7. PMID 18955790 DOI: 10.3346/jkms.2008.23.5.833 |
0.083 |
|
| 2021 |
Ahn SY, Park HK, Moon JH, Baek DW, Cho HJ, Sohn SK, Kang SR, Min JJ, Bom HS, Hong CM, Jeong SY, Song GY, Yang DH, Ahn JS, Kim HJ, et al. Prognostic impact of F-FDG PET/CT in patients with multiple myeloma presenting with renal impairment. International Journal of Hematology. PMID 33475961 DOI: 10.1007/s12185-021-03079-w |
0.083 |
|
| 2021 |
Basivi PK, Ramesh S, Kakani V, Yadav HM, Bathula C, Afsar N, Sivasamy A, Kim HS, Pasupuleti VR, Lee H. Ultrasonication-mediated nitrogen-doped multiwalled carbon nanotubes involving carboxy methylcellulose composite for solid-state supercapacitor applications. Scientific Reports. 11: 9918. PMID 33972653 DOI: 10.1038/s41598-021-89430-x |
0.083 |
|
| 2009 |
Jin CJ, Hong CY, Takei M, Chung SY, Park JS, Pham TN, Choi SJ, Nam JH, Chung IJ, Kim HJ, Lee JJ. All-trans retinoic acid inhibits the differentiation, maturation, and function of human monocyte-derived dendritic cells. Leukemia Research. 34: 513-20. PMID 19883939 DOI: 10.1016/j.leukres.2009.10.006 |
0.082 |
|
| Hide low-probability matches. |